date generated: 2022-10-13
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## 0610009B22Rik 0.5780015
## 0610009E02Rik 0.4394343
## 0610009L18Rik 1.4508124
## 0610010K14Rik 2.1194691
## 0610012G03Rik 2.6585547
## 0610030E20Rik -1.5015909
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 1604 |
num_genes_in_profile | 17352 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8397 |
num_profile_genes_not_in_sets | 8955 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Gene sets metrics | |
---|---|
num_genesets | 1604 |
num_genesets_excluded | 424 |
num_genesets_included | 1180 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
EUKARYOTIC TRANSLATION ELONGATION | 87 | 4.06e-44 | 0.862 | 1.60e-41 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 95 | 1.55e-37 | 0.759 | 1.83e-35 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 1.13e-41 | 0.759 | 2.66e-39 |
MITOCHONDRIAL TRANSLATION | 93 | 3.00e-36 | 0.753 | 2.95e-34 |
EUKARYOTIC TRANSLATION INITIATION | 114 | 1.77e-43 | 0.748 | 5.22e-41 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 4.11e-08 | 0.747 | 7.82e-07 |
ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 4.94e-05 | -0.741 | 4.38e-04 |
COMPLEX I BIOGENESIS | 56 | 6.16e-21 | 0.725 | 3.64e-19 |
SELENOAMINO ACID METABOLISM | 108 | 2.53e-38 | 0.720 | 3.32e-36 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 2.25e-34 | 0.700 | 2.04e-32 |
CRISTAE FORMATION | 31 | 2.45e-11 | 0.692 | 8.28e-10 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 1.74e-40 | 0.689 | 2.93e-38 |
NONSENSE MEDIATED DECAY NMD | 109 | 6.67e-34 | 0.672 | 5.62e-32 |
ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 2.94e-05 | -0.669 | 2.84e-04 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 1.24e-18 | 0.663 | 6.67e-17 |
MITOCHONDRIAL PROTEIN IMPORT | 63 | 5.96e-19 | 0.647 | 3.35e-17 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 6.83e-05 | 0.638 | 5.80e-04 |
TRANSLATION | 286 | 2.00e-73 | 0.621 | 2.36e-70 |
PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 3.08e-06 | -0.618 | 4.08e-05 |
RNA POLYMERASE III CHAIN ELONGATION | 18 | 8.72e-06 | 0.605 | 9.99e-05 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 1.71e-40 | 0.588 | 2.93e-38 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 9.51e-14 | 0.586 | 4.31e-12 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 3.14e-05 | -0.583 | 2.99e-04 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 162 | 1.75e-37 | 0.582 | 1.88e-35 |
CELLULAR RESPONSE TO STARVATION | 146 | 1.09e-32 | 0.570 | 8.03e-31 |
METABOLISM OF POLYAMINES | 57 | 1.07e-13 | 0.569 | 4.69e-12 |
PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 1.15e-04 | -0.557 | 8.79e-04 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 8.69e-11 | 0.553 | 2.63e-09 |
COHESIN LOADING ONTO CHROMATIN | 10 | 2.69e-03 | -0.548 | 1.29e-02 |
SIGNALING BY HIPPO | 20 | 2.26e-05 | -0.547 | 2.24e-04 |
RRNA PROCESSING | 194 | 1.95e-39 | 0.546 | 2.87e-37 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 1.97e-03 | 0.539 | 9.88e-03 |
PROCESSING OF SMDT1 | 16 | 1.95e-04 | 0.538 | 1.36e-03 |
STABILIZATION OF P53 | 54 | 6.70e-11 | 0.513 | 2.08e-09 |
PINK1 PRKN MEDIATED MITOPHAGY | 22 | 3.23e-05 | 0.512 | 3.03e-04 |
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 2.21e-05 | 0.511 | 2.21e-04 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 58 | 1.96e-11 | 0.509 | 7.22e-10 |
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 8.67e-05 | -0.507 | 7.15e-04 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 66 | 1.33e-12 | 0.505 | 5.59e-11 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 2.78e-10 | 0.501 | 7.44e-09 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 6.37e-03 | -0.498 | 2.59e-02 |
DEGRADATION OF DVL | 55 | 1.84e-10 | 0.497 | 5.31e-09 |
PYROPTOSIS | 20 | 1.28e-04 | 0.495 | 9.66e-04 |
PURINE CATABOLISM | 16 | 6.45e-04 | 0.493 | 3.78e-03 |
METABOLISM OF AMINO ACIDS AND DERIVATIVES | 317 | 1.02e-50 | 0.489 | 6.01e-48 |
ANTIMICROBIAL PEPTIDES | 16 | 7.15e-04 | 0.489 | 4.10e-03 |
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 65 | 1.36e-11 | 0.485 | 5.36e-10 |
SIGNALING BY FGFR2 IIIA TM | 19 | 2.66e-04 | 0.483 | 1.76e-03 |
INFLUENZA INFECTION | 145 | 1.00e-23 | 0.483 | 6.95e-22 |
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 8.45e-03 | -0.481 | 3.20e-02 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
EUKARYOTIC TRANSLATION ELONGATION | 87 | 4.06e-44 | 0.862000 | 1.60e-41 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 95 | 1.55e-37 | 0.759000 | 1.83e-35 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 1.13e-41 | 0.759000 | 2.66e-39 |
MITOCHONDRIAL TRANSLATION | 93 | 3.00e-36 | 0.753000 | 2.95e-34 |
EUKARYOTIC TRANSLATION INITIATION | 114 | 1.77e-43 | 0.748000 | 5.22e-41 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 4.11e-08 | 0.747000 | 7.82e-07 |
ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 4.94e-05 | -0.741000 | 4.38e-04 |
COMPLEX I BIOGENESIS | 56 | 6.16e-21 | 0.725000 | 3.64e-19 |
SELENOAMINO ACID METABOLISM | 108 | 2.53e-38 | 0.720000 | 3.32e-36 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 2.25e-34 | 0.700000 | 2.04e-32 |
CRISTAE FORMATION | 31 | 2.45e-11 | 0.692000 | 8.28e-10 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 1.74e-40 | 0.689000 | 2.93e-38 |
NONSENSE MEDIATED DECAY NMD | 109 | 6.67e-34 | 0.672000 | 5.62e-32 |
ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 2.94e-05 | -0.669000 | 2.84e-04 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 1.24e-18 | 0.663000 | 6.67e-17 |
MITOCHONDRIAL PROTEIN IMPORT | 63 | 5.96e-19 | 0.647000 | 3.35e-17 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 6.83e-05 | 0.638000 | 5.80e-04 |
TRANSLATION | 286 | 2.00e-73 | 0.621000 | 2.36e-70 |
PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 3.08e-06 | -0.618000 | 4.08e-05 |
RNA POLYMERASE III CHAIN ELONGATION | 18 | 8.72e-06 | 0.605000 | 9.99e-05 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 1.71e-40 | 0.588000 | 2.93e-38 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 9.51e-14 | 0.586000 | 4.31e-12 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 3.14e-05 | -0.583000 | 2.99e-04 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 162 | 1.75e-37 | 0.582000 | 1.88e-35 |
CELLULAR RESPONSE TO STARVATION | 146 | 1.09e-32 | 0.570000 | 8.03e-31 |
METABOLISM OF POLYAMINES | 57 | 1.07e-13 | 0.569000 | 4.69e-12 |
PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 1.15e-04 | -0.557000 | 8.79e-04 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 8.69e-11 | 0.553000 | 2.63e-09 |
COHESIN LOADING ONTO CHROMATIN | 10 | 2.69e-03 | -0.548000 | 1.29e-02 |
SIGNALING BY HIPPO | 20 | 2.26e-05 | -0.547000 | 2.24e-04 |
RRNA PROCESSING | 194 | 1.95e-39 | 0.546000 | 2.87e-37 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 1.97e-03 | 0.539000 | 9.88e-03 |
PROCESSING OF SMDT1 | 16 | 1.95e-04 | 0.538000 | 1.36e-03 |
STABILIZATION OF P53 | 54 | 6.70e-11 | 0.513000 | 2.08e-09 |
PINK1 PRKN MEDIATED MITOPHAGY | 22 | 3.23e-05 | 0.512000 | 3.03e-04 |
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 2.21e-05 | 0.511000 | 2.21e-04 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 58 | 1.96e-11 | 0.509000 | 7.22e-10 |
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 8.67e-05 | -0.507000 | 7.15e-04 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 66 | 1.33e-12 | 0.505000 | 5.59e-11 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 2.78e-10 | 0.501000 | 7.44e-09 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 6.37e-03 | -0.498000 | 2.59e-02 |
DEGRADATION OF DVL | 55 | 1.84e-10 | 0.497000 | 5.31e-09 |
PYROPTOSIS | 20 | 1.28e-04 | 0.495000 | 9.66e-04 |
PURINE CATABOLISM | 16 | 6.45e-04 | 0.493000 | 3.78e-03 |
METABOLISM OF AMINO ACIDS AND DERIVATIVES | 317 | 1.02e-50 | 0.489000 | 6.01e-48 |
ANTIMICROBIAL PEPTIDES | 16 | 7.15e-04 | 0.489000 | 4.10e-03 |
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 65 | 1.36e-11 | 0.485000 | 5.36e-10 |
SIGNALING BY FGFR2 IIIA TM | 19 | 2.66e-04 | 0.483000 | 1.76e-03 |
INFLUENZA INFECTION | 145 | 1.00e-23 | 0.483000 | 6.95e-22 |
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 8.45e-03 | -0.481000 | 3.20e-02 |
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 58 | 3.08e-10 | 0.478000 | 8.07e-09 |
MITOTIC TELOPHASE CYTOKINESIS | 13 | 2.97e-03 | -0.476000 | 1.39e-02 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 2.27e-09 | 0.475000 | 5.14e-08 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 6.56e-03 | -0.473000 | 2.62e-02 |
TRANSLESION SYNTHESIS BY POLH | 19 | 3.75e-04 | 0.471000 | 2.33e-03 |
INHIBITION OF DNA RECOMBINATION AT TELOMERE | 35 | 1.57e-06 | 0.469000 | 2.24e-05 |
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 5.88e-10 | 0.466000 | 1.48e-08 |
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 70 | 2.27e-11 | 0.462000 | 8.12e-10 |
REGULATION OF TLR BY ENDOGENOUS LIGAND | 12 | 5.67e-03 | 0.461000 | 2.38e-02 |
ACTIVATION OF RAC1 | 13 | 4.00e-03 | -0.461000 | 1.79e-02 |
SIGNALING BY ACTIVIN | 12 | 5.72e-03 | -0.461000 | 2.38e-02 |
RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 1.31e-04 | 0.461000 | 9.84e-04 |
DEGRADATION OF AXIN | 53 | 7.07e-09 | 0.460000 | 1.46e-07 |
CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 11 | 8.81e-03 | -0.456000 | 3.29e-02 |
CITRIC ACID CYCLE TCA CYCLE | 22 | 2.41e-04 | 0.452000 | 1.63e-03 |
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 22 | 2.46e-04 | 0.451000 | 1.66e-03 |
G1 S DNA DAMAGE CHECKPOINTS | 64 | 4.84e-10 | 0.450000 | 1.24e-08 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 18 | 9.84e-04 | -0.449000 | 5.38e-03 |
CA DEPENDENT EVENTS | 36 | 3.43e-06 | -0.447000 | 4.49e-05 |
DEGRADATION OF GLI1 BY THE PROTEASOME | 57 | 6.42e-09 | 0.444000 | 1.35e-07 |
TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 2.93e-03 | -0.444000 | 1.38e-02 |
REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 63 | 1.17e-09 | 0.443000 | 2.82e-08 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 5.75e-03 | -0.442000 | 2.38e-02 |
SIGNALING BY BMP | 25 | 1.38e-04 | -0.440000 | 1.02e-03 |
INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 6.61e-04 | -0.440000 | 3.86e-03 |
AMINE LIGAND BINDING RECEPTORS | 29 | 4.19e-05 | -0.440000 | 3.80e-04 |
DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 32 | 1.72e-05 | 0.439000 | 1.76e-04 |
FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 1.29e-05 | 0.439000 | 1.38e-04 |
PROTEIN LOCALIZATION | 158 | 4.81e-21 | 0.434000 | 2.99e-19 |
MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 3.55e-04 | 0.430000 | 2.26e-03 |
REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 29 | 6.15e-05 | -0.430000 | 5.34e-04 |
PURINE SALVAGE | 12 | 1.02e-02 | 0.429000 | 3.68e-02 |
ORC1 REMOVAL FROM CHROMATIN | 67 | 1.42e-09 | 0.428000 | 3.35e-08 |
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 26 | 1.66e-04 | 0.427000 | 1.19e-03 |
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 21 | 7.40e-04 | 0.425000 | 4.22e-03 |
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 2.54e-06 | -0.425000 | 3.49e-05 |
SEROTONIN RECEPTORS | 10 | 2.20e-02 | -0.418000 | 6.78e-02 |
RHOV GTPASE CYCLE | 33 | 3.23e-05 | -0.418000 | 3.03e-04 |
MITOCHONDRIAL FATTY ACID BETA OXIDATION | 33 | 3.33e-05 | 0.417000 | 3.07e-04 |
MITOPHAGY | 29 | 1.01e-04 | 0.417000 | 7.96e-04 |
POLYMERASE SWITCHING | 14 | 7.03e-03 | 0.416000 | 2.77e-02 |
INTERACTION BETWEEN L1 AND ANKYRINS | 27 | 1.83e-04 | -0.416000 | 1.29e-03 |
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 1.74e-02 | -0.414000 | 5.70e-02 |
DNA REPLICATION PRE INITIATION | 81 | 1.28e-10 | 0.413000 | 3.78e-09 |
TRANSLESION SYNTHESIS BY POLK | 17 | 3.36e-03 | 0.411000 | 1.54e-02 |
REPRESSION OF WNT TARGET GENES | 14 | 7.83e-03 | -0.411000 | 3.01e-02 |
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 81 | 1.89e-10 | 0.409000 | 5.31e-09 |
RAS PROCESSING | 24 | 5.34e-04 | 0.408000 | 3.18e-03 |
ENDOSOMAL VACUOLAR PATHWAY | 11 | 1.91e-02 | 0.408000 | 6.08e-02 |
FCGR3A MEDIATED IL10 SYNTHESIS | 32 | 6.56e-05 | -0.408000 | 5.61e-04 |
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 1.93e-02 | -0.407000 | 6.11e-02 |
METHYLATION | 11 | 1.95e-02 | 0.407000 | 6.16e-02 |
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 31 | 9.14e-05 | 0.406000 | 7.39e-04 |
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 6.55e-03 | -0.405000 | 2.62e-02 |
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 14 | 8.84e-03 | 0.404000 | 3.29e-02 |
SIGNALING BY WNT IN CANCER | 31 | 1.07e-04 | -0.402000 | 8.33e-04 |
CELLULAR RESPONSE TO HYPOXIA | 72 | 4.00e-09 | 0.401000 | 8.59e-08 |
GLUTATHIONE CONJUGATION | 30 | 1.55e-04 | 0.399000 | 1.13e-03 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 5.76e-03 | -0.399000 | 2.38e-02 |
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 2.16e-10 | -0.398000 | 5.93e-09 |
PROTEIN METHYLATION | 17 | 4.55e-03 | 0.397000 | 2.00e-02 |
BASE EXCISION REPAIR AP SITE FORMATION | 29 | 2.27e-04 | 0.396000 | 1.55e-03 |
SODIUM CALCIUM EXCHANGERS | 10 | 3.06e-02 | -0.395000 | 8.67e-02 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 1.36e-03 | 0.395000 | 6.97e-03 |
ANTIGEN PROCESSING CROSS PRESENTATION | 96 | 2.42e-11 | 0.394000 | 8.28e-10 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 2.41e-02 | -0.393000 | 7.23e-02 |
RNA POLYMERASE I PROMOTER ESCAPE | 47 | 3.77e-06 | 0.390000 | 4.86e-05 |
NEUREXINS AND NEUROLIGINS | 54 | 7.32e-07 | -0.390000 | 1.08e-05 |
OTHER SEMAPHORIN INTERACTIONS | 19 | 3.39e-03 | -0.388000 | 1.55e-02 |
HEDGEHOG LIGAND BIOGENESIS | 61 | 1.65e-07 | 0.388000 | 2.91e-06 |
ADHERENS JUNCTIONS INTERACTIONS | 31 | 1.90e-04 | -0.387000 | 1.33e-03 |
NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 11 | 2.64e-02 | -0.387000 | 7.68e-02 |
RORA ACTIVATES GENE EXPRESSION | 18 | 4.51e-03 | -0.387000 | 1.99e-02 |
SIGNALING BY ROBO RECEPTORS | 207 | 1.53e-21 | 0.384000 | 1.00e-19 |
MRNA CAPPING | 29 | 3.71e-04 | 0.382000 | 2.32e-03 |
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 86 | 9.41e-10 | 0.382000 | 2.31e-08 |
REGULATION OF PTEN STABILITY AND ACTIVITY | 66 | 8.26e-08 | 0.382000 | 1.50e-06 |
DAG AND IP3 SIGNALING | 40 | 3.02e-05 | -0.381000 | 2.90e-04 |
METABOLISM OF COFACTORS | 19 | 4.10e-03 | 0.380000 | 1.83e-02 |
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 83 | 2.54e-09 | 0.378000 | 5.66e-08 |
SYNAPTIC ADHESION LIKE MOLECULES | 21 | 2.69e-03 | -0.378000 | 1.29e-02 |
ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 62 | 2.68e-07 | 0.378000 | 4.45e-06 |
PI3K EVENTS IN ERBB2 SIGNALING | 15 | 1.20e-02 | -0.375000 | 4.22e-02 |
ERBB2 ACTIVATES PTK6 SIGNALING | 11 | 3.14e-02 | -0.375000 | 8.88e-02 |
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 3.04e-03 | -0.374000 | 1.41e-02 |
FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 2.58e-06 | 0.373000 | 3.50e-05 |
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 25 | 1.28e-03 | 0.372000 | 6.68e-03 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 1.03e-03 | 0.372000 | 5.59e-03 |
CELLULAR RESPONSE TO CHEMICAL STRESS | 150 | 4.78e-15 | 0.371000 | 2.25e-13 |
DNA DAMAGE RECOGNITION IN GG NER | 38 | 7.93e-05 | 0.370000 | 6.64e-04 |
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 6.69e-03 | -0.369000 | 2.67e-02 |
RUNX2 REGULATES BONE DEVELOPMENT | 29 | 5.86e-04 | -0.369000 | 3.48e-03 |
NEPHRIN FAMILY INTERACTIONS | 21 | 3.44e-03 | -0.369000 | 1.55e-02 |
RHOF GTPASE CYCLE | 40 | 5.46e-05 | -0.369000 | 4.80e-04 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 8.58e-03 | 0.368000 | 3.23e-02 |
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 2.16e-02 | 0.368000 | 6.66e-02 |
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 6.91e-03 | -0.368000 | 2.73e-02 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 7.81e-04 | 0.367000 | 4.39e-03 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 3.54e-02 | -0.366000 | 9.52e-02 |
CRMPS IN SEMA3A SIGNALING | 16 | 1.15e-02 | -0.365000 | 4.10e-02 |
BASE EXCISION REPAIR | 57 | 1.87e-06 | 0.365000 | 2.60e-05 |
G PROTEIN MEDIATED EVENTS | 52 | 5.53e-06 | -0.364000 | 6.73e-05 |
ABC TRANSPORTER DISORDERS | 69 | 1.77e-07 | 0.364000 | 3.08e-06 |
RRNA PROCESSING IN THE MITOCHONDRION | 10 | 4.68e-02 | 0.363000 | 1.17e-01 |
RND3 GTPASE CYCLE | 38 | 1.09e-04 | -0.363000 | 8.44e-04 |
REGULATION OF RAS BY GAPS | 66 | 4.43e-07 | 0.359000 | 6.80e-06 |
APC CDC20 MEDIATED DEGRADATION OF NEK2A | 25 | 1.96e-03 | 0.358000 | 9.88e-03 |
GLUCONEOGENESIS | 27 | 1.30e-03 | 0.358000 | 6.71e-03 |
DNA REPLICATION | 122 | 9.20e-12 | 0.357000 | 3.74e-10 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 3.37e-02 | 0.354000 | 9.27e-02 |
CYTOPROTECTION BY HMOX1 | 119 | 2.59e-11 | 0.354000 | 8.49e-10 |
BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 1.53e-02 | -0.350000 | 5.13e-02 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 1.35e-03 | 0.350000 | 6.97e-03 |
RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 7.72e-04 | 0.349000 | 4.36e-03 |
HIV TRANSCRIPTION ELONGATION | 42 | 9.44e-05 | 0.348000 | 7.55e-04 |
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 1.97e-02 | 0.348000 | 6.22e-02 |
RHOU GTPASE CYCLE | 34 | 4.71e-04 | -0.347000 | 2.86e-03 |
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 69 | 6.51e-07 | 0.346000 | 9.84e-06 |
ATTENUATION PHASE | 24 | 3.33e-03 | -0.346000 | 1.53e-02 |
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 83 | 5.56e-08 | 0.345000 | 1.04e-06 |
APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 1.22e-02 | 0.341000 | 4.27e-02 |
ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 1.09e-04 | -0.341000 | 8.44e-04 |
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 78 | 1.96e-07 | 0.341000 | 3.36e-06 |
HEME SIGNALING | 45 | 8.19e-05 | -0.339000 | 6.80e-04 |
RESOLUTION OF ABASIC SITES AP SITES | 38 | 3.08e-04 | 0.338000 | 2.01e-03 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 5.06e-03 | 0.338000 | 2.20e-02 |
FCERI MEDIATED NF KB ACTIVATION | 76 | 3.68e-07 | 0.337000 | 5.80e-06 |
UCH PROTEINASES | 89 | 3.82e-08 | 0.337000 | 7.39e-07 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION | 10 | 6.49e-02 | 0.337000 | 1.49e-01 |
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 5.14e-03 | -0.337000 | 2.22e-02 |
BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 25 | 3.61e-03 | -0.336000 | 1.63e-02 |
PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 3.33e-05 | 0.336000 | 3.07e-04 |
SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 2.01e-02 | -0.336000 | 6.30e-02 |
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 1.25e-03 | -0.335000 | 6.51e-03 |
INTERLEUKIN 12 SIGNALING | 37 | 4.46e-04 | 0.334000 | 2.73e-03 |
LONG TERM POTENTIATION | 23 | 5.63e-03 | -0.334000 | 2.38e-02 |
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 15 | 2.56e-02 | -0.333000 | 7.60e-02 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 2.58e-02 | -0.333000 | 7.62e-02 |
TNFR2 NON CANONICAL NF KB PATHWAY | 78 | 4.44e-07 | 0.331000 | 6.80e-06 |
PIWI INTERACTING RNA PIRNA BIOGENESIS | 20 | 1.08e-02 | 0.329000 | 3.89e-02 |
LAGGING STRAND SYNTHESIS | 20 | 1.09e-02 | 0.329000 | 3.90e-02 |
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 21 | 9.41e-03 | 0.327000 | 3.47e-02 |
FGFR2 MUTANT RECEPTOR ACTIVATION | 28 | 2.73e-03 | 0.327000 | 1.30e-02 |
DNA METHYLATION | 20 | 1.14e-02 | 0.327000 | 4.09e-02 |
BUDDING AND MATURATION OF HIV VIRION | 27 | 3.41e-03 | 0.326000 | 1.55e-02 |
EPHRIN SIGNALING | 19 | 1.41e-02 | -0.325000 | 4.83e-02 |
REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 6.20e-02 | -0.325000 | 1.44e-01 |
NEUROTRANSMITTER CLEARANCE | 10 | 7.56e-02 | 0.324000 | 1.67e-01 |
MRNA SPLICING MINOR PATHWAY | 52 | 5.81e-05 | 0.322000 | 5.08e-04 |
ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 13 | 4.46e-02 | -0.322000 | 1.14e-01 |
NCAM SIGNALING FOR NEURITE OUT GROWTH | 61 | 1.41e-05 | -0.322000 | 1.47e-04 |
SULFUR AMINO ACID METABOLISM | 25 | 5.68e-03 | 0.320000 | 2.38e-02 |
FGFRL1 MODULATION OF FGFR1 SIGNALING | 11 | 6.70e-02 | -0.319000 | 1.52e-01 |
LYSOSPHINGOLIPID AND LPA RECEPTORS | 13 | 4.65e-02 | -0.319000 | 1.17e-01 |
HIV TRANSCRIPTION INITIATION | 45 | 2.17e-04 | 0.319000 | 1.49e-03 |
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 78 | 1.36e-06 | 0.316000 | 1.96e-05 |
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 6.95e-02 | 0.316000 | 1.56e-01 |
SIGNALING BY NOTCH4 | 83 | 6.76e-07 | 0.316000 | 1.01e-05 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 2.08e-02 | 0.315000 | 6.46e-02 |
DUAL INCISION IN TC NER | 65 | 1.15e-05 | 0.315000 | 1.25e-04 |
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 5.93e-02 | -0.314000 | 1.39e-01 |
GAB1 SIGNALOSOME | 14 | 4.20e-02 | -0.314000 | 1.10e-01 |
PLATELET SENSITIZATION BY LDL | 15 | 3.72e-02 | -0.311000 | 9.87e-02 |
RND2 GTPASE CYCLE | 39 | 8.01e-04 | -0.310000 | 4.48e-03 |
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 16 | 3.18e-02 | 0.310000 | 8.91e-02 |
DNA STRAND ELONGATION | 32 | 2.52e-03 | 0.309000 | 1.23e-02 |
TRANSCRIPTIONAL REGULATION BY MECP2 | 59 | 4.57e-05 | -0.307000 | 4.12e-04 |
FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 20 | 1.77e-02 | 0.306000 | 5.76e-02 |
HIV ELONGATION ARREST AND RECOVERY | 32 | 2.71e-03 | 0.306000 | 1.29e-02 |
DUAL INCISION IN GG NER | 41 | 6.90e-04 | 0.306000 | 3.99e-03 |
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 25 | 8.03e-03 | 0.306000 | 3.08e-02 |
ACTIVATION OF SMO | 16 | 3.44e-02 | -0.305000 | 9.40e-02 |
TFAP2 AP 2 FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS | 11 | 7.95e-02 | -0.305000 | 1.74e-01 |
NRAGE SIGNALS DEATH THROUGH JNK | 55 | 9.12e-05 | -0.305000 | 7.39e-04 |
INTERLEUKIN 2 FAMILY SIGNALING | 33 | 2.43e-03 | -0.305000 | 1.20e-02 |
NUCLEOTIDE SALVAGE | 21 | 1.56e-02 | 0.305000 | 5.19e-02 |
INTERLEUKIN 1 SIGNALING | 95 | 3.03e-07 | 0.304000 | 4.90e-06 |
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 24 | 9.94e-03 | 0.304000 | 3.65e-02 |
PEROXISOMAL LIPID METABOLISM | 26 | 7.33e-03 | 0.304000 | 2.85e-02 |
LATE ENDOSOMAL MICROAUTOPHAGY | 32 | 3.09e-03 | 0.302000 | 1.42e-02 |
BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 1.72e-02 | 0.300000 | 5.67e-02 |
RECEPTOR MEDIATED MITOPHAGY | 11 | 8.48e-02 | 0.300000 | 1.83e-01 |
ERBB2 REGULATES CELL MOTILITY | 14 | 5.23e-02 | -0.300000 | 1.28e-01 |
NCAM1 INTERACTIONS | 41 | 9.30e-04 | -0.299000 | 5.13e-03 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 1.80e-02 | -0.298000 | 5.83e-02 |
MTORC1 MEDIATED SIGNALLING | 24 | 1.17e-02 | 0.297000 | 4.15e-02 |
TELOMERE MAINTENANCE | 77 | 6.46e-06 | 0.297000 | 7.62e-05 |
METABOLISM OF FOLATE AND PTERINES | 15 | 4.64e-02 | 0.297000 | 1.17e-01 |
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 29 | 5.69e-03 | 0.297000 | 2.38e-02 |
PHASE II CONJUGATION OF COMPOUNDS | 63 | 4.68e-05 | 0.297000 | 4.19e-04 |
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 1.40e-02 | -0.296000 | 4.81e-02 |
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 1.32e-04 | -0.295000 | 9.84e-04 |
PREGNENOLONE BIOSYNTHESIS | 12 | 7.66e-02 | 0.295000 | 1.69e-01 |
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 8.93e-05 | 0.295000 | 7.32e-04 |
INSULIN RECEPTOR RECYCLING | 20 | 2.26e-02 | 0.295000 | 6.88e-02 |
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 1.11e-03 | -0.294000 | 5.93e-03 |
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 20 | 2.28e-02 | 0.294000 | 6.93e-02 |
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 1.53e-02 | -0.292000 | 5.14e-02 |
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 5.70e-03 | 0.292000 | 2.38e-02 |
JOSEPHIN DOMAIN DUBS | 11 | 9.45e-02 | 0.291000 | 1.98e-01 |
NUCLEOTIDE EXCISION REPAIR | 110 | 1.50e-07 | 0.290000 | 2.67e-06 |
METABOLISM OF STEROID HORMONES | 22 | 1.91e-02 | 0.289000 | 6.08e-02 |
RAC1 GTPASE CYCLE | 178 | 3.30e-11 | -0.288000 | 1.05e-09 |
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 30 | 6.41e-03 | 0.288000 | 2.59e-02 |
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 84 | 5.30e-06 | 0.287000 | 6.51e-05 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 9.91e-02 | -0.287000 | 2.05e-01 |
MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 21 | 2.30e-02 | -0.287000 | 6.98e-02 |
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 84 | 5.88e-06 | 0.286000 | 7.08e-05 |
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 1.25e-03 | -0.285000 | 6.51e-03 |
CD209 DC SIGN SIGNALING | 18 | 3.67e-02 | -0.284000 | 9.82e-02 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 3.24e-02 | 0.284000 | 9.04e-02 |
SCAVENGING OF HEME FROM PLASMA | 11 | 1.04e-01 | 0.283000 | 2.10e-01 |
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 3.77e-02 | -0.283000 | 9.97e-02 |
SIGNALING BY ERBB2 IN CANCER | 25 | 1.45e-02 | -0.283000 | 4.93e-02 |
MET ACTIVATES RAP1 AND RAC1 | 11 | 1.05e-01 | -0.282000 | 2.12e-01 |
FGFR2 ALTERNATIVE SPLICING | 25 | 1.49e-02 | 0.281000 | 5.05e-02 |
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 24 | 1.71e-02 | -0.281000 | 5.65e-02 |
SIGNALING BY FGFR1 IN DISEASE | 34 | 4.62e-03 | -0.281000 | 2.02e-02 |
GABA RECEPTOR ACTIVATION | 54 | 3.70e-04 | -0.280000 | 2.32e-03 |
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 65 | 9.60e-05 | 0.280000 | 7.60e-04 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 6.13e-02 | -0.279000 | 1.43e-01 |
INTERLEUKIN 6 SIGNALING | 10 | 1.27e-01 | -0.278000 | 2.46e-01 |
VXPX CARGO TARGETING TO CILIUM | 19 | 3.61e-02 | -0.278000 | 9.68e-02 |
PKMTS METHYLATE HISTONE LYSINES | 49 | 8.11e-04 | -0.277000 | 4.52e-03 |
METABOLISM OF RNA | 645 | 6.52e-33 | 0.276000 | 5.13e-31 |
CDC42 GTPASE CYCLE | 154 | 3.49e-09 | -0.276000 | 7.63e-08 |
SIGNALING BY PDGFR IN DISEASE | 20 | 3.30e-02 | -0.275000 | 9.11e-02 |
REGULATION OF BACH1 ACTIVITY | 11 | 1.14e-01 | 0.275000 | 2.26e-01 |
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 7.47e-02 | -0.275000 | 1.65e-01 |
NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 1.18e-02 | -0.275000 | 4.16e-02 |
CELL CELL JUNCTION ORGANIZATION | 48 | 9.92e-04 | -0.275000 | 5.39e-03 |
UNWINDING OF DNA | 12 | 1.00e-01 | 0.274000 | 2.06e-01 |
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 2.31e-02 | -0.274000 | 7.00e-02 |
SIGNALING BY FGFR4 IN DISEASE | 10 | 1.35e-01 | -0.273000 | 2.56e-01 |
IRAK4 DEFICIENCY TLR2 4 | 13 | 8.89e-02 | 0.273000 | 1.90e-01 |
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 36 | 4.73e-03 | 0.272000 | 2.06e-02 |
FGFR1 MUTANT RECEPTOR ACTIVATION | 27 | 1.45e-02 | -0.272000 | 4.93e-02 |
CLEC7A DECTIN 1 SIGNALING | 93 | 6.43e-06 | 0.271000 | 7.62e-05 |
RUNX3 REGULATES NOTCH SIGNALING | 13 | 9.22e-02 | -0.270000 | 1.95e-01 |
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 1.07e-01 | -0.269000 | 2.16e-01 |
G BETA GAMMA SIGNALLING THROUGH CDC42 | 18 | 4.94e-02 | 0.268000 | 1.21e-01 |
REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 10 | 1.43e-01 | -0.268000 | 2.68e-01 |
ACTIVATION OF MATRIX METALLOPROTEINASES | 15 | 7.35e-02 | -0.267000 | 1.63e-01 |
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 27 | 1.64e-02 | -0.267000 | 5.42e-02 |
PCP CE PATHWAY | 89 | 1.35e-05 | 0.267000 | 1.44e-04 |
TRIGLYCERIDE CATABOLISM | 14 | 8.38e-02 | 0.267000 | 1.82e-01 |
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 21 | 3.45e-02 | 0.267000 | 9.40e-02 |
STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS | 10 | 1.45e-01 | 0.266000 | 2.70e-01 |
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 9.73e-02 | -0.266000 | 2.02e-01 |
SIGNALING BY NTRK2 TRKB | 24 | 2.44e-02 | -0.265000 | 7.31e-02 |
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 1.47e-01 | -0.265000 | 2.73e-01 |
PEROXISOMAL PROTEIN IMPORT | 59 | 4.36e-04 | 0.265000 | 2.68e-03 |
RHOD GTPASE CYCLE | 51 | 1.12e-03 | -0.264000 | 5.97e-03 |
SIGNALING BY FLT3 FUSION PROTEINS | 19 | 4.72e-02 | -0.263000 | 1.18e-01 |
INTERLEUKIN 12 FAMILY SIGNALING | 43 | 2.85e-03 | 0.263000 | 1.34e-02 |
IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 1.32e-01 | -0.263000 | 2.52e-01 |
REGULATED NECROSIS | 45 | 2.38e-03 | 0.262000 | 1.18e-02 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 9.05e-02 | -0.261000 | 1.92e-01 |
N GLYCAN ANTENNAE ELONGATION | 15 | 8.36e-02 | -0.258000 | 1.81e-01 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 11 | 1.38e-01 | 0.258000 | 2.61e-01 |
NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 5.95e-03 | -0.258000 | 2.45e-02 |
AMYLOID FIBER FORMATION | 57 | 7.62e-04 | 0.258000 | 4.32e-03 |
PHASE 0 RAPID DEPOLARISATION | 28 | 1.84e-02 | -0.258000 | 5.92e-02 |
VEGFR2 MEDIATED VASCULAR PERMEABILITY | 27 | 2.11e-02 | -0.256000 | 6.54e-02 |
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 1.90e-02 | -0.256000 | 6.08e-02 |
INTERLEUKIN 15 SIGNALING | 13 | 1.10e-01 | -0.256000 | 2.21e-01 |
INTERLEUKIN 7 SIGNALING | 19 | 5.36e-02 | -0.256000 | 1.31e-01 |
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 2.70e-02 | 0.256000 | 7.81e-02 |
CHROMOSOME MAINTENANCE | 99 | 1.16e-05 | 0.255000 | 1.26e-04 |
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 1.11e-01 | -0.255000 | 2.22e-01 |
B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 47 | 2.50e-03 | 0.255000 | 1.22e-02 |
HSF1 DEPENDENT TRANSACTIVATION | 34 | 1.01e-02 | -0.255000 | 3.67e-02 |
SHC1 EVENTS IN ERBB2 SIGNALING | 21 | 4.32e-02 | -0.255000 | 1.12e-01 |
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 3.96e-03 | 0.254000 | 1.78e-02 |
S PHASE | 154 | 5.64e-08 | 0.254000 | 1.04e-06 |
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 12 | 1.29e-01 | -0.253000 | 2.49e-01 |
METABOLISM OF NUCLEOTIDES | 92 | 2.91e-05 | 0.252000 | 2.84e-04 |
TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 2.63e-02 | 0.252000 | 7.68e-02 |
RND1 GTPASE CYCLE | 38 | 7.33e-03 | -0.251000 | 2.85e-02 |
RHOC GTPASE CYCLE | 74 | 2.04e-04 | -0.250000 | 1.41e-03 |
RHOA GTPASE CYCLE | 144 | 2.49e-07 | -0.249000 | 4.19e-06 |
RHOQ GTPASE CYCLE | 59 | 9.40e-04 | -0.249000 | 5.16e-03 |
SIGNALING BY NOTCH1 | 75 | 1.93e-04 | -0.249000 | 1.35e-03 |
MITOTIC G1 PHASE AND G1 S TRANSITION | 142 | 3.14e-07 | 0.249000 | 5.01e-06 |
CYTOSOLIC TRNA AMINOACYLATION | 24 | 3.50e-02 | 0.249000 | 9.48e-02 |
RHOB GTPASE CYCLE | 69 | 3.58e-04 | -0.249000 | 2.27e-03 |
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 4.87e-02 | -0.248000 | 1.20e-01 |
HOST INTERACTIONS OF HIV FACTORS | 124 | 1.84e-06 | 0.248000 | 2.58e-05 |
PYRUVATE METABOLISM | 27 | 2.60e-02 | 0.247000 | 7.64e-02 |
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 6.19e-02 | 0.247000 | 1.44e-01 |
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 11 | 1.55e-01 | -0.247000 | 2.84e-01 |
CHAPERONE MEDIATED AUTOPHAGY | 21 | 4.99e-02 | 0.247000 | 1.22e-01 |
SELECTIVE AUTOPHAGY | 72 | 2.95e-04 | 0.247000 | 1.94e-03 |
CIRCADIAN CLOCK | 67 | 4.97e-04 | -0.246000 | 2.99e-03 |
NUCLEOBASE CATABOLISM | 31 | 1.78e-02 | 0.246000 | 5.77e-02 |
G2 M CHECKPOINTS | 133 | 9.78e-07 | 0.246000 | 1.42e-05 |
SIGNALING BY ERYTHROPOIETIN | 24 | 3.70e-02 | -0.246000 | 9.86e-02 |
PECAM1 INTERACTIONS | 12 | 1.42e-01 | -0.245000 | 2.66e-01 |
RNA POLYMERASE III TRANSCRIPTION | 41 | 6.76e-03 | 0.244000 | 2.69e-02 |
RHOBTB2 GTPASE CYCLE | 23 | 4.33e-02 | -0.243000 | 1.12e-01 |
CELL CELL COMMUNICATION | 103 | 2.08e-05 | -0.243000 | 2.09e-04 |
FORMATION OF INCISION COMPLEX IN GG NER | 43 | 6.00e-03 | 0.242000 | 2.46e-02 |
TERMINATION OF TRANSLESION DNA SYNTHESIS | 32 | 1.80e-02 | 0.242000 | 5.83e-02 |
CELL JUNCTION ORGANIZATION | 72 | 3.98e-04 | -0.241000 | 2.46e-03 |
ONCOGENIC MAPK SIGNALING | 77 | 2.55e-04 | -0.241000 | 1.71e-03 |
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 39 | 9.32e-03 | 0.241000 | 3.46e-02 |
LAMININ INTERACTIONS | 29 | 2.59e-02 | -0.239000 | 7.63e-02 |
BIOLOGICAL OXIDATIONS | 126 | 3.79e-06 | 0.239000 | 4.86e-05 |
GABA B RECEPTOR ACTIVATION | 39 | 1.01e-02 | -0.238000 | 3.66e-02 |
PRC2 METHYLATES HISTONES AND DNA | 29 | 2.66e-02 | 0.238000 | 7.73e-02 |
GAP JUNCTION ASSEMBLY | 21 | 5.92e-02 | 0.238000 | 1.39e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 37 | 1.24e-02 | 0.238000 | 4.33e-02 |
RHO GTPASES ACTIVATE KTN1 | 11 | 1.73e-01 | 0.238000 | 3.08e-01 |
KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 1.02e-01 | 0.236000 | 2.09e-01 |
HS GAG BIOSYNTHESIS | 30 | 2.54e-02 | -0.236000 | 7.55e-02 |
EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 26 | 3.82e-02 | -0.235000 | 1.01e-01 |
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 6.90e-02 | -0.235000 | 1.55e-01 |
PROCESSING AND ACTIVATION OF SUMO | 10 | 1.99e-01 | 0.235000 | 3.39e-01 |
RNA POLYMERASE I TRANSCRIPTION | 67 | 9.12e-04 | 0.234000 | 5.05e-03 |
CONDENSATION OF PROPHASE CHROMOSOMES | 27 | 3.52e-02 | 0.234000 | 9.50e-02 |
MATURATION OF NUCLEOPROTEIN | 10 | 2.03e-01 | -0.233000 | 3.43e-01 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 1.48e-01 | -0.232000 | 2.74e-01 |
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 16 | 1.08e-01 | 0.232000 | 2.17e-01 |
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 44 | 7.80e-03 | -0.232000 | 3.01e-02 |
INTERLEUKIN 1 FAMILY SIGNALING | 121 | 1.07e-05 | 0.232000 | 1.18e-04 |
TCR SIGNALING | 100 | 6.26e-05 | 0.232000 | 5.39e-04 |
SIGNALING BY RETINOIC ACID | 31 | 2.59e-02 | 0.231000 | 7.63e-02 |
TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 1.51e-01 | 0.230000 | 2.78e-01 |
L1CAM INTERACTIONS | 107 | 3.95e-05 | -0.230000 | 3.61e-04 |
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 5.62e-02 | 0.230000 | 1.35e-01 |
PROTEIN FOLDING | 89 | 1.82e-04 | 0.230000 | 1.29e-03 |
PHOSPHORYLATION OF THE APC C | 17 | 1.02e-01 | 0.229000 | 2.09e-01 |
CA2 PATHWAY | 56 | 3.09e-03 | -0.229000 | 1.42e-02 |
TRANSCRIPTION OF THE HIV GENOME | 67 | 1.24e-03 | 0.228000 | 6.51e-03 |
ASSEMBLY OF THE HIV VIRION | 16 | 1.14e-01 | 0.228000 | 2.27e-01 |
DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 1.41e-01 | -0.227000 | 2.64e-01 |
MEIOTIC RECOMBINATION | 40 | 1.30e-02 | 0.227000 | 4.51e-02 |
SEMAPHORIN INTERACTIONS | 64 | 1.72e-03 | -0.227000 | 8.74e-03 |
RET SIGNALING | 37 | 1.74e-02 | -0.226000 | 5.70e-02 |
VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 8.88e-02 | -0.226000 | 1.90e-01 |
ABC FAMILY PROTEINS MEDIATED TRANSPORT | 94 | 1.62e-04 | 0.225000 | 1.17e-03 |
CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 1.31e-01 | -0.225000 | 2.51e-01 |
RHO GTPASE CYCLE | 425 | 2.49e-15 | -0.224000 | 1.23e-13 |
HEME BIOSYNTHESIS | 13 | 1.63e-01 | 0.223000 | 2.95e-01 |
REGULATION OF BETA CELL DEVELOPMENT | 30 | 3.45e-02 | -0.223000 | 9.40e-02 |
AGGREPHAGY | 35 | 2.24e-02 | 0.223000 | 6.87e-02 |
GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 2.01e-01 | 0.223000 | 3.42e-01 |
RA BIOSYNTHESIS PATHWAY | 12 | 1.83e-01 | 0.222000 | 3.19e-01 |
SIGNALING BY BRAF AND RAF FUSIONS | 60 | 2.97e-03 | -0.222000 | 1.39e-02 |
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 8.67e-02 | -0.221000 | 1.87e-01 |
HIV INFECTION | 220 | 1.59e-08 | 0.221000 | 3.19e-07 |
PYRIMIDINE CATABOLISM | 10 | 2.26e-01 | 0.221000 | 3.72e-01 |
ANCHORING FIBRIL FORMATION | 15 | 1.39e-01 | -0.221000 | 2.61e-01 |
AUTOPHAGY | 139 | 7.07e-06 | 0.221000 | 8.18e-05 |
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 82 | 5.98e-04 | 0.219000 | 3.53e-03 |
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 8.59e-03 | -0.219000 | 3.23e-02 |
SIGNAL TRANSDUCTION BY L1 | 21 | 8.27e-02 | -0.219000 | 1.80e-01 |
FCERI MEDIATED MAPK ACTIVATION | 28 | 4.53e-02 | -0.219000 | 1.15e-01 |
TP53 REGULATES METABOLIC GENES | 85 | 5.00e-04 | 0.218000 | 2.99e-03 |
INSULIN PROCESSING | 24 | 6.41e-02 | -0.218000 | 1.47e-01 |
MYOGENESIS | 24 | 6.43e-02 | -0.218000 | 1.48e-01 |
INTEGRIN SIGNALING | 24 | 6.51e-02 | -0.218000 | 1.49e-01 |
PI 3K CASCADE FGFR4 | 13 | 1.75e-01 | -0.217000 | 3.11e-01 |
RHOJ GTPASE CYCLE | 55 | 5.52e-03 | -0.216000 | 2.37e-02 |
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 22 | 7.94e-02 | 0.216000 | 1.74e-01 |
ROS AND RNS PRODUCTION IN PHAGOCYTES | 29 | 4.42e-02 | 0.216000 | 1.13e-01 |
RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 15 | 1.48e-01 | 0.216000 | 2.74e-01 |
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 7.24e-03 | -0.215000 | 2.83e-02 |
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 83 | 7.15e-04 | -0.215000 | 4.10e-03 |
SIGNALING BY TGFB FAMILY MEMBERS | 97 | 2.60e-04 | -0.215000 | 1.74e-03 |
GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 1.82e-01 | 0.214000 | 3.18e-01 |
AMINO ACIDS REGULATE MTORC1 | 51 | 8.34e-03 | 0.214000 | 3.17e-02 |
GROWTH HORMONE RECEPTOR SIGNALING | 20 | 9.92e-02 | -0.213000 | 2.05e-01 |
PHASE 2 PLATEAU PHASE | 11 | 2.22e-01 | -0.213000 | 3.68e-01 |
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 1.56e-01 | 0.212000 | 2.85e-01 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 21 | 9.41e-02 | -0.211000 | 1.98e-01 |
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 1.72e-01 | -0.211000 | 3.07e-01 |
PI METABOLISM | 80 | 1.10e-03 | -0.211000 | 5.92e-03 |
RHOBTB GTPASE CYCLE | 35 | 3.16e-02 | -0.210000 | 8.89e-02 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 12 | 2.09e-01 | 0.209000 | 3.52e-01 |
VOLTAGE GATED POTASSIUM CHANNELS | 39 | 2.38e-02 | -0.209000 | 7.18e-02 |
METABOLISM OF PORPHYRINS | 19 | 1.15e-01 | 0.209000 | 2.27e-01 |
SEPARATION OF SISTER CHROMATIDS | 168 | 3.04e-06 | 0.209000 | 4.07e-05 |
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 5.53e-03 | -0.209000 | 2.37e-02 |
GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 30 | 4.78e-02 | 0.209000 | 1.19e-01 |
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 6.56e-02 | -0.209000 | 1.49e-01 |
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 19 | 1.17e-01 | 0.208000 | 2.29e-01 |
SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 1.98e-02 | -0.208000 | 6.24e-02 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 1.78e-01 | -0.208000 | 3.14e-01 |
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 4.22e-02 | -0.208000 | 1.10e-01 |
KILLING MECHANISMS | 10 | 2.57e-01 | -0.207000 | 4.07e-01 |
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 33 | 3.95e-02 | -0.207000 | 1.04e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 14 | 1.80e-01 | -0.207000 | 3.16e-01 |
GLUCAGON SIGNALING IN METABOLIC REGULATION | 29 | 5.43e-02 | -0.207000 | 1.32e-01 |
PEXOPHAGY | 11 | 2.37e-01 | 0.206000 | 3.85e-01 |
FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 2.60e-01 | -0.206000 | 4.08e-01 |
TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 3.54e-02 | -0.205000 | 9.52e-02 |
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 2.62e-01 | -0.205000 | 4.10e-01 |
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 1.56e-01 | 0.205000 | 2.85e-01 |
SIGNALING BY NTRK3 TRKC | 17 | 1.44e-01 | -0.205000 | 2.69e-01 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 2.40e-01 | 0.205000 | 3.87e-01 |
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 76 | 2.06e-03 | -0.204000 | 1.03e-02 |
SIGNALING BY THE B CELL RECEPTOR BCR | 103 | 3.38e-04 | 0.204000 | 2.17e-03 |
NEURONAL SYSTEM | 371 | 1.50e-11 | -0.204000 | 5.71e-10 |
ERK MAPK TARGETS | 22 | 9.81e-02 | -0.204000 | 2.03e-01 |
RAC2 GTPASE CYCLE | 87 | 1.04e-03 | -0.204000 | 5.59e-03 |
NGF STIMULATED TRANSCRIPTION | 36 | 3.47e-02 | -0.203000 | 9.40e-02 |
FATTY ACID METABOLISM | 145 | 2.44e-05 | 0.203000 | 2.40e-04 |
CELLULAR RESPONSES TO EXTERNAL STIMULI | 601 | 2.28e-17 | 0.203000 | 1.17e-15 |
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 58 | 7.59e-03 | -0.203000 | 2.94e-02 |
DISEASES OF PROGRAMMED CELL DEATH | 54 | 1.00e-02 | 0.203000 | 3.66e-02 |
REGULATION OF SIGNALING BY CBL | 22 | 1.00e-01 | -0.202000 | 2.06e-01 |
MTOR SIGNALLING | 40 | 2.67e-02 | 0.202000 | 7.75e-02 |
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 61 | 6.44e-03 | 0.202000 | 2.59e-02 |
SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 2.70e-01 | -0.202000 | 4.16e-01 |
NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 3.46e-02 | -0.201000 | 9.40e-02 |
SIGNALING BY VEGF | 102 | 4.84e-04 | -0.200000 | 2.93e-03 |
HDMS DEMETHYLATE HISTONES | 28 | 6.71e-02 | -0.200000 | 1.52e-01 |
ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 2.74e-01 | -0.200000 | 4.19e-01 |
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 5.06e-02 | -0.200000 | 1.24e-01 |
C TYPE LECTIN RECEPTORS CLRS | 111 | 2.80e-04 | 0.200000 | 1.84e-03 |
PLATELET AGGREGATION PLUG FORMATION | 31 | 5.48e-02 | -0.199000 | 1.33e-01 |
RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 1.24e-01 | -0.199000 | 2.41e-01 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 2.16e-01 | 0.198000 | 3.60e-01 |
FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 9.98e-03 | 0.197000 | 3.66e-02 |
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 12 | 2.37e-01 | 0.197000 | 3.85e-01 |
MUCOPOLYSACCHARIDOSES | 11 | 2.58e-01 | -0.197000 | 4.07e-01 |
GRB2 EVENTS IN ERBB2 SIGNALING | 15 | 1.87e-01 | -0.197000 | 3.24e-01 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 1.28e-01 | 0.197000 | 2.46e-01 |
NETRIN 1 SIGNALING | 50 | 1.64e-02 | -0.196000 | 5.43e-02 |
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 1.90e-01 | 0.195000 | 3.27e-01 |
SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 1.77e-01 | -0.195000 | 3.12e-01 |
DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 1.65e-01 | 0.194000 | 2.98e-01 |
TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 5.63e-02 | 0.192000 | 1.35e-01 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 2.32e-01 | 0.191000 | 3.80e-01 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 63 | 8.62e-03 | -0.191000 | 3.23e-02 |
INITIAL TRIGGERING OF COMPLEMENT | 11 | 2.72e-01 | 0.191000 | 4.18e-01 |
PROLONGED ERK ACTIVATION EVENTS | 13 | 2.34e-01 | -0.191000 | 3.81e-01 |
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 181 | 9.80e-06 | -0.191000 | 1.11e-04 |
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 22 | 1.22e-01 | -0.191000 | 2.38e-01 |
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 2.98e-01 | -0.190000 | 4.47e-01 |
CALNEXIN CALRETICULIN CYCLE | 26 | 9.60e-02 | -0.189000 | 2.01e-01 |
COMPLEMENT CASCADE | 26 | 9.69e-02 | 0.188000 | 2.02e-01 |
PROGRAMMED CELL DEATH | 185 | 1.06e-05 | 0.188000 | 1.18e-04 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 12 | 2.61e-01 | 0.188000 | 4.08e-01 |
CS DS DEGRADATION | 14 | 2.24e-01 | -0.188000 | 3.70e-01 |
NON INTEGRIN MEMBRANE ECM INTERACTIONS | 57 | 1.48e-02 | -0.187000 | 5.01e-02 |
SHC1 EVENTS IN ERBB4 SIGNALING | 13 | 2.44e-01 | -0.186000 | 3.92e-01 |
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 35 | 5.68e-02 | 0.186000 | 1.36e-01 |
RMTS METHYLATE HISTONE ARGININES | 44 | 3.29e-02 | 0.186000 | 9.11e-02 |
SUMOYLATION OF INTRACELLULAR RECEPTORS | 27 | 9.67e-02 | -0.185000 | 2.02e-01 |
METALLOPROTEASE DUBS | 26 | 1.03e-01 | 0.185000 | 2.10e-01 |
SIGNALING BY ERBB2 ECD MUTANTS | 16 | 2.02e-01 | -0.184000 | 3.42e-01 |
DNA DAMAGE BYPASS | 48 | 2.77e-02 | 0.184000 | 7.97e-02 |
ARACHIDONIC ACID METABOLISM | 39 | 4.74e-02 | 0.184000 | 1.18e-01 |
SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 2.71e-01 | -0.183000 | 4.18e-01 |
CROSSLINKING OF COLLAGEN FIBRILS | 16 | 2.05e-01 | -0.183000 | 3.46e-01 |
SIGNALING BY EGFR | 47 | 3.00e-02 | -0.183000 | 8.55e-02 |
TRNA PROCESSING | 105 | 1.20e-03 | 0.183000 | 6.37e-03 |
COLLAGEN CHAIN TRIMERIZATION | 41 | 4.28e-02 | -0.183000 | 1.11e-01 |
SIGNALING BY NOTCH3 | 48 | 2.86e-02 | -0.183000 | 8.18e-02 |
PROLACTIN RECEPTOR SIGNALING | 11 | 2.95e-01 | -0.182000 | 4.42e-01 |
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 12 | 2.75e-01 | 0.182000 | 4.20e-01 |
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 25 | 1.15e-01 | -0.182000 | 2.27e-01 |
HYALURONAN METABOLISM | 15 | 2.24e-01 | -0.181000 | 3.70e-01 |
MITOTIC METAPHASE AND ANAPHASE | 208 | 6.92e-06 | 0.181000 | 8.09e-05 |
CELLULAR RESPONSE TO HEAT STRESS | 95 | 2.32e-03 | -0.181000 | 1.15e-02 |
COLLAGEN DEGRADATION | 52 | 2.41e-02 | -0.181000 | 7.23e-02 |
PLASMA LIPOPROTEIN ASSEMBLY | 12 | 2.80e-01 | 0.180000 | 4.27e-01 |
EPH EPHRIN MEDIATED REPULSION OF CELLS | 50 | 2.76e-02 | -0.180000 | 7.96e-02 |
RHO GTPASES ACTIVATE PKNS | 47 | 3.31e-02 | 0.180000 | 9.12e-02 |
APOPTOTIC EXECUTION PHASE | 45 | 3.78e-02 | -0.179000 | 9.97e-02 |
NEDDYLATION | 220 | 4.99e-06 | 0.179000 | 6.20e-05 |
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 2.16e-01 | -0.179000 | 3.61e-01 |
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 8.68e-02 | -0.178000 | 1.87e-01 |
G ALPHA 12 13 SIGNALLING EVENTS | 75 | 8.08e-03 | -0.177000 | 3.08e-02 |
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 2.35e-01 | 0.177000 | 3.83e-01 |
INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 2.79e-02 | 0.176000 | 8.01e-02 |
MAPK6 MAPK4 SIGNALING | 83 | 5.60e-03 | 0.176000 | 2.38e-02 |
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 73 | 9.38e-03 | -0.176000 | 3.47e-02 |
RAC3 GTPASE CYCLE | 89 | 4.26e-03 | -0.175000 | 1.88e-02 |
DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 1.03e-01 | -0.175000 | 2.09e-01 |
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 1.76e-01 | 0.175000 | 3.11e-01 |
DNA REPAIR | 292 | 2.98e-07 | 0.175000 | 4.88e-06 |
CHEMOKINE RECEPTORS BIND CHEMOKINES | 14 | 2.59e-01 | -0.174000 | 4.08e-01 |
TRIGLYCERIDE METABOLISM | 23 | 1.48e-01 | 0.174000 | 2.74e-01 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 3.41e-01 | -0.174000 | 4.96e-01 |
PERK REGULATES GENE EXPRESSION | 28 | 1.11e-01 | 0.174000 | 2.22e-01 |
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 84 | 6.16e-03 | -0.173000 | 2.52e-02 |
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 6.92e-02 | -0.173000 | 1.56e-01 |
PLASMA LIPOPROTEIN REMODELING | 14 | 2.64e-01 | 0.173000 | 4.12e-01 |
IRON UPTAKE AND TRANSPORT | 52 | 3.19e-02 | 0.172000 | 8.92e-02 |
RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 1.74e-01 | -0.171000 | 3.10e-01 |
APOPTOSIS | 164 | 1.57e-04 | 0.171000 | 1.14e-03 |
TRANSMISSION ACROSS CHEMICAL SYNAPSES | 243 | 4.82e-06 | -0.171000 | 6.05e-05 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 2.26e-01 | -0.170000 | 3.72e-01 |
SIGNALING BY KIT IN DISEASE | 20 | 1.90e-01 | -0.169000 | 3.27e-01 |
SIGNALING BY FGFR2 IN DISEASE | 38 | 7.10e-02 | 0.169000 | 1.58e-01 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 13 | 2.91e-01 | 0.169000 | 4.38e-01 |
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 65 | 1.89e-02 | -0.168000 | 6.08e-02 |
OPIOID SIGNALLING | 86 | 6.99e-03 | -0.168000 | 2.76e-02 |
SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 1.37e-02 | -0.168000 | 4.73e-02 |
MITOTIC G2 G2 M PHASES | 183 | 9.47e-05 | 0.167000 | 7.55e-04 |
HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 52 | 3.71e-02 | -0.167000 | 9.86e-02 |
LDL CLEARANCE | 16 | 2.48e-01 | -0.167000 | 3.97e-01 |
EPHA MEDIATED GROWTH CONE COLLAPSE | 28 | 1.27e-01 | -0.167000 | 2.45e-01 |
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 23 | 1.68e-01 | 0.166000 | 3.01e-01 |
TRNA AMINOACYLATION | 42 | 6.25e-02 | 0.166000 | 1.45e-01 |
MICRORNA MIRNA BIOGENESIS | 24 | 1.62e-01 | 0.165000 | 2.93e-01 |
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 15 | 2.70e-01 | 0.165000 | 4.16e-01 |
FANCONI ANEMIA PATHWAY | 37 | 8.31e-02 | 0.165000 | 1.81e-01 |
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 2.54e-01 | 0.165000 | 4.04e-01 |
KINESINS | 48 | 4.87e-02 | -0.164000 | 1.20e-01 |
PI3K AKT SIGNALING IN CANCER | 92 | 6.43e-03 | -0.164000 | 2.59e-02 |
REGULATION OF GENE EXPRESSION BY HYPOXIA INDUCIBLE FACTOR | 10 | 3.69e-01 | -0.164000 | 5.27e-01 |
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 3.69e-01 | 0.164000 | 5.27e-01 |
PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 2.89e-01 | -0.164000 | 4.36e-01 |
REVERSIBLE HYDRATION OF CARBON DIOXIDE | 10 | 3.70e-01 | 0.164000 | 5.28e-01 |
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 50 | 4.59e-02 | 0.163000 | 1.16e-01 |
CLASS A 1 RHODOPSIN LIKE RECEPTORS | 185 | 1.34e-04 | -0.163000 | 9.91e-04 |
TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | 10 | 3.73e-01 | 0.163000 | 5.29e-01 |
INTERLEUKIN 17 SIGNALING | 67 | 2.14e-02 | -0.163000 | 6.61e-02 |
PARASITE INFECTION | 55 | 3.71e-02 | -0.163000 | 9.86e-02 |
ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 32 | 1.13e-01 | 0.162000 | 2.24e-01 |
NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 98 | 5.61e-03 | -0.162000 | 2.38e-02 |
COLLAGEN FORMATION | 79 | 1.29e-02 | -0.162000 | 4.48e-02 |
G PROTEIN BETA GAMMA SIGNALLING | 30 | 1.25e-01 | 0.162000 | 2.43e-01 |
P75NTR RECRUITS SIGNALLING COMPLEXES | 12 | 3.32e-01 | 0.162000 | 4.88e-01 |
DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 51 | 4.59e-02 | -0.162000 | 1.16e-01 |
EXTRA NUCLEAR ESTROGEN SIGNALING | 67 | 2.25e-02 | -0.161000 | 6.88e-02 |
SIGNALING BY GPCR | 484 | 1.67e-09 | -0.160000 | 3.87e-08 |
G ALPHA Z SIGNALLING EVENTS | 44 | 6.58e-02 | -0.160000 | 1.49e-01 |
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 4.18e-02 | -0.160000 | 1.10e-01 |
CELL CYCLE CHECKPOINTS | 243 | 1.76e-05 | 0.160000 | 1.79e-04 |
MRNA SPLICING | 188 | 1.57e-04 | 0.160000 | 1.14e-03 |
HSF1 ACTIVATION | 26 | 1.59e-01 | -0.160000 | 2.88e-01 |
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 25 | 1.67e-01 | -0.160000 | 3.01e-01 |
GLUCAGON TYPE LIGAND RECEPTORS | 25 | 1.68e-01 | 0.159000 | 3.01e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 20 | 2.17e-01 | -0.159000 | 3.61e-01 |
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 46 | 6.16e-02 | -0.159000 | 1.44e-01 |
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 35 | 1.03e-01 | -0.159000 | 2.10e-01 |
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 62 | 3.04e-02 | 0.159000 | 8.64e-02 |
SIGNALING BY NTRKS | 129 | 1.91e-03 | -0.158000 | 9.66e-03 |
ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY | 10 | 3.87e-01 | -0.158000 | 5.42e-01 |
EXTENSION OF TELOMERES | 48 | 5.83e-02 | 0.158000 | 1.38e-01 |
INSULIN RECEPTOR SIGNALLING CASCADE | 46 | 6.41e-02 | -0.158000 | 1.47e-01 |
EFFECTS OF PIP2 HYDROLYSIS | 27 | 1.58e-01 | -0.157000 | 2.87e-01 |
INTEGRATION OF ENERGY METABOLISM | 98 | 7.23e-03 | -0.157000 | 2.83e-02 |
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 35 | 1.08e-01 | -0.157000 | 2.17e-01 |
HEDGEHOG ON STATE | 82 | 1.41e-02 | 0.157000 | 4.83e-02 |
MET PROMOTES CELL MOTILITY | 39 | 9.16e-02 | -0.156000 | 1.94e-01 |
SIGNALING BY FGFR1 | 45 | 7.02e-02 | -0.156000 | 1.57e-01 |
NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 31 | 1.34e-01 | -0.156000 | 2.54e-01 |
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 82 | 1.52e-02 | -0.155000 | 5.13e-02 |
RAB GERANYLGERANYLATION | 57 | 4.32e-02 | 0.155000 | 1.12e-01 |
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 3.74e-01 | 0.155000 | 5.30e-01 |
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 1.37e-01 | -0.155000 | 2.58e-01 |
REGULATION OF INSULIN SECRETION | 71 | 2.45e-02 | -0.154000 | 7.32e-02 |
SYNTHESIS OF PA | 29 | 1.51e-01 | -0.154000 | 2.78e-01 |
PLATELET CALCIUM HOMEOSTASIS | 25 | 1.83e-01 | -0.154000 | 3.19e-01 |
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 3.78e-01 | 0.153000 | 5.33e-01 |
MITOCHONDRIAL BIOGENESIS | 92 | 1.16e-02 | 0.152000 | 4.14e-02 |
DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 144 | 1.64e-03 | 0.152000 | 8.40e-03 |
SYNTHESIS OF PC | 26 | 1.81e-01 | 0.152000 | 3.17e-01 |
SIGNALING BY SCF KIT | 41 | 9.45e-02 | -0.151000 | 1.98e-01 |
SIGNALING BY NOTCH2 | 33 | 1.34e-01 | -0.151000 | 2.54e-01 |
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 3.66e-01 | 0.151000 | 5.26e-01 |
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 12 | 3.66e-01 | 0.151000 | 5.26e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 27 | 1.77e-01 | -0.150000 | 3.12e-01 |
ION TRANSPORT BY P TYPE ATPASES | 49 | 6.94e-02 | -0.150000 | 1.56e-01 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 3.89e-01 | -0.150000 | 5.44e-01 |
TERMINATION OF O GLYCAN BIOSYNTHESIS | 10 | 4.12e-01 | 0.150000 | 5.63e-01 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 4.14e-01 | 0.149000 | 5.64e-01 |
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 46 | 8.17e-02 | -0.148000 | 1.78e-01 |
PHASE I FUNCTIONALIZATION OF COMPOUNDS | 60 | 4.74e-02 | 0.148000 | 1.18e-01 |
SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 40 | 1.07e-01 | -0.147000 | 2.16e-01 |
P75NTR SIGNALS VIA NF KB | 15 | 3.24e-01 | 0.147000 | 4.78e-01 |
COPI MEDIATED ANTEROGRADE TRANSPORT | 91 | 1.54e-02 | 0.147000 | 5.15e-02 |
REGULATION OF FZD BY UBIQUITINATION | 19 | 2.68e-01 | -0.147000 | 4.15e-01 |
IRS MEDIATED SIGNALLING | 41 | 1.04e-01 | -0.147000 | 2.10e-01 |
INTERLEUKIN 37 SIGNALING | 18 | 2.82e-01 | -0.147000 | 4.28e-01 |
HCMV LATE EVENTS | 65 | 4.19e-02 | 0.146000 | 1.10e-01 |
OVARIAN TUMOR DOMAIN PROTEASES | 36 | 1.31e-01 | -0.146000 | 2.51e-01 |
G PROTEIN ACTIVATION | 22 | 2.38e-01 | 0.145000 | 3.85e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX3 | 93 | 1.55e-02 | 0.145000 | 5.16e-02 |
TRAF6 MEDIATED NF KB ACTIVATION | 22 | 2.38e-01 | -0.145000 | 3.86e-01 |
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 28 | 1.86e-01 | 0.145000 | 3.23e-01 |
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 4.31e-01 | -0.144000 | 5.80e-01 |
CTLA4 INHIBITORY SIGNALING | 20 | 2.66e-01 | -0.144000 | 4.14e-01 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 4.34e-01 | -0.143000 | 5.82e-01 |
FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 24 | 2.27e-01 | -0.142000 | 3.73e-01 |
G ALPHA S SIGNALLING EVENTS | 105 | 1.17e-02 | -0.142000 | 4.15e-02 |
EXTRACELLULAR MATRIX ORGANIZATION | 248 | 1.15e-04 | -0.142000 | 8.79e-04 |
RAF ACTIVATION | 34 | 1.52e-01 | -0.142000 | 2.79e-01 |
METAL ION SLC TRANSPORTERS | 25 | 2.20e-01 | -0.142000 | 3.64e-01 |
FORMATION OF APOPTOSOME | 10 | 4.39e-01 | 0.141000 | 5.88e-01 |
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 1.88e-01 | -0.141000 | 3.26e-01 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 3.97e-01 | -0.141000 | 5.50e-01 |
SENSORY PROCESSING OF SOUND | 60 | 5.88e-02 | -0.141000 | 1.39e-01 |
TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 61 | 5.71e-02 | 0.141000 | 1.36e-01 |
MET ACTIVATES PTK2 SIGNALING | 29 | 1.90e-01 | -0.141000 | 3.27e-01 |
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 3.99e-01 | 0.141000 | 5.52e-01 |
SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 1.40e-01 | -0.140000 | 2.63e-01 |
HIV LIFE CYCLE | 142 | 4.15e-03 | 0.139000 | 1.84e-02 |
SCAVENGING BY CLASS A RECEPTORS | 14 | 3.68e-01 | 0.139000 | 5.26e-01 |
RHOBTB1 GTPASE CYCLE | 23 | 2.48e-01 | -0.139000 | 3.97e-01 |
DERMATAN SULFATE BIOSYNTHESIS | 11 | 4.26e-01 | -0.139000 | 5.75e-01 |
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 20 | 2.84e-01 | -0.138000 | 4.31e-01 |
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 52 | 8.61e-02 | -0.138000 | 1.86e-01 |
KERATAN SULFATE DEGRADATION | 11 | 4.30e-01 | 0.138000 | 5.79e-01 |
CARGO CONCENTRATION IN THE ER | 29 | 2.00e-01 | -0.137000 | 3.41e-01 |
IRE1ALPHA ACTIVATES CHAPERONES | 50 | 9.33e-02 | -0.137000 | 1.97e-01 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 2.03e-01 | 0.137000 | 3.43e-01 |
EPHB MEDIATED FORWARD SIGNALING | 42 | 1.26e-01 | -0.136000 | 2.44e-01 |
TRAFFICKING OF AMPA RECEPTORS | 31 | 1.89e-01 | -0.136000 | 3.26e-01 |
CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 3.62e-01 | 0.136000 | 5.24e-01 |
SUMOYLATION | 166 | 2.55e-03 | -0.136000 | 1.24e-02 |
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 1.33e-01 | -0.136000 | 2.53e-01 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 5.86e-02 | 0.136000 | 1.39e-01 |
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 6.78e-02 | 0.135000 | 1.53e-01 |
PI 3K CASCADE FGFR3 | 14 | 3.83e-01 | -0.135000 | 5.38e-01 |
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 3.72e-04 | 0.134000 | 2.32e-03 |
INOSITOL PHOSPHATE METABOLISM | 46 | 1.15e-01 | -0.134000 | 2.27e-01 |
MISMATCH REPAIR | 14 | 3.85e-01 | 0.134000 | 5.41e-01 |
REGULATION OF IFNG SIGNALING | 13 | 4.04e-01 | 0.134000 | 5.56e-01 |
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 631 | 1.10e-08 | -0.134000 | 2.23e-07 |
ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 116 | 1.29e-02 | -0.134000 | 4.49e-02 |
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 64 | 6.45e-02 | -0.134000 | 1.48e-01 |
NEGATIVE REGULATION OF FLT3 | 14 | 3.87e-01 | 0.134000 | 5.42e-01 |
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 20 | 3.02e-01 | 0.133000 | 4.52e-01 |
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 4.50e-02 | 0.133000 | 1.14e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 4.06e-01 | 0.133000 | 5.60e-01 |
SNRNP ASSEMBLY | 51 | 1.01e-01 | 0.133000 | 2.08e-01 |
PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 2.25e-01 | 0.133000 | 3.70e-01 |
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 34 | 1.81e-01 | -0.133000 | 3.17e-01 |
RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 24 | 2.62e-01 | -0.132000 | 4.10e-01 |
RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 1.17e-01 | 0.132000 | 2.29e-01 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 13 | 4.09e-01 | 0.132000 | 5.61e-01 |
PENTOSE PHOSPHATE PATHWAY | 13 | 4.11e-01 | 0.132000 | 5.63e-01 |
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 38 | 1.62e-01 | 0.131000 | 2.93e-01 |
NEUTROPHIL DEGRANULATION | 387 | 9.96e-06 | 0.131000 | 1.12e-04 |
EPH EPHRIN SIGNALING | 91 | 3.09e-02 | -0.131000 | 8.74e-02 |
REGULATION OF KIT SIGNALING | 16 | 3.64e-01 | -0.131000 | 5.26e-01 |
SIGNALING BY ERBB4 | 57 | 8.74e-02 | -0.131000 | 1.87e-01 |
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 25 | 2.58e-01 | -0.131000 | 4.07e-01 |
REGULATION OF IFNA SIGNALING | 12 | 4.33e-01 | -0.131000 | 5.81e-01 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 14 | 3.97e-01 | 0.131000 | 5.50e-01 |
STRIATED MUSCLE CONTRACTION | 25 | 2.60e-01 | 0.130000 | 4.08e-01 |
TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 1.89e-01 | -0.130000 | 3.26e-01 |
INTERFERON GAMMA SIGNALING | 79 | 4.57e-02 | -0.130000 | 1.16e-01 |
METABOLISM OF VITAMINS AND COFACTORS | 153 | 5.54e-03 | 0.130000 | 2.37e-02 |
TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 91 | 3.25e-02 | -0.130000 | 9.05e-02 |
DEGRADATION OF THE EXTRACELLULAR MATRIX | 110 | 1.91e-02 | -0.129000 | 6.08e-02 |
CHOLESTEROL BIOSYNTHESIS | 24 | 2.73e-01 | -0.129000 | 4.19e-01 |
SURFACTANT METABOLISM | 16 | 3.72e-01 | -0.129000 | 5.29e-01 |
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 103 | 2.46e-02 | 0.128000 | 7.32e-02 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 3.35e-01 | 0.128000 | 4.92e-01 |
GPCR LIGAND BINDING | 267 | 3.33e-04 | -0.128000 | 2.15e-03 |
ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 31 | 2.20e-01 | 0.127000 | 3.64e-01 |
TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 4.46e-01 | -0.127000 | 5.93e-01 |
AQUAPORIN MEDIATED TRANSPORT | 38 | 1.77e-01 | -0.127000 | 3.13e-01 |
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 2.64e-01 | -0.127000 | 4.12e-01 |
ASPARTATE AND ASPARAGINE METABOLISM | 11 | 4.68e-01 | 0.126000 | 6.14e-01 |
HYALURONAN UPTAKE AND DEGRADATION | 11 | 4.70e-01 | -0.126000 | 6.15e-01 |
DEATH RECEPTOR SIGNALLING | 133 | 1.24e-02 | -0.126000 | 4.34e-02 |
M PHASE | 341 | 7.12e-05 | 0.125000 | 6.00e-04 |
LEISHMANIA INFECTION | 195 | 2.64e-03 | -0.125000 | 1.28e-02 |
SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 8.88e-02 | 0.125000 | 1.90e-01 |
PI 3K CASCADE FGFR2 | 18 | 3.59e-01 | -0.125000 | 5.21e-01 |
INTEGRIN CELL SURFACE INTERACTIONS | 73 | 6.57e-02 | -0.125000 | 1.49e-01 |
CARDIAC CONDUCTION | 107 | 2.63e-02 | -0.124000 | 7.68e-02 |
SIGNALING BY NODAL | 16 | 3.92e-01 | -0.124000 | 5.47e-01 |
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 15 | 4.08e-01 | 0.123000 | 5.60e-01 |
MET RECEPTOR RECYCLING | 10 | 4.99e-01 | -0.123000 | 6.41e-01 |
PYRIMIDINE SALVAGE | 10 | 5.02e-01 | 0.123000 | 6.44e-01 |
INFECTIOUS DISEASE | 730 | 2.31e-08 | 0.122000 | 4.54e-07 |
ERYTHROPOIETIN ACTIVATES RAS | 13 | 4.47e-01 | -0.122000 | 5.93e-01 |
FC EPSILON RECEPTOR FCERI SIGNALING | 122 | 2.04e-02 | 0.122000 | 6.39e-02 |
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 15 | 4.16e-01 | -0.121000 | 5.66e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 19 | 3.63e-01 | 0.121000 | 5.24e-01 |
MEIOTIC SYNAPSIS | 41 | 1.83e-01 | 0.120000 | 3.19e-01 |
GP1B IX V ACTIVATION SIGNALLING | 10 | 5.12e-01 | -0.120000 | 6.50e-01 |
P75 NTR RECEPTOR MEDIATED SIGNALLING | 94 | 4.49e-02 | -0.120000 | 1.14e-01 |
PROTEIN UBIQUITINATION | 69 | 8.94e-02 | 0.118000 | 1.90e-01 |
SIGNALING BY RECEPTOR TYROSINE KINASES | 464 | 1.41e-05 | -0.118000 | 1.47e-04 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 4.01e-01 | -0.118000 | 5.53e-01 |
CHROMATIN MODIFYING ENZYMES | 219 | 2.73e-03 | -0.118000 | 1.30e-02 |
TRANSCRIPTIONAL REGULATION BY RUNX2 | 110 | 3.39e-02 | 0.117000 | 9.30e-02 |
INTERLEUKIN 10 SIGNALING | 19 | 3.78e-01 | -0.117000 | 5.33e-01 |
CLATHRIN MEDIATED ENDOCYTOSIS | 132 | 2.07e-02 | -0.117000 | 6.45e-02 |
POTASSIUM CHANNELS | 90 | 5.62e-02 | -0.117000 | 1.35e-01 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 2.35e-01 | -0.116000 | 3.83e-01 |
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 4.07e-01 | -0.116000 | 5.60e-01 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 4.69e-01 | -0.116000 | 6.15e-01 |
O LINKED GLYCOSYLATION | 86 | 6.33e-02 | -0.116000 | 1.46e-01 |
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 58 | 1.27e-01 | -0.116000 | 2.46e-01 |
CELL CYCLE MITOTIC | 477 | 1.70e-05 | 0.115000 | 1.76e-04 |
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 3.42e-01 | -0.114000 | 4.98e-01 |
ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 92 | 5.90e-02 | -0.114000 | 1.39e-01 |
TELOMERE EXTENSION BY TELOMERASE | 21 | 3.67e-01 | 0.114000 | 5.26e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 12 | 4.95e-01 | 0.114000 | 6.38e-01 |
SMOOTH MUSCLE CONTRACTION | 32 | 2.66e-01 | 0.114000 | 4.14e-01 |
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 3.21e-01 | -0.112000 | 4.75e-01 |
ECM PROTEOGLYCANS | 68 | 1.10e-01 | -0.112000 | 2.21e-01 |
SUMOYLATION OF RNA BINDING PROTEINS | 45 | 1.96e-01 | -0.112000 | 3.35e-01 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 3.57e-01 | 0.111000 | 5.18e-01 |
REGULATION OF PTEN GENE TRANSCRIPTION | 58 | 1.44e-01 | -0.111000 | 2.69e-01 |
CELLULAR HEXOSE TRANSPORT | 12 | 5.07e-01 | 0.111000 | 6.46e-01 |
CELL CYCLE | 596 | 4.34e-06 | 0.111000 | 5.50e-05 |
NUCLEAR IMPORT OF REV PROTEIN | 32 | 2.80e-01 | -0.110000 | 4.27e-01 |
ORGANIC CATION ANION ZWITTERION TRANSPORT | 11 | 5.27e-01 | 0.110000 | 6.60e-01 |
DEFECTS IN COBALAMIN B12 METABOLISM | 13 | 4.92e-01 | 0.110000 | 6.35e-01 |
VIRAL MESSENGER RNA SYNTHESIS | 42 | 2.17e-01 | 0.110000 | 3.61e-01 |
KERATINIZATION | 31 | 2.90e-01 | 0.110000 | 4.36e-01 |
PLATELET HOMEOSTASIS | 77 | 9.58e-02 | -0.110000 | 2.01e-01 |
SUPPRESSION OF PHAGOSOMAL MATURATION | 13 | 4.94e-01 | 0.110000 | 6.38e-01 |
RHO GTPASES ACTIVATE NADPH OXIDASES | 20 | 3.96e-01 | 0.110000 | 5.50e-01 |
GLYCOGEN STORAGE DISEASES | 12 | 5.12e-01 | 0.109000 | 6.50e-01 |
CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 4.23e-01 | -0.109000 | 5.74e-01 |
DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 370 | 3.28e-04 | -0.109000 | 2.13e-03 |
MEIOSIS | 67 | 1.23e-01 | 0.109000 | 2.40e-01 |
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 4.24e-01 | -0.109000 | 5.74e-01 |
G ALPHA I SIGNALLING EVENTS | 200 | 8.23e-03 | -0.109000 | 3.13e-02 |
DEADENYLATION DEPENDENT MRNA DECAY | 55 | 1.65e-01 | 0.108000 | 2.98e-01 |
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 2.69e-01 | -0.108000 | 4.16e-01 |
RAP1 SIGNALLING | 15 | 4.70e-01 | -0.108000 | 6.15e-01 |
HOMOLOGY DIRECTED REPAIR | 106 | 5.65e-02 | 0.107000 | 1.35e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 21 | 3.95e-01 | -0.107000 | 5.49e-01 |
GAP JUNCTION TRAFFICKING AND REGULATION | 33 | 2.90e-01 | 0.106000 | 4.36e-01 |
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 63 | 1.45e-01 | 0.106000 | 2.70e-01 |
HS GAG DEGRADATION | 20 | 4.13e-01 | -0.106000 | 5.64e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 25 | 3.66e-01 | -0.104000 | 5.26e-01 |
NUCLEAR ENVELOPE NE REASSEMBLY | 63 | 1.54e-01 | 0.104000 | 2.83e-01 |
RHOG GTPASE CYCLE | 74 | 1.23e-01 | -0.104000 | 2.40e-01 |
GLYCOSAMINOGLYCAN METABOLISM | 114 | 5.64e-02 | -0.104000 | 1.35e-01 |
SIGNALING BY MET | 75 | 1.23e-01 | -0.103000 | 2.40e-01 |
COSTIMULATION BY THE CD28 FAMILY | 49 | 2.12e-01 | -0.103000 | 3.56e-01 |
ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 36 | 2.85e-01 | -0.103000 | 4.32e-01 |
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 34 | 3.00e-01 | 0.103000 | 4.49e-01 |
ONCOGENE INDUCED SENESCENCE | 32 | 3.15e-01 | -0.103000 | 4.68e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 44 | 2.40e-01 | -0.102000 | 3.87e-01 |
METABOLISM OF STEROIDS | 116 | 5.68e-02 | -0.102000 | 1.36e-01 |
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 5.08e-01 | 0.102000 | 6.47e-01 |
INTRAFLAGELLAR TRANSPORT | 51 | 2.08e-01 | 0.102000 | 3.51e-01 |
CD28 DEPENDENT VAV1 PATHWAY | 11 | 5.59e-01 | -0.102000 | 6.88e-01 |
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 13 | 5.25e-01 | 0.102000 | 6.60e-01 |
THE NLRP3 INFLAMMASOME | 15 | 4.96e-01 | -0.102000 | 6.38e-01 |
FORMATION OF THE CORNIFIED ENVELOPE | 30 | 3.36e-01 | 0.101000 | 4.92e-01 |
NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 20 | 4.32e-01 | 0.101000 | 5.81e-01 |
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 120 | 5.61e-02 | -0.101000 | 1.35e-01 |
SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 3.17e-01 | -0.101000 | 4.71e-01 |
DNA DOUBLE STRAND BREAK REPAIR | 135 | 4.38e-02 | 0.101000 | 1.13e-01 |
BETA CATENIN INDEPENDENT WNT SIGNALING | 137 | 4.31e-02 | 0.100000 | 1.12e-01 |
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 44 | 2.51e-01 | 0.100000 | 4.00e-01 |
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 4.63e-01 | 0.099900 | 6.10e-01 |
ESTROGEN DEPENDENT GENE EXPRESSION | 104 | 7.85e-02 | -0.099900 | 1.73e-01 |
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 92 | 9.86e-02 | -0.099700 | 2.04e-01 |
LYSINE CATABOLISM | 11 | 5.67e-01 | 0.099600 | 6.93e-01 |
TRNA PROCESSING IN THE NUCLEUS | 56 | 1.98e-01 | 0.099600 | 3.37e-01 |
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 4.55e-01 | 0.099000 | 6.03e-01 |
STIMULI SENSING CHANNELS | 78 | 1.34e-01 | -0.098300 | 2.54e-01 |
ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 4.36e-01 | -0.098200 | 5.84e-01 |
MYD88 INDEPENDENT TLR4 CASCADE | 93 | 1.02e-01 | -0.098100 | 2.09e-01 |
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 1.47e-01 | -0.098100 | 2.73e-01 |
RHOBTB3 ATPASE CYCLE | 10 | 5.92e-01 | -0.098000 | 7.12e-01 |
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 48 | 2.40e-01 | -0.098000 | 3.87e-01 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 5.57e-01 | 0.098000 | 6.87e-01 |
HEDGEHOG OFF STATE | 106 | 8.18e-02 | 0.097900 | 1.78e-01 |
TIE2 SIGNALING | 17 | 4.86e-01 | -0.097600 | 6.30e-01 |
SIGNALING BY ERBB2 | 48 | 2.44e-01 | -0.097300 | 3.91e-01 |
SLC MEDIATED TRANSMEMBRANE TRANSPORT | 190 | 2.11e-02 | -0.097200 | 6.54e-02 |
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 16 | 5.03e-01 | 0.096800 | 6.44e-01 |
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 26 | 3.93e-01 | -0.096700 | 5.48e-01 |
DEPOLYMERISATION OF THE NUCLEAR LAMINA | 13 | 5.47e-01 | -0.096600 | 6.77e-01 |
TRANSCRIPTIONAL REGULATION BY TP53 | 341 | 2.24e-03 | 0.096500 | 1.12e-02 |
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 5.47e-01 | 0.096500 | 6.77e-01 |
MET ACTIVATES RAS SIGNALING | 10 | 5.98e-01 | -0.096400 | 7.17e-01 |
ESR MEDIATED SIGNALING | 167 | 3.18e-02 | -0.096400 | 8.91e-02 |
ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 4.68e-01 | 0.096200 | 6.14e-01 |
DSCAM INTERACTIONS | 11 | 5.82e-01 | -0.096000 | 7.05e-01 |
SIGNALING BY PDGF | 57 | 2.11e-01 | -0.095900 | 3.54e-01 |
NUCLEAR ENVELOPE BREAKDOWN | 48 | 2.51e-01 | -0.095700 | 4.00e-01 |
ACYL CHAIN REMODELLING OF PG | 10 | 6.01e-01 | -0.095500 | 7.20e-01 |
SIGNALING BY CSF3 G CSF | 29 | 3.73e-01 | 0.095500 | 5.30e-01 |
NEUROTRANSMITTER RELEASE CYCLE | 48 | 2.53e-01 | -0.095300 | 4.03e-01 |
INTERLEUKIN 20 FAMILY SIGNALING | 15 | 5.23e-01 | -0.095300 | 6.58e-01 |
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 69 | 1.72e-01 | 0.095000 | 3.08e-01 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 5.25e-01 | 0.094700 | 6.60e-01 |
O LINKED GLYCOSYLATION OF MUCINS | 42 | 2.90e-01 | -0.094400 | 4.36e-01 |
RHO GTPASES ACTIVATE IQGAPS | 24 | 4.24e-01 | 0.094200 | 5.74e-01 |
ERKS ARE INACTIVATED | 13 | 5.57e-01 | -0.094100 | 6.87e-01 |
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 30 | 3.73e-01 | 0.094100 | 5.29e-01 |
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 21 | 4.63e-01 | 0.092600 | 6.10e-01 |
EARLY PHASE OF HIV LIFE CYCLE | 13 | 5.64e-01 | 0.092300 | 6.92e-01 |
DAP12 INTERACTIONS | 31 | 3.76e-01 | 0.091800 | 5.31e-01 |
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 20 | 4.79e-01 | -0.091500 | 6.24e-01 |
ER TO GOLGI ANTEROGRADE TRANSPORT | 139 | 6.41e-02 | 0.091000 | 1.47e-01 |
LYSOSOME VESICLE BIOGENESIS | 32 | 3.74e-01 | 0.090800 | 5.30e-01 |
DNA DOUBLE STRAND BREAK RESPONSE | 52 | 2.58e-01 | 0.090600 | 4.08e-01 |
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 74 | 1.80e-01 | -0.090200 | 3.16e-01 |
ACYL CHAIN REMODELLING OF PC | 16 | 5.32e-01 | -0.090200 | 6.63e-01 |
CD28 CO STIMULATION | 31 | 3.86e-01 | -0.090100 | 5.41e-01 |
HCMV INFECTION | 103 | 1.15e-01 | 0.089900 | 2.27e-01 |
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 2.33e-01 | 0.089800 | 3.81e-01 |
PTEN REGULATION | 133 | 7.40e-02 | 0.089800 | 1.64e-01 |
REPRODUCTION | 78 | 1.71e-01 | 0.089800 | 3.05e-01 |
SENSORY PERCEPTION | 148 | 6.11e-02 | -0.089300 | 1.43e-01 |
SIGNALING BY PTK6 | 51 | 2.72e-01 | -0.089000 | 4.18e-01 |
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 16 | 5.39e-01 | 0.088800 | 6.69e-01 |
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 14 | 5.69e-01 | 0.087900 | 6.94e-01 |
EGFR DOWNREGULATION | 28 | 4.24e-01 | -0.087400 | 5.74e-01 |
PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 13 | 5.86e-01 | -0.087300 | 7.09e-01 |
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 79 | 1.81e-01 | -0.087000 | 3.17e-01 |
TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 6.17e-01 | 0.087000 | 7.34e-01 |
SIGNALING BY LEPTIN | 10 | 6.35e-01 | -0.086700 | 7.48e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 5.62e-01 | 0.086500 | 6.89e-01 |
INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 4.65e-01 | 0.086100 | 6.12e-01 |
SIGNALING BY FGFR4 | 34 | 3.88e-01 | -0.085600 | 5.42e-01 |
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 4.87e-01 | -0.085500 | 6.31e-01 |
CD28 DEPENDENT PI3K AKT SIGNALING | 21 | 4.98e-01 | -0.085400 | 6.40e-01 |
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 50 | 2.97e-01 | 0.085300 | 4.45e-01 |
KERATAN SULFATE BIOSYNTHESIS | 24 | 4.71e-01 | 0.085100 | 6.15e-01 |
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 4.23e-01 | 0.084600 | 5.74e-01 |
PI 3K CASCADE FGFR1 | 17 | 5.47e-01 | -0.084400 | 6.77e-01 |
DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 21 | 5.04e-01 | 0.084300 | 6.44e-01 |
GAP JUNCTION DEGRADATION | 11 | 6.30e-01 | -0.084000 | 7.45e-01 |
PHOSPHOLIPID METABOLISM | 186 | 4.89e-02 | -0.083800 | 1.21e-01 |
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 3.37e-01 | 0.083700 | 4.92e-01 |
SIGNALLING TO RAS | 19 | 5.28e-01 | 0.083700 | 6.60e-01 |
G ALPHA Q SIGNALLING EVENTS | 157 | 7.15e-02 | -0.083400 | 1.59e-01 |
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 38 | 3.75e-01 | -0.083100 | 5.30e-01 |
MHC CLASS II ANTIGEN PRESENTATION | 101 | 1.52e-01 | 0.082600 | 2.79e-01 |
POTENTIAL THERAPEUTICS FOR SARS | 77 | 2.11e-01 | -0.082500 | 3.54e-01 |
SIGNALING BY FGFR2 | 64 | 2.55e-01 | 0.082400 | 4.04e-01 |
INFLAMMASOMES | 19 | 5.35e-01 | -0.082100 | 6.66e-01 |
MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 4.46e-01 | -0.081700 | 5.93e-01 |
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 28 | 4.58e-01 | 0.081100 | 6.05e-01 |
PEPTIDE HORMONE METABOLISM | 62 | 2.71e-01 | -0.080800 | 4.18e-01 |
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 11 | 6.43e-01 | 0.080700 | 7.55e-01 |
TRP CHANNELS | 21 | 5.22e-01 | -0.080700 | 6.58e-01 |
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 33 | 4.24e-01 | -0.080400 | 5.74e-01 |
SARS COV 1 INFECTION | 48 | 3.39e-01 | 0.079900 | 4.94e-01 |
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 12 | 6.34e-01 | 0.079500 | 7.48e-01 |
NICOTINATE METABOLISM | 25 | 4.92e-01 | 0.079500 | 6.35e-01 |
RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 87 | 2.02e-01 | -0.079200 | 3.42e-01 |
MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 5.31e-01 | 0.078900 | 6.62e-01 |
REGULATION OF LIPID METABOLISM BY PPARALPHA | 108 | 1.58e-01 | -0.078600 | 2.88e-01 |
ACTIVATION OF BH3 ONLY PROTEINS | 30 | 4.58e-01 | 0.078300 | 6.05e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 18 | 5.69e-01 | 0.077500 | 6.94e-01 |
SHC1 EVENTS IN EGFR SIGNALING | 11 | 6.57e-01 | -0.077400 | 7.65e-01 |
TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 5.70e-01 | 0.077300 | 6.94e-01 |
KERATAN SULFATE KERATIN METABOLISM | 30 | 4.64e-01 | 0.077200 | 6.11e-01 |
DEADENYLATION OF MRNA | 25 | 5.04e-01 | -0.077200 | 6.44e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 15 | 6.05e-01 | -0.077200 | 7.22e-01 |
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 29 | 4.73e-01 | 0.076900 | 6.18e-01 |
UB SPECIFIC PROCESSING PROTEASES | 166 | 8.91e-02 | 0.076500 | 1.90e-01 |
SPRY REGULATION OF FGF SIGNALING | 16 | 5.96e-01 | 0.076500 | 7.17e-01 |
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 4.41e-01 | -0.076400 | 5.88e-01 |
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 5.28e-01 | -0.076100 | 6.60e-01 |
VISUAL PHOTOTRANSDUCTION | 58 | 3.20e-01 | -0.075500 | 4.74e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 23 | 5.31e-01 | 0.075500 | 6.62e-01 |
RIPK1 MEDIATED REGULATED NECROSIS | 25 | 5.18e-01 | 0.074700 | 6.56e-01 |
INTERFERON SIGNALING | 167 | 9.66e-02 | -0.074600 | 2.02e-01 |
TNF SIGNALING | 43 | 3.98e-01 | -0.074500 | 5.50e-01 |
PLASMA LIPOPROTEIN CLEARANCE | 27 | 5.03e-01 | -0.074400 | 6.44e-01 |
COPII MEDIATED VESICLE TRANSPORT | 63 | 3.09e-01 | 0.074100 | 4.60e-01 |
FCERI MEDIATED CA 2 MOBILIZATION | 25 | 5.23e-01 | -0.073900 | 6.58e-01 |
SIGNALING BY FLT3 ITD AND TKD MUTANTS | 16 | 6.10e-01 | 0.073700 | 7.27e-01 |
INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 285 | 3.29e-02 | -0.073600 | 9.11e-02 |
ACYL CHAIN REMODELLING OF PS | 14 | 6.38e-01 | -0.072700 | 7.50e-01 |
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 6.78e-01 | -0.072300 | 7.85e-01 |
RECYCLING PATHWAY OF L1 | 40 | 4.30e-01 | -0.072200 | 5.79e-01 |
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 65 | 3.17e-01 | 0.071900 | 4.70e-01 |
INNATE IMMUNE SYSTEM | 780 | 6.82e-04 | 0.071800 | 3.96e-03 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 5.26e-01 | -0.071800 | 6.60e-01 |
TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 63 | 3.26e-01 | 0.071600 | 4.80e-01 |
RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 2.87e-01 | 0.071600 | 4.35e-01 |
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 69 | 3.05e-01 | -0.071400 | 4.55e-01 |
G2 M DNA DAMAGE CHECKPOINT | 65 | 3.22e-01 | 0.071000 | 4.76e-01 |
HDACS DEACETYLATE HISTONES | 46 | 4.08e-01 | 0.070500 | 5.60e-01 |
REGULATION OF GENE EXPRESSION IN BETA CELLS | 12 | 6.73e-01 | 0.070300 | 7.80e-01 |
TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 93 | 2.42e-01 | -0.070200 | 3.89e-01 |
DARPP 32 EVENTS | 23 | 5.60e-01 | -0.070200 | 6.88e-01 |
GLYCOGEN SYNTHESIS | 14 | 6.50e-01 | 0.070100 | 7.58e-01 |
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 50 | 3.94e-01 | -0.069800 | 5.48e-01 |
SHC MEDIATED CASCADE FGFR4 | 13 | 6.63e-01 | -0.069700 | 7.71e-01 |
IRAK1 RECRUITS IKK COMPLEX | 14 | 6.52e-01 | -0.069700 | 7.60e-01 |
EPIGENETIC REGULATION OF GENE EXPRESSION | 103 | 2.27e-01 | 0.068900 | 3.73e-01 |
PROCESSING OF INTRONLESS PRE MRNAS | 19 | 6.04e-01 | -0.068800 | 7.22e-01 |
CHONDROITIN SULFATE BIOSYNTHESIS | 18 | 6.15e-01 | -0.068500 | 7.32e-01 |
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 348 | 2.93e-02 | 0.068100 | 8.37e-02 |
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 36 | 4.82e-01 | 0.067800 | 6.26e-01 |
SUMOYLATION OF DNA REPLICATION PROTEINS | 43 | 4.46e-01 | -0.067200 | 5.93e-01 |
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 4.58e-01 | -0.067000 | 6.05e-01 |
ACYL CHAIN REMODELLING OF PE | 16 | 6.44e-01 | -0.066700 | 7.56e-01 |
SIGNALING BY EGFR IN CANCER | 22 | 5.88e-01 | -0.066700 | 7.11e-01 |
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 91 | 2.73e-01 | 0.066500 | 4.19e-01 |
P38MAPK EVENTS | 13 | 6.79e-01 | 0.066400 | 7.85e-01 |
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 6.09e-01 | -0.066100 | 7.26e-01 |
NUCLEOBASE BIOSYNTHESIS | 15 | 6.58e-01 | 0.066000 | 7.66e-01 |
G1 S SPECIFIC TRANSCRIPTION | 26 | 5.66e-01 | 0.065100 | 6.92e-01 |
UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 7.09e-01 | -0.065000 | 8.10e-01 |
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 74 | 3.37e-01 | -0.064600 | 4.92e-01 |
GLYCOGEN METABOLISM | 25 | 5.79e-01 | -0.064200 | 7.02e-01 |
GENE SILENCING BY RNA | 84 | 3.11e-01 | 0.063900 | 4.63e-01 |
PEPTIDE LIGAND BINDING RECEPTORS | 109 | 2.49e-01 | -0.063900 | 3.98e-01 |
MAPK FAMILY SIGNALING CASCADES | 290 | 6.18e-02 | -0.063900 | 1.44e-01 |
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 4.41e-01 | -0.063700 | 5.88e-01 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 7.27e-01 | 0.063600 | 8.23e-01 |
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 104 | 2.65e-01 | 0.063300 | 4.13e-01 |
ION CHANNEL TRANSPORT | 144 | 1.95e-01 | -0.062600 | 3.34e-01 |
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 6.68e-01 | -0.061900 | 7.75e-01 |
FLT3 SIGNALING | 36 | 5.22e-01 | -0.061600 | 6.58e-01 |
SIGNALING BY FGFR3 | 36 | 5.23e-01 | -0.061600 | 6.58e-01 |
TOLL LIKE RECEPTOR CASCADES | 138 | 2.15e-01 | -0.061200 | 3.60e-01 |
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 288 | 7.46e-02 | 0.061200 | 1.65e-01 |
FRS MEDIATED FGFR4 SIGNALING | 15 | 6.83e-01 | -0.060900 | 7.87e-01 |
SYNDECAN INTERACTIONS | 26 | 5.91e-01 | -0.060900 | 7.12e-01 |
CYCLIN D ASSOCIATED EVENTS IN G1 | 45 | 4.80e-01 | 0.060800 | 6.25e-01 |
CGMP EFFECTS | 15 | 6.85e-01 | -0.060500 | 7.89e-01 |
NUCLEAR SIGNALING BY ERBB4 | 31 | 5.67e-01 | -0.059500 | 6.93e-01 |
MITOTIC PROPHASE | 93 | 3.26e-01 | 0.058900 | 4.80e-01 |
RAB REGULATION OF TRAFFICKING | 117 | 2.75e-01 | -0.058400 | 4.20e-01 |
FGFR2 LIGAND BINDING AND ACTIVATION | 13 | 7.16e-01 | -0.058300 | 8.16e-01 |
ZINC TRANSPORTERS | 16 | 6.90e-01 | -0.057600 | 7.92e-01 |
RHO GTPASES ACTIVATE PAKS | 21 | 6.48e-01 | -0.057500 | 7.58e-01 |
TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 5.10e-01 | -0.057400 | 6.50e-01 |
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 35 | 5.62e-01 | 0.056700 | 6.89e-01 |
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 86 | 3.67e-01 | 0.056300 | 5.26e-01 |
PRE NOTCH EXPRESSION AND PROCESSING | 63 | 4.40e-01 | -0.056200 | 5.88e-01 |
MITOTIC SPINDLE CHECKPOINT | 99 | 3.36e-01 | 0.056000 | 4.92e-01 |
ACTIVATION OF THE TFAP2 AP 2 FAMILY OF TRANSCRIPTION FACTORS | 10 | 7.61e-01 | 0.055700 | 8.50e-01 |
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 6.25e-01 | -0.055400 | 7.41e-01 |
PRE NOTCH PROCESSING IN GOLGI | 17 | 6.94e-01 | -0.055100 | 7.95e-01 |
SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 7.52e-01 | 0.055100 | 8.42e-01 |
NEGATIVE REGULATION OF MET ACTIVITY | 21 | 6.67e-01 | -0.054300 | 7.74e-01 |
HEMOSTASIS | 474 | 4.46e-02 | -0.054000 | 1.14e-01 |
MAP2K AND MAPK ACTIVATION | 36 | 5.75e-01 | -0.054000 | 6.99e-01 |
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 25 | 6.43e-01 | 0.053600 | 7.55e-01 |
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 12 | 7.48e-01 | 0.053500 | 8.42e-01 |
E2F MEDIATED REGULATION OF DNA REPLICATION | 20 | 6.83e-01 | -0.052700 | 7.87e-01 |
ION HOMEOSTASIS | 49 | 5.30e-01 | -0.051900 | 6.62e-01 |
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 18 | 7.05e-01 | -0.051500 | 8.06e-01 |
RESOLUTION OF D LOOP STRUCTURES | 30 | 6.27e-01 | -0.051200 | 7.42e-01 |
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 44 | 5.60e-01 | 0.050900 | 6.88e-01 |
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 39 | 5.84e-01 | 0.050700 | 7.08e-01 |
APOPTOSIS INDUCED DNA FRAGMENTATION | 11 | 7.75e-01 | 0.049700 | 8.59e-01 |
SIGNALING BY INTERLEUKINS | 350 | 1.12e-01 | 0.049600 | 2.23e-01 |
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 7.40e-01 | 0.049400 | 8.35e-01 |
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 31 | 6.35e-01 | 0.049300 | 7.48e-01 |
MUSCLE CONTRACTION | 158 | 2.86e-01 | -0.049200 | 4.34e-01 |
MEMBRANE TRAFFICKING | 575 | 4.74e-02 | -0.048600 | 1.18e-01 |
VITAMIN B5 PANTOTHENATE METABOLISM | 15 | 7.45e-01 | -0.048600 | 8.39e-01 |
CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 7.19e-01 | -0.047700 | 8.17e-01 |
INTRA GOLGI TRAFFIC | 43 | 5.90e-01 | -0.047600 | 7.11e-01 |
RHO GTPASES ACTIVATE ROCKS | 19 | 7.24e-01 | 0.046800 | 8.20e-01 |
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 14 | 7.66e-01 | 0.045900 | 8.54e-01 |
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 7.93e-01 | -0.045800 | 8.76e-01 |
SIGNALING BY NUCLEAR RECEPTORS | 222 | 2.41e-01 | -0.045800 | 3.87e-01 |
ELASTIC FIBRE FORMATION | 39 | 6.21e-01 | -0.045700 | 7.38e-01 |
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 6.45e-01 | -0.045700 | 7.56e-01 |
BILE ACID AND BILE SALT METABOLISM | 25 | 6.93e-01 | -0.045600 | 7.95e-01 |
VESICLE MEDIATED TRANSPORT | 608 | 5.71e-02 | -0.045400 | 1.36e-01 |
ASPARAGINE N LINKED GLYCOSYLATION | 282 | 1.92e-01 | 0.045300 | 3.29e-01 |
ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 8.07e-01 | -0.044600 | 8.89e-01 |
HDR THROUGH SINGLE STRAND ANNEALING SSA | 36 | 6.49e-01 | 0.043800 | 7.58e-01 |
SLC TRANSPORTER DISORDERS | 75 | 5.13e-01 | -0.043700 | 6.51e-01 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 7.78e-01 | -0.043600 | 8.61e-01 |
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 7.69e-01 | 0.042500 | 8.56e-01 |
GOLGI ASSOCIATED VESICLE BIOGENESIS | 54 | 5.93e-01 | -0.042000 | 7.14e-01 |
OLFACTORY SIGNALING PATHWAY | 32 | 6.83e-01 | -0.041700 | 7.87e-01 |
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 96 | 4.81e-01 | -0.041700 | 6.25e-01 |
GLUCOSE METABOLISM | 80 | 5.21e-01 | 0.041600 | 6.58e-01 |
DISEASES OF IMMUNE SYSTEM | 25 | 7.21e-01 | 0.041300 | 8.18e-01 |
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 7.17e-01 | -0.041000 | 8.17e-01 |
TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 8.09e-01 | 0.040400 | 8.89e-01 |
THE PHOTOTRANSDUCTION CASCADE | 19 | 7.65e-01 | -0.039600 | 8.54e-01 |
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 63 | 5.87e-01 | -0.039500 | 7.10e-01 |
NOD1 2 SIGNALING PATHWAY | 35 | 6.88e-01 | 0.039200 | 7.92e-01 |
AURKA ACTIVATION BY TPX2 | 71 | 5.70e-01 | 0.039000 | 6.94e-01 |
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 84 | 5.39e-01 | 0.038800 | 6.69e-01 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 8.11e-01 | -0.038300 | 8.90e-01 |
SIGNALING BY NOTCH | 188 | 3.73e-01 | 0.037700 | 5.29e-01 |
G0 AND EARLY G1 | 24 | 7.50e-01 | 0.037500 | 8.42e-01 |
ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | 10 | 8.39e-01 | -0.037100 | 9.11e-01 |
HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | 10 | 8.39e-01 | -0.037100 | 9.11e-01 |
DISEASES OF CARBOHYDRATE METABOLISM | 29 | 7.35e-01 | 0.036400 | 8.29e-01 |
LGI ADAM INTERACTIONS | 14 | 8.17e-01 | -0.035800 | 8.93e-01 |
ADAPTIVE IMMUNE SYSTEM | 607 | 1.36e-01 | 0.035600 | 2.57e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 12 | 8.34e-01 | 0.034900 | 9.09e-01 |
DISEASES OF MITOTIC CELL CYCLE | 37 | 7.21e-01 | 0.033900 | 8.18e-01 |
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 6.03e-01 | 0.033900 | 7.22e-01 |
DISEASES OF METABOLISM | 198 | 4.15e-01 | 0.033700 | 5.65e-01 |
UNFOLDED PROTEIN RESPONSE UPR | 86 | 5.98e-01 | -0.032900 | 7.17e-01 |
NEGATIVE REGULATION OF FGFR1 SIGNALING | 28 | 7.67e-01 | 0.032400 | 8.54e-01 |
RHOH GTPASE CYCLE | 37 | 7.34e-01 | -0.032300 | 8.29e-01 |
RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 7.42e-01 | -0.031700 | 8.37e-01 |
ORGANELLE BIOGENESIS AND MAINTENANCE | 283 | 3.63e-01 | 0.031500 | 5.24e-01 |
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 7.71e-01 | -0.029700 | 8.57e-01 |
SARS COV INFECTIONS | 140 | 5.48e-01 | -0.029500 | 6.77e-01 |
RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 8.44e-01 | -0.029400 | 9.13e-01 |
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 8.10e-01 | 0.029000 | 8.89e-01 |
SHC MEDIATED CASCADE FGFR1 | 17 | 8.40e-01 | 0.028300 | 9.11e-01 |
FLT3 SIGNALING IN DISEASE | 28 | 8.00e-01 | -0.027700 | 8.82e-01 |
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 92 | 6.47e-01 | -0.027600 | 7.58e-01 |
CILIUM ASSEMBLY | 191 | 5.15e-01 | -0.027400 | 6.53e-01 |
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 8.70e-01 | 0.027300 | 9.29e-01 |
FERTILIZATION | 11 | 8.76e-01 | -0.027100 | 9.32e-01 |
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 26 | 8.12e-01 | 0.027000 | 8.90e-01 |
METABOLISM OF LIPIDS | 616 | 2.59e-01 | 0.026700 | 4.08e-01 |
DEUBIQUITINATION | 240 | 4.84e-01 | 0.026300 | 6.28e-01 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 8.76e-01 | 0.025900 | 9.32e-01 |
TBC RABGAPS | 42 | 7.76e-01 | -0.025400 | 8.59e-01 |
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 23 | 8.35e-01 | -0.025100 | 9.09e-01 |
FRS MEDIATED FGFR1 SIGNALING | 19 | 8.51e-01 | 0.024900 | 9.18e-01 |
FOXO MEDIATED TRANSCRIPTION | 57 | 7.51e-01 | 0.024300 | 8.42e-01 |
SIGNALING BY WNT | 266 | 4.96e-01 | -0.024300 | 6.38e-01 |
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 8.63e-01 | -0.024100 | 9.28e-01 |
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 7.76e-01 | 0.023800 | 8.59e-01 |
RNA POLYMERASE II TRANSCRIPTION | 1093 | 1.89e-01 | -0.023700 | 3.26e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 8.24e-01 | -0.023500 | 9.00e-01 |
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 8.65e-01 | 0.023200 | 9.28e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 15 | 8.77e-01 | 0.023000 | 9.32e-01 |
GLYCOLYSIS | 66 | 7.49e-01 | -0.022800 | 8.42e-01 |
RESOLUTION OF SISTER CHROMATID COHESION | 103 | 6.90e-01 | 0.022800 | 7.92e-01 |
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 8.92e-01 | -0.022700 | 9.42e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 8.88e-01 | -0.022500 | 9.41e-01 |
DOWNREGULATION OF ERBB2 SIGNALING | 28 | 8.39e-01 | -0.022200 | 9.11e-01 |
GLYCOSPHINGOLIPID METABOLISM | 38 | 8.13e-01 | 0.022200 | 8.90e-01 |
REGULATION OF TP53 EXPRESSION AND DEGRADATION | 33 | 8.27e-01 | 0.022000 | 9.03e-01 |
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 168 | 6.25e-01 | 0.021900 | 7.41e-01 |
SARS COV 2 INFECTION | 65 | 7.61e-01 | 0.021900 | 8.50e-01 |
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 177 | 6.20e-01 | -0.021700 | 7.36e-01 |
ENDOGENOUS STEROLS | 20 | 8.67e-01 | 0.021600 | 9.28e-01 |
SPHINGOLIPID DE NOVO BIOSYNTHESIS | 42 | 8.09e-01 | -0.021500 | 8.89e-01 |
DISEASES OF GLYCOSYLATION | 124 | 6.82e-01 | 0.021300 | 7.87e-01 |
INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 8.87e-01 | -0.021200 | 9.41e-01 |
POST TRANSLATIONAL PROTEIN MODIFICATION | 1226 | 2.16e-01 | 0.021200 | 3.60e-01 |
GPVI MEDIATED ACTIVATION CASCADE | 31 | 8.41e-01 | -0.020800 | 9.11e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX1 | 179 | 6.37e-01 | 0.020500 | 7.50e-01 |
NICOTINAMIDE SALVAGING | 15 | 8.91e-01 | 0.020400 | 9.42e-01 |
RETROGRADE NEUROTROPHIN SIGNALLING | 13 | 8.99e-01 | -0.020300 | 9.44e-01 |
NEGATIVE REGULATION OF FGFR4 SIGNALING | 24 | 8.65e-01 | -0.020100 | 9.28e-01 |
SEMA4D IN SEMAPHORIN SIGNALING | 24 | 8.66e-01 | -0.019900 | 9.28e-01 |
DEVELOPMENTAL BIOLOGY | 821 | 3.47e-01 | -0.019400 | 5.04e-01 |
DAP12 SIGNALING | 24 | 8.69e-01 | 0.019400 | 9.29e-01 |
SIALIC ACID METABOLISM | 32 | 8.50e-01 | -0.019400 | 9.18e-01 |
ELEVATION OF CYTOSOLIC CA2 LEVELS | 14 | 9.01e-01 | -0.019300 | 9.45e-01 |
RHO GTPASES ACTIVATE FORMINS | 121 | 7.19e-01 | 0.019000 | 8.17e-01 |
UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 28 | 8.63e-01 | -0.018900 | 9.28e-01 |
SIGNALING BY HEDGEHOG | 141 | 7.01e-01 | -0.018700 | 8.03e-01 |
DISEASES OF DNA REPAIR | 11 | 9.16e-01 | 0.018500 | 9.52e-01 |
NEGATIVE REGULATION OF FGFR3 SIGNALING | 25 | 8.75e-01 | 0.018200 | 9.32e-01 |
OTHER INTERLEUKIN SIGNALING | 20 | 8.89e-01 | 0.018100 | 9.41e-01 |
CLASS B 2 SECRETIN FAMILY RECEPTORS | 71 | 7.95e-01 | 0.017800 | 8.77e-01 |
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 14 | 9.08e-01 | 0.017800 | 9.49e-01 |
REGULATION OF TNFR1 SIGNALING | 34 | 8.58e-01 | -0.017800 | 9.23e-01 |
TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 8.74e-01 | -0.017400 | 9.32e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 9.08e-01 | -0.017300 | 9.49e-01 |
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 85 | 7.87e-01 | 0.017000 | 8.70e-01 |
FRS MEDIATED FGFR2 SIGNALING | 20 | 8.96e-01 | -0.016900 | 9.43e-01 |
INTERLEUKIN 6 FAMILY SIGNALING | 20 | 8.97e-01 | 0.016700 | 9.43e-01 |
SUMOYLATION OF TRANSCRIPTION FACTORS | 18 | 9.03e-01 | -0.016600 | 9.45e-01 |
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 22 | 8.95e-01 | -0.016300 | 9.43e-01 |
REGULATED PROTEOLYSIS OF P75NTR | 12 | 9.23e-01 | -0.016100 | 9.58e-01 |
TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 8.90e-01 | -0.014800 | 9.42e-01 |
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 87 | 8.12e-01 | -0.014800 | 8.90e-01 |
REGULATION OF TP53 ACTIVITY | 150 | 7.56e-01 | -0.014700 | 8.46e-01 |
PLATELET ACTIVATION SIGNALING AND AGGREGATION | 221 | 7.14e-01 | -0.014300 | 8.15e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS | 22 | 9.08e-01 | -0.014200 | 9.49e-01 |
RHO GTPASES ACTIVATE CIT | 18 | 9.18e-01 | 0.014000 | 9.54e-01 |
WNT LIGAND BIOGENESIS AND TRAFFICKING | 21 | 9.12e-01 | -0.013900 | 9.51e-01 |
FATTY ACYL COA BIOSYNTHESIS | 32 | 8.94e-01 | 0.013600 | 9.43e-01 |
BASIGIN INTERACTIONS | 22 | 9.14e-01 | -0.013300 | 9.51e-01 |
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 53 | 8.67e-01 | -0.013300 | 9.28e-01 |
BIOTIN TRANSPORT AND METABOLISM | 11 | 9.40e-01 | -0.013200 | 9.69e-01 |
MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 34 | 8.94e-01 | -0.013200 | 9.43e-01 |
VLDLR INTERNALISATION AND DEGRADATION | 12 | 9.37e-01 | 0.013200 | 9.69e-01 |
SIGNALING BY INSULIN RECEPTOR | 65 | 8.55e-01 | -0.013100 | 9.21e-01 |
RHO GTPASE EFFECTORS | 252 | 7.26e-01 | 0.012800 | 8.23e-01 |
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 78 | 8.50e-01 | 0.012400 | 9.18e-01 |
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 40 | 8.98e-01 | 0.011800 | 9.43e-01 |
BLOOD GROUP SYSTEMS BIOSYNTHESIS | 14 | 9.40e-01 | 0.011700 | 9.69e-01 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 9.29e-01 | -0.011500 | 9.63e-01 |
GOLGI TO ER RETROGRADE TRANSPORT | 120 | 8.34e-01 | -0.011100 | 9.09e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 15 | 9.44e-01 | -0.010500 | 9.72e-01 |
HDR THROUGH MMEJ ALT NHEJ | 10 | 9.55e-01 | -0.010300 | 9.82e-01 |
CELLULAR SENESCENCE | 141 | 8.41e-01 | -0.009790 | 9.11e-01 |
NONHOMOLOGOUS END JOINING NHEJ | 43 | 9.14e-01 | 0.009510 | 9.51e-01 |
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 9.58e-01 | -0.009110 | 9.83e-01 |
FGFR1 LIGAND BINDING AND ACTIVATION | 11 | 9.59e-01 | 0.009040 | 9.83e-01 |
GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 107 | 8.76e-01 | 0.008730 | 9.32e-01 |
SYNTHESIS OF PE | 13 | 9.58e-01 | 0.008350 | 9.83e-01 |
TRANS GOLGI NETWORK VESICLE BUDDING | 69 | 9.11e-01 | -0.007740 | 9.51e-01 |
SIGNALLING TO ERKS | 33 | 9.39e-01 | -0.007650 | 9.69e-01 |
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 9.27e-01 | 0.007630 | 9.61e-01 |
NERVOUS SYSTEM DEVELOPMENT | 549 | 7.72e-01 | 0.007250 | 8.58e-01 |
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 9.62e-01 | -0.006340 | 9.83e-01 |
INTERFERON ALPHA BETA SIGNALING | 56 | 9.39e-01 | 0.005920 | 9.69e-01 |
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 186 | 9.03e-01 | -0.005190 | 9.45e-01 |
PLATELET ADHESION TO EXPOSED COLLAGEN | 11 | 9.78e-01 | -0.004750 | 9.93e-01 |
METABOLISM OF FAT SOLUBLE VITAMINS | 32 | 9.66e-01 | -0.004400 | 9.86e-01 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 9.81e-01 | 0.004360 | 9.93e-01 |
RESPONSE OF MTB TO PHAGOCYTOSIS | 22 | 9.73e-01 | 0.004240 | 9.92e-01 |
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 9.82e-01 | 0.004110 | 9.93e-01 |
CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | 10 | 9.83e-01 | 0.004000 | 9.93e-01 |
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 9.81e-01 | 0.003760 | 9.93e-01 |
CARNITINE METABOLISM | 14 | 9.83e-01 | -0.003370 | 9.93e-01 |
HCMV EARLY EVENTS | 80 | 9.59e-01 | 0.003310 | 9.83e-01 |
NEGATIVE REGULATION OF FGFR2 SIGNALING | 29 | 9.76e-01 | 0.003280 | 9.93e-01 |
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 9.82e-01 | 0.002930 | 9.93e-01 |
HATS ACETYLATE HISTONES | 93 | 9.63e-01 | -0.002770 | 9.84e-01 |
GENERATION OF SECOND MESSENGER MOLECULES | 18 | 9.87e-01 | 0.002220 | 9.94e-01 |
TIGHT JUNCTION INTERACTIONS | 15 | 9.88e-01 | 0.002170 | 9.94e-01 |
POLO LIKE KINASE MEDIATED EVENTS | 13 | 9.89e-01 | 0.002160 | 9.94e-01 |
METABOLISM OF CARBOHYDRATES | 259 | 9.52e-01 | -0.002160 | 9.80e-01 |
SHC MEDIATED CASCADE FGFR3 | 14 | 9.89e-01 | 0.002050 | 9.94e-01 |
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 49 | 9.81e-01 | -0.001980 | 9.93e-01 |
INWARDLY RECTIFYING K CHANNELS | 31 | 9.85e-01 | -0.001920 | 9.94e-01 |
TRANSPORT OF SMALL MOLECULES | 582 | 9.42e-01 | -0.001770 | 9.71e-01 |
NEGATIVE REGULATION OF MAPK PATHWAY | 42 | 9.86e-01 | 0.001580 | 9.94e-01 |
OXIDATIVE STRESS INDUCED SENESCENCE | 78 | 9.83e-01 | -0.001400 | 9.93e-01 |
SIGNAL AMPLIFICATION | 30 | 9.90e-01 | 0.001380 | 9.94e-01 |
FRS MEDIATED FGFR3 SIGNALING | 16 | 9.93e-01 | 0.001340 | 9.95e-01 |
MITOTIC PROMETAPHASE | 178 | 9.76e-01 | 0.001290 | 9.93e-01 |
CYTOKINE SIGNALING IN IMMUNE SYSTEM | 547 | 9.61e-01 | 0.001220 | 9.83e-01 |
ENOS ACTIVATION | 11 | 9.96e-01 | -0.000865 | 9.97e-01 |
SPHINGOLIPID METABOLISM | 80 | 9.91e-01 | -0.000769 | 9.94e-01 |
SIGNALING BY FGFR IN DISEASE | 57 | 9.95e-01 | -0.000498 | 9.97e-01 |
SIGNALING BY FGFR | 75 | 9.97e-01 | -0.000237 | 9.97e-01 |
EUKARYOTIC TRANSLATION ELONGATION
305 | |
---|---|
set | EUKARYOTIC TRANSLATION ELONGATION |
setSize | 87 |
pANOVA | 4.06e-44 |
s.dist | 0.862 |
p.adjustANOVA | 1.6e-41 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Rps15 | 7805 |
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Rps15 | 7805 |
Rps10 | 7793 |
Rpl13 | 7786 |
Rpl11 | 7781 |
Rpl31 | 7729 |
Rpl34 | 7726 |
Rps12 | 7721 |
Rpl26 | 7699 |
Rps8 | 7676 |
Rplp1 | 7662 |
Rpl23 | 7655 |
Rpl27 | 7644 |
Rpl7a | 7609 |
Rpl24 | 7605 |
Rps23 | 7560 |
Rps27a | 7519 |
Rpl36a | 7511 |
Rps18 | 7494 |
Rpl18 | 7478 |
Rps7 | 7471 |
Rps9 | 7456 |
Rps15a | 7440 |
Rpl18a | 7438 |
Rpl9 | 7416 |
Rpl21 | 7270 |
Rps19 | 7268 |
Uba52 | 7262 |
Rpl29 | 7250 |
Rpl30 | 7145 |
Rpl8 | 7137 |
Rps13 | 7086 |
Rplp0 | 7009 |
Rpl10a | 6965 |
Rpl22l1 | 6916 |
Rps16 | 6913 |
Rps2 | 6912 |
Rpl7 | 6885 |
Rps11 | 6883 |
Rps25 | 6881 |
Rpl14 | 6873 |
Eef1d | 6818 |
Eef1b2 | 6809 |
Rpl13a | 6776 |
Rpl4 | 6774 |
Rps3 | 6754 |
Rps27l | 6682 |
Rps6 | 6648 |
Rpl3 | 6642 |
Rps24 | 6631 |
Rps5 | 6627 |
Rpl23a | 6619 |
Rpl17 | 6604 |
Rpl27a | 6473 |
Rps26 | 6384 |
Rps3a1 | 6345 |
Rpl28 | 6319 |
Rpl15 | 6281 |
Rpl5 | 6276 |
Rps20 | 6232 |
Rpl12 | 6198 |
Eef1g | 6077 |
Rps4x | 5999 |
Eef1a1 | 5792 |
Rpsa | 5712 |
Rpl6 | 5583 |
Rpl10 | 2228 |
Eef2 | 1448 |
Eef1a2 | 159 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY
840 | |
---|---|
set | RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY |
setSize | 95 |
pANOVA | 1.55e-37 |
s.dist | 0.759 |
p.adjustANOVA | 1.83e-35 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Rps15 | 7805 |
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Rps15 | 7805 |
Rps10 | 7793 |
Rpl13 | 7786 |
Rpl11 | 7781 |
Rpl31 | 7729 |
Rpl34 | 7726 |
Rps12 | 7721 |
Atf4 | 7703 |
Rpl26 | 7699 |
Rps8 | 7676 |
Rplp1 | 7662 |
Rpl23 | 7655 |
Rpl27 | 7644 |
Rpl7a | 7609 |
Rpl24 | 7605 |
Rps23 | 7560 |
Rps27a | 7519 |
Rpl36a | 7511 |
Rps18 | 7494 |
Rpl18 | 7478 |
Rps7 | 7471 |
Rps9 | 7456 |
Rps15a | 7440 |
Rpl18a | 7438 |
Rpl9 | 7416 |
Rpl21 | 7270 |
Rps19 | 7268 |
Uba52 | 7262 |
Rpl29 | 7250 |
Rpl30 | 7145 |
Rpl8 | 7137 |
Rps13 | 7086 |
Rplp0 | 7009 |
Rpl10a | 6965 |
Rpl22l1 | 6916 |
Rps16 | 6913 |
Rps2 | 6912 |
Rpl7 | 6885 |
Rps11 | 6883 |
Rps25 | 6881 |
Rpl14 | 6873 |
Rpl13a | 6776 |
Rpl4 | 6774 |
Rps3 | 6754 |
Rps27l | 6682 |
Rps6 | 6648 |
Rpl3 | 6642 |
Rps24 | 6631 |
Rps5 | 6627 |
Rpl23a | 6619 |
Rpl17 | 6604 |
Rpl27a | 6473 |
Eif2s1 | 6435 |
Rps26 | 6384 |
Rps3a1 | 6345 |
Rpl28 | 6319 |
Rpl15 | 6281 |
Rpl5 | 6276 |
Rps20 | 6232 |
Rpl12 | 6198 |
Rps4x | 5999 |
Rpsa | 5712 |
Ddit3 | 5632 |
Rpl6 | 5583 |
Eif2s2 | 4515 |
Rpl10 | 2228 |
Cebpb | 1745 |
Trib3 | 491 |
Atf3 | 449 |
Cebpg | -545 |
Eif2s3x | -729 |
Asns | -1790 |
Eif2ak4 | -5310 |
Impact | -5768 |
Gcn1 | -7117 |
Atf2 | -7475 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE
1013 | |
---|---|
set | SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE |
setSize | 106 |
pANOVA | 1.13e-41 |
s.dist | 0.759 |
p.adjustANOVA | 2.66e-39 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Sec61b | 8019 |
Rpl32 | 8005 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Sec61b | 8019 |
Rpl32 | 8005 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Rps15 | 7805 |
Rps10 | 7793 |
Rpl13 | 7786 |
Rpl11 | 7781 |
Rpl31 | 7729 |
Rpl34 | 7726 |
Rps12 | 7721 |
Sec11c | 7713 |
Rpl26 | 7699 |
Rps8 | 7676 |
Rplp1 | 7662 |
Rpl23 | 7655 |
Rpl27 | 7644 |
Rpl7a | 7609 |
Rpl24 | 7605 |
Rps23 | 7560 |
Rps27a | 7519 |
Rpl36a | 7511 |
Rps18 | 7494 |
Rpl18 | 7478 |
Rps7 | 7471 |
Rps9 | 7456 |
Rps15a | 7440 |
Rpl18a | 7438 |
Srp9 | 7428 |
Rpl9 | 7416 |
Rpl21 | 7270 |
Rps19 | 7268 |
Uba52 | 7262 |
Rpl29 | 7250 |
Rpl30 | 7145 |
Rpl8 | 7137 |
Rps13 | 7086 |
Srp14 | 7072 |
Sec61g | 7020 |
Rplp0 | 7009 |
Rpl10a | 6965 |
Rpl22l1 | 6916 |
Rps16 | 6913 |
Rps2 | 6912 |
Rpl7 | 6885 |
Rps11 | 6883 |
Rps25 | 6881 |
Rpl14 | 6873 |
Sec11a | 6840 |
Spcs1 | 6830 |
Rpl13a | 6776 |
Rpl4 | 6774 |
Rps3 | 6754 |
Rps27l | 6682 |
Rps6 | 6648 |
Rpl3 | 6642 |
Rps24 | 6631 |
Rps5 | 6627 |
Rpl23a | 6619 |
Rpl17 | 6604 |
Rpl27a | 6473 |
Ssr4 | 6450 |
Rps26 | 6384 |
Rps3a1 | 6345 |
Rpl28 | 6319 |
Rpl15 | 6281 |
Rpl5 | 6276 |
Rps20 | 6232 |
Rpl12 | 6198 |
Rps4x | 5999 |
Ssr2 | 5935 |
Srp19 | 5834 |
Rpsa | 5712 |
Rpl6 | 5583 |
Srprb | 5181 |
Spcs2 | 4468 |
Ddost | 2939 |
Ssr3 | 2761 |
Rpl10 | 2228 |
Srp54a | 1716 |
Sec61a2 | 1290 |
Rpn1 | 1064 |
Sec61a1 | 997 |
Spcs3 | 5 |
Srp68 | -1233 |
Rpn2 | -1692 |
Ssr1 | -2771 |
Srpr | -5713 |
Srp72 | -6413 |
Tram1 | -6559 |
MITOCHONDRIAL TRANSLATION
572 | |
---|---|
set | MITOCHONDRIAL TRANSLATION |
setSize | 93 |
pANOVA | 3e-36 |
s.dist | 0.753 |
p.adjustANOVA | 2.95e-34 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mrpl58 | 8214 |
Mrps28 | 8103 |
Mrps21 | 8096 |
Mrpl52 | 8073 |
Mrpl2 | 7995 |
Mrpl54 | 7979 |
Mrpl53 | 7963 |
Mrpl20 | 7935 |
Gadd45gip1 | 7925 |
Mrps26 | 7914 |
Mrps34 | 7892 |
Mrpl41 | 7862 |
Mrps18c | 7852 |
Mrps33 | 7840 |
Mrps16 | 7811 |
Mrpl30 | 7759 |
Mrpl51 | 7714 |
Mrps12 | 7682 |
Mrps24 | 7658 |
Mrpl9 | 7634 |
GeneID | Gene Rank |
---|---|
Mrpl58 | 8214 |
Mrps28 | 8103 |
Mrps21 | 8096 |
Mrpl52 | 8073 |
Mrpl2 | 7995 |
Mrpl54 | 7979 |
Mrpl53 | 7963 |
Mrpl20 | 7935 |
Gadd45gip1 | 7925 |
Mrps26 | 7914 |
Mrps34 | 7892 |
Mrpl41 | 7862 |
Mrps18c | 7852 |
Mrps33 | 7840 |
Mrps16 | 7811 |
Mrpl30 | 7759 |
Mrpl51 | 7714 |
Mrps12 | 7682 |
Mrps24 | 7658 |
Mrpl9 | 7634 |
Mrpl44 | 7629 |
Mrpl48 | 7613 |
Aurkaip1 | 7607 |
Mrpl40 | 7597 |
Mrpl43 | 7584 |
Mrpl11 | 7504 |
Mrpl27 | 7435 |
Mrpl28 | 7434 |
Mrps27 | 7433 |
Mrpl21 | 7329 |
Mrpl14 | 7319 |
Mrpl1 | 7306 |
Mrpl12 | 7266 |
Mrpl39 | 7228 |
Mrps23 | 7220 |
Mrpl13 | 7209 |
Mrpl33 | 7159 |
Mrpl49 | 7147 |
Mrps36 | 7138 |
Mrpl34 | 7119 |
Mrps10 | 6998 |
Mrpl23 | 6996 |
Mrpl55 | 6981 |
Mrps14 | 6937 |
Mrps7 | 6882 |
Mrpl46 | 6880 |
Mrps9 | 6863 |
Mrpl42 | 6852 |
Mrps15 | 6821 |
Mrpl15 | 6817 |
Mrps17 | 6815 |
Mrpl35 | 6775 |
Tsfm | 6732 |
Mrpl57 | 6671 |
Mrpl17 | 6518 |
Mrpl18 | 6485 |
Mrpl16 | 6368 |
Mtfmt | 6338 |
Mrps18b | 6221 |
Mrpl36 | 6087 |
Mrps22 | 6072 |
Mrpl32 | 5936 |
Mrps35 | 5721 |
Mrps18a | 5714 |
Mrps6 | 5692 |
Mrpl22 | 5672 |
Mrrf | 5635 |
Mrpl38 | 5614 |
Mtif3 | 5553 |
Eral1 | 5486 |
Mrpl50 | 5286 |
Mrpl10 | 5121 |
Chchd1 | 5107 |
Mrps25 | 5084 |
Mrpl3 | 5004 |
Mrps11 | 4972 |
Mrpl47 | 4959 |
Mtif2 | 4929 |
Mrpl19 | 4784 |
Mrpl4 | 4557 |
Tufm | 4339 |
Mrpl24 | 3938 |
Mrpl37 | 3706 |
Dap3 | 3603 |
Mrps2 | 3578 |
Mrps30 | 3131 |
Oxa1l | 2368 |
Gfm1 | 1820 |
Mrps31 | 1637 |
Mrps5 | 1615 |
Ptcd3 | 1490 |
Mtrf1l | -4850 |
Gfm2 | -7057 |
EUKARYOTIC TRANSLATION INITIATION
306 | |
---|---|
set | EUKARYOTIC TRANSLATION INITIATION |
setSize | 114 |
pANOVA | 1.77e-43 |
s.dist | 0.748 |
p.adjustANOVA | 5.22e-41 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Rps15 | 7805 |
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Rps15 | 7805 |
Rps10 | 7793 |
Rpl13 | 7786 |
Rpl11 | 7781 |
Rpl31 | 7729 |
Rpl34 | 7726 |
Rps12 | 7721 |
Rpl26 | 7699 |
Rps8 | 7676 |
Rplp1 | 7662 |
Rpl23 | 7655 |
Rpl27 | 7644 |
Rpl7a | 7609 |
Rpl24 | 7605 |
Rps23 | 7560 |
Rps27a | 7519 |
Rpl36a | 7511 |
Rps18 | 7494 |
Rpl18 | 7478 |
Eif3g | 7476 |
Rps7 | 7471 |
Rps9 | 7456 |
Rps15a | 7440 |
Rpl18a | 7438 |
Rpl9 | 7416 |
Rpl21 | 7270 |
Rps19 | 7268 |
Uba52 | 7262 |
Rpl29 | 7250 |
Eif3i | 7245 |
Eif3m | 7176 |
Rpl30 | 7145 |
Rpl8 | 7137 |
Rps13 | 7086 |
Rplp0 | 7009 |
Rpl10a | 6965 |
Rpl22l1 | 6916 |
Rps16 | 6913 |
Rps2 | 6912 |
Rpl7 | 6885 |
Rps11 | 6883 |
Rps25 | 6881 |
Rpl14 | 6873 |
Rpl13a | 6776 |
Rpl4 | 6774 |
Rps3 | 6754 |
Eif3h | 6729 |
Rps27l | 6682 |
Eif2b1 | 6658 |
Rps6 | 6648 |
Rpl3 | 6642 |
Rps24 | 6631 |
Rps5 | 6627 |
Rpl23a | 6619 |
Rpl17 | 6604 |
Eif3j1 | 6602 |
Rpl27a | 6473 |
Eif2s1 | 6435 |
Rps26 | 6384 |
Rps3a1 | 6345 |
Rpl28 | 6319 |
Rpl15 | 6281 |
Rpl5 | 6276 |
Eif2b2 | 6268 |
Eif4a1 | 6253 |
Rps20 | 6232 |
Rpl12 | 6198 |
Rps4x | 5999 |
Eif3k | 5919 |
Rpsa | 5712 |
Rpl6 | 5583 |
Eif3d | 5574 |
Eif3f | 5282 |
Eif2b4 | 5067 |
Eif5 | 5019 |
Eif4e | 4744 |
Eif3l | 4682 |
Eif2s2 | 4515 |
Eif4a2 | 4494 |
Eif4h | 4352 |
Eif3e | 4145 |
Eif4ebp1 | 4008 |
Eif2b5 | 3736 |
Eif5b | 2307 |
Eif3c | 2238 |
Rpl10 | 2228 |
Eif3b | 204 |
Eif1ax | -705 |
Eif2s3x | -729 |
Eif4b | -764 |
Eif2b3 | -1065 |
Pabpc1 | -2626 |
Eif4g1 | -4562 |
Eif3a | -5496 |
Eif3j2 | -7834 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING
331 | |
---|---|
set | FORMATION OF ATP BY CHEMIOSMOTIC COUPLING |
setSize | 18 |
pANOVA | 4.11e-08 |
s.dist | 0.747 |
p.adjustANOVA | 7.82e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Atp5k | 8246 |
Atp5g1 | 8061 |
Atp5j | 8037 |
Atp5e | 8029 |
Atp5j2 | 7996 |
mt-Atp8 | 7872 |
Atp5g3 | 7732 |
Atp5pb | 7715 |
Atp5c1 | 7702 |
Atp5h | 7646 |
Atp5l | 7551 |
Atp5o | 7535 |
Atp5b | 7287 |
Atp5d | 7201 |
Dmac2l | 5595 |
Atp5a1 | 2242 |
mt-Atp6 | 117 |
Atp5g2 | -7609 |
GeneID | Gene Rank |
---|---|
Atp5k | 8246 |
Atp5g1 | 8061 |
Atp5j | 8037 |
Atp5e | 8029 |
Atp5j2 | 7996 |
mt-Atp8 | 7872 |
Atp5g3 | 7732 |
Atp5pb | 7715 |
Atp5c1 | 7702 |
Atp5h | 7646 |
Atp5l | 7551 |
Atp5o | 7535 |
Atp5b | 7287 |
Atp5d | 7201 |
Dmac2l | 5595 |
Atp5a1 | 2242 |
mt-Atp6 | 117 |
Atp5g2 | -7609 |
ADENYLATE CYCLASE ACTIVATING PATHWAY
36 | |
---|---|
set | ADENYLATE CYCLASE ACTIVATING PATHWAY |
setSize | 10 |
pANOVA | 4.94e-05 |
s.dist | -0.741 |
p.adjustANOVA | 0.000438 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Adcy4 | -9080 |
Adcy7 | -8971 |
Adcy6 | -8795 |
Adcy3 | -7802 |
Adcy5 | -7709 |
Adcy8 | -7344 |
Gnal | -7090 |
Adcy2 | -6526 |
Adcy9 | -4486 |
Adcy1 | -640 |
GeneID | Gene Rank |
---|---|
Adcy4 | -9080 |
Adcy7 | -8971 |
Adcy6 | -8795 |
Adcy3 | -7802 |
Adcy5 | -7709 |
Adcy8 | -7344 |
Gnal | -7090 |
Adcy2 | -6526 |
Adcy9 | -4486 |
Adcy1 | -640 |
COMPLEX I BIOGENESIS
172 | |
---|---|
set | COMPLEX I BIOGENESIS |
setSize | 56 |
pANOVA | 6.16e-21 |
s.dist | 0.725 |
p.adjustANOVA | 3.64e-19 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ndufb1 | 8224 |
Ndufa1 | 8209 |
Ndufa3 | 8206 |
Ndufa2 | 8193 |
Ndufc1 | 8100 |
Ndufa5 | 8056 |
Ndufa13 | 8055 |
Ndufs6 | 8051 |
Ndufs5 | 8023 |
Ndufb9 | 8002 |
Ndufb3 | 7998 |
Ndufs4 | 7985 |
Ndufa6 | 7968 |
Ndufc2 | 7955 |
Ndufb8 | 7931 |
Ndufaf2 | 7875 |
Ndufa11 | 7874 |
Ndufa7 | 7857 |
Ndufb7 | 7734 |
Ndufa12 | 7696 |
GeneID | Gene Rank |
---|---|
Ndufb1 | 8224 |
Ndufa1 | 8209 |
Ndufa3 | 8206 |
Ndufa2 | 8193 |
Ndufc1 | 8100 |
Ndufa5 | 8056 |
Ndufa13 | 8055 |
Ndufs6 | 8051 |
Ndufs5 | 8023 |
Ndufb9 | 8002 |
Ndufb3 | 7998 |
Ndufs4 | 7985 |
Ndufa6 | 7968 |
Ndufc2 | 7955 |
Ndufb8 | 7931 |
Ndufaf2 | 7875 |
Ndufa11 | 7874 |
Ndufa7 | 7857 |
Ndufb7 | 7734 |
Ndufa12 | 7696 |
Ndufv3 | 7667 |
Ndufab1 | 7639 |
Ndufv2 | 7630 |
Timmdc1 | 7567 |
Ndufs2 | 7533 |
Ndufv1 | 7518 |
Ndufb10 | 7509 |
Ndufb2 | 7466 |
Ndufb5 | 7429 |
Ndufb6 | 7399 |
Ndufb11 | 7389 |
Ndufs8 | 7370 |
Nubpl | 7321 |
Ndufaf3 | 7290 |
Ndufb4 | 7263 |
Tmem186 | 7110 |
Ndufaf6 | 6943 |
Ndufa10 | 6876 |
Ndufs3 | 6805 |
Ndufa8 | 6782 |
Tmem126b | 6712 |
Ndufs7 | 6616 |
Ndufaf5 | 6479 |
Ndufa9 | 6396 |
Ndufaf7 | 5975 |
mt-Nd3 | 5608 |
Ndufaf1 | 5059 |
Ecsit | 3430 |
Ndufaf4 | 3377 |
Ndufs1 | 1403 |
mt-Nd6 | 108 |
Acad9 | -1666 |
mt-Nd1 | -4019 |
mt-Nd4 | -7084 |
mt-Nd5 | -8584 |
mt-Nd2 | -8859 |
SELENOAMINO ACID METABOLISM
914 | |
---|---|
set | SELENOAMINO ACID METABOLISM |
setSize | 108 |
pANOVA | 2.53e-38 |
s.dist | 0.72 |
p.adjustANOVA | 3.32e-36 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Pstk | 7909 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Pstk | 7909 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Rps15 | 7805 |
Rps10 | 7793 |
Rpl13 | 7786 |
Rpl11 | 7781 |
Rpl31 | 7729 |
Rpl34 | 7726 |
Rps12 | 7721 |
Rpl26 | 7699 |
Rps8 | 7676 |
Rplp1 | 7662 |
Rpl23 | 7655 |
Rpl27 | 7644 |
Rpl7a | 7609 |
Rpl24 | 7605 |
Rps23 | 7560 |
Rps27a | 7519 |
Rpl36a | 7511 |
Rps18 | 7494 |
Rpl18 | 7478 |
Rps7 | 7471 |
Rps9 | 7456 |
Rps15a | 7440 |
Rpl18a | 7438 |
Rpl9 | 7416 |
Rpl21 | 7270 |
Rps19 | 7268 |
Uba52 | 7262 |
Rpl29 | 7250 |
Rpl30 | 7145 |
Rpl8 | 7137 |
Rps13 | 7086 |
Rplp0 | 7009 |
Rpl10a | 6965 |
Rpl22l1 | 6916 |
Rps16 | 6913 |
Rps2 | 6912 |
Rpl7 | 6885 |
Rps11 | 6883 |
Rps25 | 6881 |
Rpl14 | 6873 |
Aimp1 | 6838 |
Rpl13a | 6776 |
Rpl4 | 6774 |
Rps3 | 6754 |
Rps27l | 6682 |
Rps6 | 6648 |
Rpl3 | 6642 |
Rps24 | 6631 |
Rps5 | 6627 |
Rpl23a | 6619 |
Rpl17 | 6604 |
Rpl27a | 6473 |
Rps26 | 6384 |
Rps3a1 | 6345 |
Rpl28 | 6319 |
Rpl15 | 6281 |
Rpl5 | 6276 |
Rps20 | 6232 |
Hnmt | 6205 |
Rpl12 | 6198 |
Rps4x | 5999 |
Rpsa | 5712 |
Rars | 5661 |
Aimp2 | 5587 |
Rpl6 | 5583 |
Sars | 5488 |
Kars | 4985 |
Gnmt | 4925 |
Ahcy | 4336 |
Sephs2 | 4018 |
Eef1e1 | 3982 |
Cbs | 3934 |
Lars | 3073 |
Rpl10 | 2228 |
Sepsecs | 1756 |
Scly | 1184 |
Dars | 1026 |
Eprs | 817 |
Mars1 | 200 |
Qars | -1167 |
Gsr | -1485 |
Secisbp2 | -1908 |
Eefsec | -2058 |
Papss1 | -3074 |
Cth | -4528 |
Txnrd1 | -4597 |
Papss2 | -5124 |
Iars | -7028 |
RESPIRATORY ELECTRON TRANSPORT
837 | |
---|---|
set | RESPIRATORY ELECTRON TRANSPORT |
setSize | 102 |
pANOVA | 2.25e-34 |
s.dist | 0.7 |
p.adjustANOVA | 2.04e-32 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ndufb1 | 8224 |
Ndufa1 | 8209 |
Ndufa3 | 8206 |
Cox7c | 8197 |
Cox8a | 8196 |
Ndufa2 | 8193 |
Uqcrq | 8158 |
Ndufa4 | 8129 |
Uqcr11 | 8116 |
Ndufc1 | 8100 |
Uqcr10 | 8099 |
Cox6c | 8086 |
Cox6b1 | 8069 |
Cox5b | 8059 |
Ndufa5 | 8056 |
Ndufa13 | 8055 |
Ndufs6 | 8051 |
Cox14 | 8038 |
Cox5a | 8028 |
Ndufs5 | 8023 |
GeneID | Gene Rank |
---|---|
Ndufb1 | 8224 |
Ndufa1 | 8209 |
Ndufa3 | 8206 |
Cox7c | 8197 |
Cox8a | 8196 |
Ndufa2 | 8193 |
Uqcrq | 8158 |
Ndufa4 | 8129 |
Uqcr11 | 8116 |
Ndufc1 | 8100 |
Uqcr10 | 8099 |
Cox6c | 8086 |
Cox6b1 | 8069 |
Cox5b | 8059 |
Ndufa5 | 8056 |
Ndufa13 | 8055 |
Ndufs6 | 8051 |
Cox14 | 8038 |
Cox5a | 8028 |
Ndufs5 | 8023 |
Cox7b | 8014 |
Ndufb9 | 8002 |
Ndufb3 | 7998 |
Ndufs4 | 7985 |
Ndufa6 | 7968 |
Ndufc2 | 7955 |
Ndufb8 | 7931 |
Cox4i1 | 7897 |
Cox6a1 | 7893 |
Ndufaf2 | 7875 |
Ndufa11 | 7874 |
Sdhd | 7866 |
Ndufa7 | 7857 |
Cyc1 | 7848 |
Uqcrh | 7843 |
Uqcrb | 7828 |
Uqcrc1 | 7775 |
Ndufb7 | 7734 |
Ndufa12 | 7696 |
Ndufv3 | 7667 |
Ndufab1 | 7639 |
Ndufv2 | 7630 |
Uqcrfs1 | 7578 |
Timmdc1 | 7567 |
Ndufs2 | 7533 |
Surf1 | 7526 |
Ndufv1 | 7518 |
Ndufb10 | 7509 |
Ndufb2 | 7466 |
Ndufb5 | 7429 |
Ndufb6 | 7399 |
Ndufb11 | 7389 |
Ndufs8 | 7370 |
Nubpl | 7321 |
Ndufaf3 | 7290 |
Ndufb4 | 7263 |
Etfb | 7230 |
Cox16 | 7173 |
Tmem186 | 7110 |
Cox20 | 7109 |
Cox7a2l | 6959 |
Ndufaf6 | 6943 |
Ndufa10 | 6876 |
Ndufs3 | 6805 |
Ndufa8 | 6782 |
Tmem126b | 6712 |
Sdhb | 6683 |
Cox19 | 6625 |
Ndufs7 | 6616 |
Ndufaf5 | 6479 |
Uqcrc2 | 6477 |
Ndufa9 | 6396 |
Coq10a | 6250 |
Cycs | 6115 |
Ndufaf7 | 5975 |
mt-Nd3 | 5608 |
Etfa | 5550 |
Etfdh | 5529 |
Sdhc | 5132 |
Ndufaf1 | 5059 |
Trap1 | 4600 |
Cox11 | 4162 |
mt-Co3 | 4094 |
Cox18 | 3590 |
Ecsit | 3430 |
Ndufaf4 | 3377 |
Sco2 | 2254 |
Ndufs1 | 1403 |
mt-Nd6 | 108 |
Sco1 | -24 |
Sdha | -346 |
mt-Co2 | -461 |
Acad9 | -1666 |
Lrpprc | -1807 |
Coq10b | -1846 |
mt-Cytb | -3144 |
mt-Nd1 | -4019 |
Taco1 | -4549 |
mt-Co1 | -5320 |
mt-Nd4 | -7084 |
mt-Nd5 | -8584 |
mt-Nd2 | -8859 |
CRISTAE FORMATION
189 | |
---|---|
set | CRISTAE FORMATION |
setSize | 31 |
pANOVA | 2.45e-11 |
s.dist | 0.692 |
p.adjustANOVA | 8.28e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Atp5k | 8246 |
Atp5g1 | 8061 |
Atp5j | 8037 |
Atp5e | 8029 |
Apoo | 8027 |
Atp5j2 | 7996 |
Micos13 | 7904 |
mt-Atp8 | 7872 |
Chchd3 | 7851 |
Atp5g3 | 7732 |
Atp5pb | 7715 |
Atp5c1 | 7702 |
Atp5h | 7646 |
Mtx1 | 7558 |
Atp5l | 7551 |
Atp5o | 7535 |
Tmem11 | 7481 |
Chchd6 | 7383 |
Atp5b | 7287 |
Atp5d | 7201 |
GeneID | Gene Rank |
---|---|
Atp5k | 8246 |
Atp5g1 | 8061 |
Atp5j | 8037 |
Atp5e | 8029 |
Apoo | 8027 |
Atp5j2 | 7996 |
Micos13 | 7904 |
mt-Atp8 | 7872 |
Chchd3 | 7851 |
Atp5g3 | 7732 |
Atp5pb | 7715 |
Atp5c1 | 7702 |
Atp5h | 7646 |
Mtx1 | 7558 |
Atp5l | 7551 |
Atp5o | 7535 |
Tmem11 | 7481 |
Chchd6 | 7383 |
Atp5b | 7287 |
Atp5d | 7201 |
Micos10 | 6921 |
Mtx2 | 6163 |
Dmac2l | 5595 |
Apool | 3953 |
Immt | 2725 |
Atp5a1 | 2242 |
Dnajc11 | 444 |
mt-Atp6 | 117 |
Hspa9 | -454 |
Samm50 | -1966 |
Atp5g2 | -7609 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS
838 | |
---|---|
set | RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS |
setSize | 125 |
pANOVA | 1.74e-40 |
s.dist | 0.689 |
p.adjustANOVA | 2.93e-38 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Atp5k | 8246 |
Ndufb1 | 8224 |
Ucp2 | 8219 |
Ndufa1 | 8209 |
Ndufa3 | 8206 |
Cox7c | 8197 |
Cox8a | 8196 |
Ndufa2 | 8193 |
Uqcrq | 8158 |
Ndufa4 | 8129 |
Uqcr11 | 8116 |
Ndufc1 | 8100 |
Uqcr10 | 8099 |
Cox6c | 8086 |
Cox6b1 | 8069 |
Atp5g1 | 8061 |
Cox5b | 8059 |
Ndufa5 | 8056 |
Ndufa13 | 8055 |
Ndufs6 | 8051 |
GeneID | Gene Rank |
---|---|
Atp5k | 8246 |
Ndufb1 | 8224 |
Ucp2 | 8219 |
Ndufa1 | 8209 |
Ndufa3 | 8206 |
Cox7c | 8197 |
Cox8a | 8196 |
Ndufa2 | 8193 |
Uqcrq | 8158 |
Ndufa4 | 8129 |
Uqcr11 | 8116 |
Ndufc1 | 8100 |
Uqcr10 | 8099 |
Cox6c | 8086 |
Cox6b1 | 8069 |
Atp5g1 | 8061 |
Cox5b | 8059 |
Ndufa5 | 8056 |
Ndufa13 | 8055 |
Ndufs6 | 8051 |
Cox14 | 8038 |
Atp5j | 8037 |
Atp5e | 8029 |
Cox5a | 8028 |
Ndufs5 | 8023 |
Cox7b | 8014 |
Ndufb9 | 8002 |
Ndufb3 | 7998 |
Atp5j2 | 7996 |
Ndufs4 | 7985 |
Ndufa6 | 7968 |
Ndufc2 | 7955 |
Ndufb8 | 7931 |
Cox4i1 | 7897 |
Cox6a1 | 7893 |
Ndufaf2 | 7875 |
Ndufa11 | 7874 |
mt-Atp8 | 7872 |
Sdhd | 7866 |
Ndufa7 | 7857 |
Cyc1 | 7848 |
Uqcrh | 7843 |
Uqcrb | 7828 |
Uqcrc1 | 7775 |
Ndufb7 | 7734 |
Atp5g3 | 7732 |
Atp5pb | 7715 |
Atp5c1 | 7702 |
Ndufa12 | 7696 |
Ndufv3 | 7667 |
Ucp3 | 7660 |
Atp5h | 7646 |
Ndufab1 | 7639 |
Ndufv2 | 7630 |
Uqcrfs1 | 7578 |
Timmdc1 | 7567 |
Atp5l | 7551 |
Atp5o | 7535 |
Ndufs2 | 7533 |
Surf1 | 7526 |
Ndufv1 | 7518 |
Ndufb10 | 7509 |
Ndufb2 | 7466 |
Ndufb5 | 7429 |
Ndufb6 | 7399 |
Ndufb11 | 7389 |
Ndufs8 | 7370 |
Nubpl | 7321 |
Ndufaf3 | 7290 |
Atp5b | 7287 |
Ndufb4 | 7263 |
Etfb | 7230 |
Atp5d | 7201 |
Cox16 | 7173 |
Tmem186 | 7110 |
Cox20 | 7109 |
Cox7a2l | 6959 |
Ndufaf6 | 6943 |
Ndufa10 | 6876 |
Ndufs3 | 6805 |
Ndufa8 | 6782 |
Tmem126b | 6712 |
Sdhb | 6683 |
Cox19 | 6625 |
Ndufs7 | 6616 |
Ndufaf5 | 6479 |
Uqcrc2 | 6477 |
Ndufa9 | 6396 |
Coq10a | 6250 |
Cycs | 6115 |
Ndufaf7 | 5975 |
mt-Nd3 | 5608 |
Dmac2l | 5595 |
Etfa | 5550 |
Etfdh | 5529 |
Sdhc | 5132 |
Ndufaf1 | 5059 |
Slc25a14 | 4843 |
Trap1 | 4600 |
Cox11 | 4162 |
mt-Co3 | 4094 |
Cox18 | 3590 |
Ecsit | 3430 |
Ndufaf4 | 3377 |
Sco2 | 2254 |
Atp5a1 | 2242 |
Ndufs1 | 1403 |
mt-Atp6 | 117 |
mt-Nd6 | 108 |
Sco1 | -24 |
Sdha | -346 |
mt-Co2 | -461 |
Acad9 | -1666 |
Lrpprc | -1807 |
Coq10b | -1846 |
mt-Cytb | -3144 |
mt-Nd1 | -4019 |
Taco1 | -4549 |
mt-Co1 | -5320 |
Slc25a27 | -5449 |
mt-Nd4 | -7084 |
Atp5g2 | -7609 |
Pm20d1 | -7755 |
mt-Nd5 | -8584 |
mt-Nd2 | -8859 |
NONSENSE MEDIATED DECAY NMD
635 | |
---|---|
set | NONSENSE MEDIATED DECAY NMD |
setSize | 109 |
pANOVA | 6.67e-34 |
s.dist | 0.672 |
p.adjustANOVA | 5.62e-32 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Magoh | 7916 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Magoh | 7916 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Rps15 | 7805 |
Rps10 | 7793 |
Rpl13 | 7786 |
Rpl11 | 7781 |
Rpl31 | 7729 |
Rpl34 | 7726 |
Rps12 | 7721 |
Rpl26 | 7699 |
Rps8 | 7676 |
Rplp1 | 7662 |
Rpl23 | 7655 |
Rpl27 | 7644 |
Magohb | 7626 |
Rpl7a | 7609 |
Rpl24 | 7605 |
Rps23 | 7560 |
Rps27a | 7519 |
Rpl36a | 7511 |
Rps18 | 7494 |
Rpl18 | 7478 |
Rps7 | 7471 |
Rps9 | 7456 |
Rps15a | 7440 |
Rpl18a | 7438 |
Rpl9 | 7416 |
Rpl21 | 7270 |
Rps19 | 7268 |
Uba52 | 7262 |
Rpl29 | 7250 |
Rpl30 | 7145 |
Rpl8 | 7137 |
Rps13 | 7086 |
Rplp0 | 7009 |
Rpl10a | 6965 |
Rpl22l1 | 6916 |
Rps16 | 6913 |
Rps2 | 6912 |
Rpl7 | 6885 |
Rps11 | 6883 |
Rps25 | 6881 |
Rpl14 | 6873 |
Eif4a3 | 6842 |
Rpl13a | 6776 |
Rpl4 | 6774 |
Rps3 | 6754 |
Rps27l | 6682 |
Rps6 | 6648 |
Rpl3 | 6642 |
Rps24 | 6631 |
Rps5 | 6627 |
Rpl23a | 6619 |
Rpl17 | 6604 |
Rpl27a | 6473 |
Smg9 | 6401 |
Rps26 | 6384 |
Rps3a1 | 6345 |
Rpl28 | 6319 |
Rpl15 | 6281 |
Rpl5 | 6276 |
Rps20 | 6232 |
Rpl12 | 6198 |
Rps4x | 5999 |
Ncbp2 | 5725 |
Rpsa | 5712 |
Rpl6 | 5583 |
Ppp2ca | 5554 |
Upf3a | 5389 |
Smg5 | 4871 |
Upf3b | 3070 |
Pnrc2 | 2996 |
Etf1 | 2515 |
Rbm8a | 2513 |
Rpl10 | 2228 |
Upf2 | 1989 |
Rnps1 | 1394 |
Ncbp1 | 1338 |
Ppp2r1a | 325 |
Ppp2r2a | -1793 |
Pabpc1 | -2626 |
Smg8 | -4329 |
Eif4g1 | -4562 |
Dcp1a | -4652 |
Gspt2 | -5434 |
Gspt1 | -5841 |
Casc3 | -5851 |
Upf1 | -6569 |
Smg6 | -6698 |
Smg1 | -8022 |
Smg7 | -8241 |
ADENYLATE CYCLASE INHIBITORY PATHWAY
37 | |
---|---|
set | ADENYLATE CYCLASE INHIBITORY PATHWAY |
setSize | 13 |
pANOVA | 2.94e-05 |
s.dist | -0.669 |
p.adjustANOVA | 0.000284 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Adcy4 | -9080 |
Adcy7 | -8971 |
Adcy6 | -8795 |
Adcy3 | -7802 |
Adcy5 | -7709 |
Adcy8 | -7344 |
Gnal | -7090 |
Adcy2 | -6526 |
Gnai3 | -5032 |
Gnai1 | -4880 |
Adcy9 | -4486 |
Gnai2 | -2502 |
Adcy1 | -640 |
GeneID | Gene Rank |
---|---|
Adcy4 | -9080 |
Adcy7 | -8971 |
Adcy6 | -8795 |
Adcy3 | -7802 |
Adcy5 | -7709 |
Adcy8 | -7344 |
Gnal | -7090 |
Adcy2 | -6526 |
Gnai3 | -5032 |
Gnai1 | -4880 |
Adcy9 | -4486 |
Gnai2 | -2502 |
Adcy1 | -640 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S
28 | |
---|---|
set | ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S |
setSize | 59 |
pANOVA | 1.24e-18 |
s.dist | 0.663 |
p.adjustANOVA | 6.67e-17 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rps27 | 8135 |
Rps28 | 8081 |
Fau | 7889 |
Rps17 | 7858 |
Rps14 | 7821 |
Rps15 | 7805 |
Rps10 | 7793 |
Rps12 | 7721 |
Rps8 | 7676 |
Rps23 | 7560 |
Rps27a | 7519 |
Rps18 | 7494 |
Eif3g | 7476 |
Rps7 | 7471 |
Rps9 | 7456 |
Rps15a | 7440 |
Rps19 | 7268 |
Eif3i | 7245 |
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rps27 | 8135 |
Rps28 | 8081 |
Fau | 7889 |
Rps17 | 7858 |
Rps14 | 7821 |
Rps15 | 7805 |
Rps10 | 7793 |
Rps12 | 7721 |
Rps8 | 7676 |
Rps23 | 7560 |
Rps27a | 7519 |
Rps18 | 7494 |
Eif3g | 7476 |
Rps7 | 7471 |
Rps9 | 7456 |
Rps15a | 7440 |
Rps19 | 7268 |
Eif3i | 7245 |
Eif3m | 7176 |
Rps13 | 7086 |
Rps16 | 6913 |
Rps2 | 6912 |
Rps11 | 6883 |
Rps25 | 6881 |
Rps3 | 6754 |
Eif3h | 6729 |
Rps27l | 6682 |
Rps6 | 6648 |
Rps24 | 6631 |
Rps5 | 6627 |
Eif3j1 | 6602 |
Eif2s1 | 6435 |
Rps26 | 6384 |
Rps3a1 | 6345 |
Eif4a1 | 6253 |
Rps20 | 6232 |
Rps4x | 5999 |
Eif3k | 5919 |
Rpsa | 5712 |
Eif3d | 5574 |
Eif3f | 5282 |
Eif4e | 4744 |
Eif3l | 4682 |
Eif2s2 | 4515 |
Eif4a2 | 4494 |
Eif4h | 4352 |
Eif3e | 4145 |
Eif4ebp1 | 4008 |
Eif3c | 2238 |
Eif3b | 204 |
Eif1ax | -705 |
Eif2s3x | -729 |
Eif4b | -764 |
Pabpc1 | -2626 |
Eif4g1 | -4562 |
Eif3a | -5496 |
Eif3j2 | -7834 |
MITOCHONDRIAL PROTEIN IMPORT
571 | |
---|---|
set | MITOCHONDRIAL PROTEIN IMPORT |
setSize | 63 |
pANOVA | 5.96e-19 |
s.dist | 0.647 |
p.adjustANOVA | 3.35e-17 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tomm7 | 8227 |
Timm13 | 8160 |
Dnajc19 | 8153 |
Atp5g1 | 8061 |
Cox17 | 8040 |
Grpel1 | 7986 |
Timm8b | 7974 |
Pam16 | 7971 |
Tomm22 | 7943 |
Ndufb8 | 7931 |
Timm23 | 7881 |
Chchd3 | 7851 |
Cyc1 | 7848 |
Timm10 | 7750 |
Tomm6 | 7722 |
Timm10b | 7591 |
Mtx1 | 7558 |
Chchd10 | 7472 |
Tomm5 | 7349 |
Atp5b | 7287 |
GeneID | Gene Rank |
---|---|
Tomm7 | 8227 |
Timm13 | 8160 |
Dnajc19 | 8153 |
Atp5g1 | 8061 |
Cox17 | 8040 |
Grpel1 | 7986 |
Timm8b | 7974 |
Pam16 | 7971 |
Tomm22 | 7943 |
Ndufb8 | 7931 |
Timm23 | 7881 |
Chchd3 | 7851 |
Cyc1 | 7848 |
Timm10 | 7750 |
Tomm6 | 7722 |
Timm10b | 7591 |
Mtx1 | 7558 |
Chchd10 | 7472 |
Tomm5 | 7349 |
Atp5b | 7287 |
Timm22 | 7105 |
Idh3g | 7082 |
Timm9 | 7019 |
Fxn | 6879 |
Coq2 | 6837 |
Timm21 | 6826 |
Timm8a1 | 6812 |
Chchd7 | 6705 |
Chchd4 | 6695 |
Tomm40 | 6684 |
Cox19 | 6625 |
Hscb | 6603 |
Slc25a13 | 6600 |
Slc25a4 | 6365 |
Cmc2 | 6347 |
Timm50 | 6282 |
Chchd5 | 6197 |
Pmpca | 6174 |
Mtx2 | 6163 |
Chchd2 | 5973 |
Ldhd | 5861 |
Timm44 | 5723 |
Coa4 | 5611 |
Pmpcb | 5609 |
Timm17a | 5567 |
Grpel2 | 5382 |
Gfer | 5262 |
Vdac1 | 5077 |
Timm17b | 4318 |
Coa6 | 4242 |
Cmc4 | 3107 |
Aco2 | 2503 |
Atp5a1 | 2242 |
Taz | 1571 |
Cs | 698 |
Tomm20 | 206 |
Hspa9 | -454 |
Bcs1l | -627 |
Samm50 | -1966 |
Tomm70a | -2163 |
Slc25a12 | -6200 |
Hspd1 | -6898 |
Pitrm1 | -7222 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS
570 | |
---|---|
set | MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS |
setSize | 13 |
pANOVA | 6.83e-05 |
s.dist | 0.638 |
p.adjustANOVA | 0.00058 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Lyrm4 | 7510 |
Glrx5 | 7394 |
Fdx1 | 7071 |
Fxn | 6879 |
Iscu | 6607 |
Hscb | 6603 |
Fdx2 | 6508 |
Nfs1 | 6293 |
Isca1 | 5556 |
Fdxr | 4994 |
Isca2 | 4714 |
Slc25a28 | 4388 |
Slc25a37 | -8075 |
GeneID | Gene Rank |
---|---|
Lyrm4 | 7510 |
Glrx5 | 7394 |
Fdx1 | 7071 |
Fxn | 6879 |
Iscu | 6607 |
Hscb | 6603 |
Fdx2 | 6508 |
Nfs1 | 6293 |
Isca1 | 5556 |
Fdxr | 4994 |
Isca2 | 4714 |
Slc25a28 | 4388 |
Slc25a37 | -8075 |
TRANSLATION
1131 | |
---|---|
set | TRANSLATION |
setSize | 286 |
pANOVA | 2e-73 |
s.dist | 0.621 |
p.adjustANOVA | 2.36e-70 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mrpl58 | 8214 |
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Mrps28 | 8103 |
Mrps21 | 8096 |
Rps28 | 8081 |
Rpl36 | 8077 |
Mrpl52 | 8073 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Sec61b | 8019 |
Rpl32 | 8005 |
Mrpl2 | 7995 |
Mrpl54 | 7979 |
Mrpl53 | 7963 |
Mrpl20 | 7935 |
GeneID | Gene Rank |
---|---|
Mrpl58 | 8214 |
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Mrps28 | 8103 |
Mrps21 | 8096 |
Rps28 | 8081 |
Rpl36 | 8077 |
Mrpl52 | 8073 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Sec61b | 8019 |
Rpl32 | 8005 |
Mrpl2 | 7995 |
Mrpl54 | 7979 |
Mrpl53 | 7963 |
Mrpl20 | 7935 |
Gadd45gip1 | 7925 |
Mrps26 | 7914 |
Mrps34 | 7892 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Mrpl41 | 7862 |
Rps17 | 7858 |
Mrps18c | 7852 |
Rpl37 | 7845 |
Mrps33 | 7840 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Mrps16 | 7811 |
Rps15 | 7805 |
Rps10 | 7793 |
Rpl13 | 7786 |
Rpl11 | 7781 |
Mrpl30 | 7759 |
Rpl31 | 7729 |
Rpl34 | 7726 |
Rps12 | 7721 |
Mrpl51 | 7714 |
Sec11c | 7713 |
Rpl26 | 7699 |
Mrps12 | 7682 |
Rps8 | 7676 |
N6amt1 | 7672 |
Ppa2 | 7666 |
Rplp1 | 7662 |
Mrps24 | 7658 |
Rpl23 | 7655 |
Rpl27 | 7644 |
Mrpl9 | 7634 |
Mrpl44 | 7629 |
Mrpl48 | 7613 |
Rpl7a | 7609 |
Aurkaip1 | 7607 |
Rpl24 | 7605 |
Mrpl40 | 7597 |
Mrpl43 | 7584 |
Rps23 | 7560 |
Rps27a | 7519 |
Rpl36a | 7511 |
Mrpl11 | 7504 |
Rps18 | 7494 |
Rpl18 | 7478 |
Eif3g | 7476 |
Rps7 | 7471 |
Rps9 | 7456 |
Rps15a | 7440 |
Rpl18a | 7438 |
Mrpl27 | 7435 |
Mrpl28 | 7434 |
Mrps27 | 7433 |
Srp9 | 7428 |
Rpl9 | 7416 |
Mrpl21 | 7329 |
Mrpl14 | 7319 |
Mrpl1 | 7306 |
Rpl21 | 7270 |
Rps19 | 7268 |
Mrpl12 | 7266 |
Uba52 | 7262 |
Rpl29 | 7250 |
Eif3i | 7245 |
Mrpl39 | 7228 |
Mrps23 | 7220 |
Mrpl13 | 7209 |
Eif3m | 7176 |
Mrpl33 | 7159 |
Mrpl49 | 7147 |
Rpl30 | 7145 |
Mrps36 | 7138 |
Rpl8 | 7137 |
Mrpl34 | 7119 |
Rps13 | 7086 |
Srp14 | 7072 |
Sec61g | 7020 |
Rplp0 | 7009 |
Mrps10 | 6998 |
Mrpl23 | 6996 |
Mrpl55 | 6981 |
Rpl10a | 6965 |
Mrps14 | 6937 |
Rpl22l1 | 6916 |
Rps16 | 6913 |
Rps2 | 6912 |
Rpl7 | 6885 |
Rps11 | 6883 |
Mrps7 | 6882 |
Rps25 | 6881 |
Mrpl46 | 6880 |
Rpl14 | 6873 |
Mrps9 | 6863 |
Mrpl42 | 6852 |
Sec11a | 6840 |
Aimp1 | 6838 |
Spcs1 | 6830 |
Mrps15 | 6821 |
Eef1d | 6818 |
Mrpl15 | 6817 |
Mrps17 | 6815 |
Eef1b2 | 6809 |
Rpl13a | 6776 |
Mrpl35 | 6775 |
Rpl4 | 6774 |
Rps3 | 6754 |
Tsfm | 6732 |
Eif3h | 6729 |
Rps27l | 6682 |
Mrpl57 | 6671 |
Eif2b1 | 6658 |
Rps6 | 6648 |
Rpl3 | 6642 |
Rps24 | 6631 |
Rps5 | 6627 |
Rpl23a | 6619 |
Rpl17 | 6604 |
Eif3j1 | 6602 |
Mrpl17 | 6518 |
Mrpl18 | 6485 |
Rpl27a | 6473 |
Ssr4 | 6450 |
Eif2s1 | 6435 |
Rps26 | 6384 |
Mrpl16 | 6368 |
Rps3a1 | 6345 |
Mtfmt | 6338 |
Rpl28 | 6319 |
Rpl15 | 6281 |
Rpl5 | 6276 |
Rars2 | 6273 |
Eif2b2 | 6268 |
Eif4a1 | 6253 |
Rps20 | 6232 |
Mrps18b | 6221 |
Rpl12 | 6198 |
Mrpl36 | 6087 |
Yars2 | 6083 |
Eef1g | 6077 |
Mrps22 | 6072 |
Rps4x | 5999 |
Mrpl32 | 5936 |
Ssr2 | 5935 |
Eif3k | 5919 |
Srp19 | 5834 |
Eef1a1 | 5792 |
Trmt112 | 5791 |
Mrps35 | 5721 |
Mrps18a | 5714 |
Rpsa | 5712 |
Mrps6 | 5692 |
Mrpl22 | 5672 |
Rars | 5661 |
Mrrf | 5635 |
Mrpl38 | 5614 |
Aimp2 | 5587 |
Rpl6 | 5583 |
Eif3d | 5574 |
Mtif3 | 5553 |
Fars2 | 5540 |
Sars | 5488 |
Eral1 | 5486 |
Sars2 | 5476 |
Mrpl50 | 5286 |
Eif3f | 5282 |
Srprb | 5181 |
Mrpl10 | 5121 |
Chchd1 | 5107 |
Mrps25 | 5084 |
Eif2b4 | 5067 |
Eif5 | 5019 |
Mrpl3 | 5004 |
Kars | 4985 |
Mrps11 | 4972 |
Mrpl47 | 4959 |
Mtif2 | 4929 |
Mrpl19 | 4784 |
Eif4e | 4744 |
Eif3l | 4682 |
Mrpl4 | 4557 |
Eif2s2 | 4515 |
Ppa1 | 4510 |
Eif4a2 | 4494 |
Spcs2 | 4468 |
Eif4h | 4352 |
Tufm | 4339 |
Eif3e | 4145 |
Eif4ebp1 | 4008 |
Eef1e1 | 3982 |
Mrpl24 | 3938 |
Eif2b5 | 3736 |
Mrpl37 | 3706 |
Dap3 | 3603 |
Mrps2 | 3578 |
Farsa | 3491 |
Apeh | 3393 |
Lars2 | 3277 |
Cars | 3177 |
Mrps30 | 3131 |
Lars | 3073 |
Ddost | 2939 |
Tars2 | 2879 |
Nars | 2868 |
Ssr3 | 2761 |
Etf1 | 2515 |
Oxa1l | 2368 |
Eif5b | 2307 |
Eif3c | 2238 |
Rpl10 | 2228 |
Hars2 | 2071 |
Wars | 1893 |
Gfm1 | 1820 |
Srp54a | 1716 |
Mrps31 | 1637 |
Mrps5 | 1615 |
Ptcd3 | 1490 |
Eef2 | 1448 |
Sec61a2 | 1290 |
Nars2 | 1268 |
Rpn1 | 1064 |
Dars | 1026 |
Sec61a1 | 997 |
Eprs | 817 |
Gars | 592 |
Vars | 564 |
Farsb | 497 |
Tars | 364 |
Yars | 324 |
Eif3b | 204 |
Mars1 | 200 |
Eef1a2 | 159 |
Iars2 | 143 |
Spcs3 | 5 |
Cars2 | -17 |
Hars | -165 |
Eif1ax | -705 |
Eif2s3x | -729 |
Eif4b | -764 |
Dars2 | -909 |
Aars2 | -994 |
Eif2b3 | -1065 |
Qars | -1167 |
Srp68 | -1233 |
Rpn2 | -1692 |
Pabpc1 | -2626 |
Ssr1 | -2771 |
Eif4g1 | -4562 |
Mtrf1l | -4850 |
Gspt2 | -5434 |
Eif3a | -5496 |
Srpr | -5713 |
Gspt1 | -5841 |
Aars | -5931 |
Mars2 | -6102 |
Pars2 | -6176 |
Srp72 | -6413 |
Tram1 | -6559 |
Iars | -7028 |
Gfm2 | -7057 |
Ears2 | -7757 |
Eif3j2 | -7834 |
Wars2 | -8725 |
Vars2 | -8832 |
PKA MEDIATED PHOSPHORYLATION OF CREB
711 | |
---|---|
set | PKA MEDIATED PHOSPHORYLATION OF CREB |
setSize | 19 |
pANOVA | 3.08e-06 |
s.dist | -0.618 |
p.adjustANOVA | 4.08e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Adcy4 | -9080 |
Adcy7 | -8971 |
Prkar2a | -8858 |
Adcy6 | -8795 |
Creb1 | -8717 |
Adcy3 | -7802 |
Adcy5 | -7709 |
Prkx | -7616 |
Adcy8 | -7344 |
Prkacb | -7235 |
Nbea | -6617 |
Adcy2 | -6526 |
Adcy9 | -4486 |
Prkar2b | -3762 |
Prkar1a | -3133 |
Prkar1b | -1887 |
Prkaca | -1090 |
Adcy1 | -640 |
Calm1 | 533 |
GeneID | Gene Rank |
---|---|
Adcy4 | -9080 |
Adcy7 | -8971 |
Prkar2a | -8858 |
Adcy6 | -8795 |
Creb1 | -8717 |
Adcy3 | -7802 |
Adcy5 | -7709 |
Prkx | -7616 |
Adcy8 | -7344 |
Prkacb | -7235 |
Nbea | -6617 |
Adcy2 | -6526 |
Adcy9 | -4486 |
Prkar2b | -3762 |
Prkar1a | -3133 |
Prkar1b | -1887 |
Prkaca | -1090 |
Adcy1 | -640 |
Calm1 | 533 |
RNA POLYMERASE III CHAIN ELONGATION
883 | |
---|---|
set | RNA POLYMERASE III CHAIN ELONGATION |
setSize | 18 |
pANOVA | 8.72e-06 |
s.dist | 0.605 |
p.adjustANOVA | 9.99e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Polr2l | 8217 |
Polr3e | 8026 |
Polr2f | 7953 |
Polr2h | 7653 |
Polr3h | 7489 |
Polr2k | 7373 |
Polr1c | 7063 |
Polr1d | 7027 |
Crcp | 7012 |
Polr2e | 7011 |
Polr3d | 6079 |
Polr3c | 5729 |
Polr3k | 4182 |
Polr3gl | 3984 |
Polr3b | 1909 |
Polr3f | -424 |
Polr3g | -1536 |
Polr3a | -7849 |
GeneID | Gene Rank |
---|---|
Polr2l | 8217 |
Polr3e | 8026 |
Polr2f | 7953 |
Polr2h | 7653 |
Polr3h | 7489 |
Polr2k | 7373 |
Polr1c | 7063 |
Polr1d | 7027 |
Crcp | 7012 |
Polr2e | 7011 |
Polr3d | 6079 |
Polr3c | 5729 |
Polr3k | 4182 |
Polr3gl | 3984 |
Polr3b | 1909 |
Polr3f | -424 |
Polr3g | -1536 |
Polr3a | -7849 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT
1072 | |
---|---|
set | THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT |
setSize | 172 |
pANOVA | 1.71e-40 |
s.dist | 0.588 |
p.adjustANOVA | 2.93e-38 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Atp5k | 8246 |
Ndufb1 | 8224 |
Ucp2 | 8219 |
Ndufa1 | 8209 |
Ndufa3 | 8206 |
Cox7c | 8197 |
Cox8a | 8196 |
Ndufa2 | 8193 |
Mpc2 | 8161 |
Uqcrq | 8158 |
Ndufa4 | 8129 |
Uqcr11 | 8116 |
Ndufc1 | 8100 |
Uqcr10 | 8099 |
Cox6c | 8086 |
Cox6b1 | 8069 |
Atp5g1 | 8061 |
Cox5b | 8059 |
Ndufa5 | 8056 |
Ndufa13 | 8055 |
GeneID | Gene Rank |
---|---|
Atp5k | 8246 |
Ndufb1 | 8224 |
Ucp2 | 8219 |
Ndufa1 | 8209 |
Ndufa3 | 8206 |
Cox7c | 8197 |
Cox8a | 8196 |
Ndufa2 | 8193 |
Mpc2 | 8161 |
Uqcrq | 8158 |
Ndufa4 | 8129 |
Uqcr11 | 8116 |
Ndufc1 | 8100 |
Uqcr10 | 8099 |
Cox6c | 8086 |
Cox6b1 | 8069 |
Atp5g1 | 8061 |
Cox5b | 8059 |
Ndufa5 | 8056 |
Ndufa13 | 8055 |
Ndufs6 | 8051 |
Ldhb | 8049 |
Cox14 | 8038 |
Atp5j | 8037 |
Atp5e | 8029 |
Cox5a | 8028 |
Ndufs5 | 8023 |
Cox7b | 8014 |
Ndufb9 | 8002 |
Ndufb3 | 7998 |
Atp5j2 | 7996 |
Ndufs4 | 7985 |
Ndufa6 | 7968 |
Ndufc2 | 7955 |
Ndufb8 | 7931 |
Idh3b | 7900 |
Cox4i1 | 7897 |
Cox6a1 | 7893 |
Ndufaf2 | 7875 |
Ndufa11 | 7874 |
mt-Atp8 | 7872 |
Sdhd | 7866 |
Ndufa7 | 7857 |
Cyc1 | 7848 |
Uqcrh | 7843 |
Uqcrb | 7828 |
Uqcrc1 | 7775 |
Ndufb7 | 7734 |
Atp5g3 | 7732 |
Atp5pb | 7715 |
Atp5c1 | 7702 |
Ndufa12 | 7696 |
Ndufv3 | 7667 |
Ucp3 | 7660 |
Atp5h | 7646 |
Ndufab1 | 7639 |
Ndufv2 | 7630 |
Uqcrfs1 | 7578 |
Timmdc1 | 7567 |
Atp5l | 7551 |
Pdhb | 7550 |
Atp5o | 7535 |
Ndufs2 | 7533 |
Surf1 | 7526 |
Ndufv1 | 7518 |
Ndufb10 | 7509 |
Ndufb2 | 7466 |
Ndufb5 | 7429 |
Ndufb6 | 7399 |
Ndufb11 | 7389 |
Suclg1 | 7384 |
Mpc1 | 7371 |
Ndufs8 | 7370 |
Nubpl | 7321 |
Ndufaf3 | 7290 |
Atp5b | 7287 |
Ndufb4 | 7263 |
Etfb | 7230 |
Atp5d | 7201 |
Cox16 | 7173 |
Tmem186 | 7110 |
Cox20 | 7109 |
Idh3g | 7082 |
Hagh | 6971 |
Cox7a2l | 6959 |
Fahd1 | 6950 |
Ndufaf6 | 6943 |
Ndufa10 | 6876 |
Ndufs3 | 6805 |
Ndufa8 | 6782 |
Tmem126b | 6712 |
Sdhb | 6683 |
Cox19 | 6625 |
Ndufs7 | 6616 |
Sucla2 | 6578 |
Ndufaf5 | 6479 |
Uqcrc2 | 6477 |
Ndufa9 | 6396 |
Gstz1 | 6366 |
Coq10a | 6250 |
Cycs | 6115 |
Pdk4 | 6000 |
Ndufaf7 | 5975 |
Fh1 | 5948 |
Mdh2 | 5641 |
mt-Nd3 | 5608 |
Dmac2l | 5595 |
Idh3a | 5585 |
Etfa | 5550 |
Etfdh | 5529 |
Idh2 | 5190 |
Sdhc | 5132 |
Vdac1 | 5077 |
Ndufaf1 | 5059 |
D2hgdh | 4933 |
Slc25a14 | 4843 |
Trap1 | 4600 |
Pdhx | 4176 |
Cox11 | 4162 |
mt-Co3 | 4094 |
Pdk2 | 3886 |
Cox18 | 3590 |
Glo1 | 3431 |
Ecsit | 3430 |
Ndufaf4 | 3377 |
Ldha | 3351 |
Me1 | 3307 |
Pdha1 | 2836 |
Bsg | 2733 |
Dld | 2564 |
Aco2 | 2503 |
Me3 | 2429 |
Sco2 | 2254 |
Atp5a1 | 2242 |
Dlst | 1937 |
Ndufs1 | 1403 |
Slc16a3 | 1099 |
Suclg2 | 819 |
Adhfe1 | 710 |
Cs | 698 |
Dlat | 495 |
Ppard | 254 |
L2hgdh | 184 |
mt-Atp6 | 117 |
mt-Nd6 | 108 |
Sco1 | -24 |
Sdha | -346 |
Pdk1 | -353 |
mt-Co2 | -461 |
Me2 | -890 |
Acad9 | -1666 |
Lrpprc | -1807 |
Coq10b | -1846 |
Pdp2 | -2053 |
mt-Cytb | -3144 |
Pdk3 | -3687 |
mt-Nd1 | -4019 |
Slc16a8 | -4207 |
Taco1 | -4549 |
Slc16a1 | -4799 |
Nnt | -5258 |
mt-Co1 | -5320 |
Ogdh | -5395 |
Slc25a27 | -5449 |
Pdpr | -6351 |
Rxra | -6734 |
mt-Nd4 | -7084 |
Atp5g2 | -7609 |
Pm20d1 | -7755 |
mt-Nd5 | -8584 |
mt-Nd2 | -8859 |
Pdp1 | -8911 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING
612 | |
---|---|
set | NEGATIVE REGULATION OF NOTCH4 SIGNALING |
setSize | 54 |
pANOVA | 9.51e-14 |
s.dist | 0.586 |
p.adjustANOVA | 4.31e-12 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Uba52 | 7262 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
Psmd7 | 7050 |
Rbx1 | 6958 |
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Uba52 | 7262 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
Psmd7 | 7050 |
Rbx1 | 6958 |
Psma2 | 6851 |
Psme1 | 6829 |
Psmb10 | 6606 |
Psmd8 | 6594 |
Psmb1 | 6446 |
Tacc3 | 6339 |
Psmc1 | 6270 |
Notch4 | 6122 |
Psmc2 | 5913 |
Psmd14 | 5733 |
Psmc5 | 5693 |
Psmc3 | 5625 |
Psmd4 | 5559 |
Psma1 | 5378 |
Psme2 | 5280 |
Psma5 | 5259 |
Skp1 | 4875 |
Psmd12 | 3996 |
Akt1 | 3834 |
Psmc6 | 3784 |
Psmd10 | 3670 |
Psmf1 | 3034 |
Psmd6 | 2341 |
Psmb8 | 1878 |
Psmd1 | 1686 |
Psmd2 | -281 |
Fbxw7 | -894 |
Psmb9 | -1520 |
Ubc | -2250 |
Cul1 | -2566 |
Ywhaz | -3960 |
Psme3 | -4000 |
Psmd11 | -4032 |
Psmd5 | -4580 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY
818 | |
---|---|
set | REGULATION OF RUNX1 EXPRESSION AND ACTIVITY |
setSize | 17 |
pANOVA | 3.14e-05 |
s.dist | -0.583 |
p.adjustANOVA | 0.000299 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mov10 | -8985 |
Ccnd2 | -8853 |
Ago3 | -8733 |
Ago2 | -8551 |
Cdk6 | -8201 |
Ago1 | -8048 |
Tnrc6a | -7926 |
Tnrc6c | -7641 |
Tnrc6b | -6445 |
Ccnd1 | -5372 |
Ago4 | -5091 |
Cbfb | -4841 |
Pml | -4147 |
Src | -3681 |
Ccnd3 | 89 |
Runx1 | 490 |
Ptpn11 | 2900 |
GeneID | Gene Rank |
---|---|
Mov10 | -8985 |
Ccnd2 | -8853 |
Ago3 | -8733 |
Ago2 | -8551 |
Cdk6 | -8201 |
Ago1 | -8048 |
Tnrc6a | -7926 |
Tnrc6c | -7641 |
Tnrc6b | -6445 |
Ccnd1 | -5372 |
Ago4 | -5091 |
Cbfb | -4841 |
Pml | -4147 |
Src | -3681 |
Ccnd3 | 89 |
Runx1 | 490 |
Ptpn11 | 2900 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS
793 | |
---|---|
set | REGULATION OF EXPRESSION OF SLITS AND ROBOS |
setSize | 162 |
pANOVA | 1.75e-37 |
s.dist | 0.582 |
p.adjustANOVA | 1.88e-35 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Psmb5 | 8036 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Magoh | 7916 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Psma3 | 7831 |
Psmb3 | 7826 |
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Psmb5 | 8036 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Magoh | 7916 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Psma3 | 7831 |
Psmb3 | 7826 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Psmb7 | 7813 |
Rps15 | 7805 |
Rps10 | 7793 |
Rpl13 | 7786 |
Rpl11 | 7781 |
Rpl31 | 7729 |
Rpl34 | 7726 |
Rps12 | 7721 |
Rpl26 | 7699 |
Psmb2 | 7679 |
Rps8 | 7676 |
Rplp1 | 7662 |
Rpl23 | 7655 |
Rpl27 | 7644 |
Sem1 | 7641 |
Magohb | 7626 |
Rpl7a | 7609 |
Rpl24 | 7605 |
Psmb6 | 7604 |
Rps23 | 7560 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Rpl36a | 7511 |
Psma4 | 7495 |
Rps18 | 7494 |
Rpl18 | 7478 |
Rps7 | 7471 |
Rps9 | 7456 |
Rps15a | 7440 |
Rpl18a | 7438 |
Rpl9 | 7416 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Rpl21 | 7270 |
Rps19 | 7268 |
Uba52 | 7262 |
Rpl29 | 7250 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
Rpl30 | 7145 |
Rpl8 | 7137 |
Rps13 | 7086 |
Psmd7 | 7050 |
Rplp0 | 7009 |
Rpl10a | 6965 |
Rbx1 | 6958 |
Rpl22l1 | 6916 |
Rps16 | 6913 |
Rps2 | 6912 |
Rpl7 | 6885 |
Rps11 | 6883 |
Rps25 | 6881 |
Rpl14 | 6873 |
Psma2 | 6851 |
Eif4a3 | 6842 |
Psme1 | 6829 |
Rpl13a | 6776 |
Rpl4 | 6774 |
Rps3 | 6754 |
Rps27l | 6682 |
Rps6 | 6648 |
Rpl3 | 6642 |
Rps24 | 6631 |
Rps5 | 6627 |
Rpl23a | 6619 |
Psmb10 | 6606 |
Rpl17 | 6604 |
Psmd8 | 6594 |
Eloc | 6528 |
Rpl27a | 6473 |
Psmb1 | 6446 |
Rps26 | 6384 |
Rps3a1 | 6345 |
Rpl28 | 6319 |
Rpl15 | 6281 |
Rpl5 | 6276 |
Psmc1 | 6270 |
Rps20 | 6232 |
Elob | 6216 |
Rpl12 | 6198 |
Rps4x | 5999 |
Psmc2 | 5913 |
Psmd14 | 5733 |
Ncbp2 | 5725 |
Rpsa | 5712 |
Psmc5 | 5693 |
Psmc3 | 5625 |
Rpl6 | 5583 |
Psmd4 | 5559 |
Lhx3 | 5449 |
Upf3a | 5389 |
Psma1 | 5378 |
Psme2 | 5280 |
Psma5 | 5259 |
Psmd12 | 3996 |
Psmc6 | 3784 |
Psmd10 | 3670 |
Upf3b | 3070 |
Psmf1 | 3034 |
Etf1 | 2515 |
Rbm8a | 2513 |
Psmd6 | 2341 |
Rpl10 | 2228 |
Upf2 | 1989 |
Psmb8 | 1878 |
Psmd1 | 1686 |
Cul2 | 1613 |
Rnps1 | 1394 |
Ncbp1 | 1338 |
Psmd2 | -281 |
Ldb1 | -553 |
Psmb9 | -1520 |
Ubc | -2250 |
Pabpc1 | -2626 |
Psme3 | -4000 |
Psmd11 | -4032 |
Eif4g1 | -4562 |
Psmd5 | -4580 |
Psme4 | -4962 |
Isl1 | -5035 |
Robo2 | -5272 |
Gspt2 | -5434 |
Gspt1 | -5841 |
Msi1 | -5844 |
Casc3 | -5851 |
Col4a5 | -6422 |
Slit2 | -6451 |
Lhx4 | -6621 |
Dag1 | -6855 |
Robo3 | -7106 |
Usp33 | -7892 |
Slit1 | -7905 |
Robo1 | -8470 |
Zswim8 | -8764 |
Lhx9 | -8779 |
Lhx2 | -8991 |
CELLULAR RESPONSE TO STARVATION
141 | |
---|---|
set | CELLULAR RESPONSE TO STARVATION |
setSize | 146 |
pANOVA | 1.09e-32 |
s.dist | 0.57 |
p.adjustANOVA | 8.03e-31 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Lamtor1 | 8184 |
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Lamtor4 | 8058 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Castor1 | 8025 |
Rpl32 | 8005 |
Lamtor3 | 7926 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
GeneID | Gene Rank |
---|---|
Lamtor1 | 8184 |
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Lamtor4 | 8058 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Castor1 | 8025 |
Rpl32 | 8005 |
Lamtor3 | 7926 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Rps15 | 7805 |
Rps10 | 7793 |
Rpl13 | 7786 |
Rpl11 | 7781 |
Rpl31 | 7729 |
Rpl34 | 7726 |
Rps12 | 7721 |
Atf4 | 7703 |
Rpl26 | 7699 |
Rps8 | 7676 |
Rplp1 | 7662 |
Rpl23 | 7655 |
Atp6v1f | 7647 |
Rpl27 | 7644 |
Rpl7a | 7609 |
Rpl24 | 7605 |
Rps23 | 7560 |
Rps27a | 7519 |
Rpl36a | 7511 |
Rps18 | 7494 |
Rpl18 | 7478 |
Rps7 | 7471 |
Rps9 | 7456 |
Rps15a | 7440 |
Rpl18a | 7438 |
Rpl9 | 7416 |
Atp6v1g1 | 7387 |
Lamtor2 | 7296 |
Rpl21 | 7270 |
Rps19 | 7268 |
Uba52 | 7262 |
Rpl29 | 7250 |
Lamtor5 | 7208 |
Sesn1 | 7206 |
Rpl30 | 7145 |
Rpl8 | 7137 |
Rps13 | 7086 |
Rplp0 | 7009 |
Atp6v0b | 6969 |
Rpl10a | 6965 |
Rpl22l1 | 6916 |
Rps16 | 6913 |
Rps2 | 6912 |
Rpl7 | 6885 |
Rps11 | 6883 |
Rps25 | 6881 |
Rpl14 | 6873 |
Atp6v1e1 | 6861 |
Kptn | 6848 |
Rpl13a | 6776 |
Rpl4 | 6774 |
Rps3 | 6754 |
Rps27l | 6682 |
Rps6 | 6648 |
Rpl3 | 6642 |
Rps24 | 6631 |
Rps5 | 6627 |
Rpl23a | 6619 |
Rpl17 | 6604 |
Rpl27a | 6473 |
Eif2s1 | 6435 |
Rps26 | 6384 |
Rps3a1 | 6345 |
Rpl28 | 6319 |
Rpl15 | 6281 |
Rpl5 | 6276 |
Rps20 | 6232 |
Rpl12 | 6198 |
Sec13 | 6081 |
Rps4x | 5999 |
Rpsa | 5712 |
Ddit3 | 5632 |
Rpl6 | 5583 |
Atp6v0d1 | 5492 |
Atp6v1g2 | 5253 |
Nprl2 | 5244 |
Mlst8 | 4656 |
Atp6v1c1 | 4617 |
Eif2s2 | 4515 |
Atp6v1d | 4360 |
Rraga | 4343 |
Atp6v0e2 | 4214 |
Atp6v1h | 3848 |
Atp6v0c | 3691 |
Rragc | 3568 |
Rheb | 3534 |
Mios | 3055 |
BC048403 | 2337 |
Atp6v0e | 2264 |
Rpl10 | 2228 |
Wdr24 | 1889 |
Cebpb | 1745 |
Atp6v1b2 | 971 |
Atp6v1c2 | 578 |
Trib3 | 491 |
Atf3 | 449 |
Itfg2 | 340 |
Nprl3 | -451 |
Cebpg | -545 |
Eif2s3x | -729 |
Rragb | -927 |
Seh1l | -1259 |
Fnip2 | -1349 |
Atp6v1a | -1401 |
Sesn2 | -1515 |
Asns | -1790 |
Rptor | -2954 |
Wdr59 | -3778 |
Depdc5 | -5135 |
Eif2ak4 | -5310 |
Sh3bp4 | -5647 |
Tcirg1 | -5687 |
Impact | -5768 |
Flcn | -6012 |
Fnip1 | -6592 |
Mtor | -6812 |
Bmt2 | -6893 |
Gcn1 | -7117 |
Szt2 | -7355 |
Slc38a9 | -7362 |
Atf2 | -7475 |
Castor2 | -7604 |
Rragd | -8342 |
METABOLISM OF POLYAMINES
553 | |
---|---|
set | METABOLISM OF POLYAMINES |
setSize | 57 |
pANOVA | 1.07e-13 |
s.dist | 0.569 |
p.adjustANOVA | 4.69e-12 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Smox | 7730 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Psma6 | 7167 |
Psmd7 | 7050 |
Psma2 | 6851 |
Psme1 | 6829 |
Psmb10 | 6606 |
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Smox | 7730 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Psma6 | 7167 |
Psmd7 | 7050 |
Psma2 | 6851 |
Psme1 | 6829 |
Psmb10 | 6606 |
Psmd8 | 6594 |
Psmb1 | 6446 |
Oaz1 | 6405 |
Oaz2 | 6349 |
Psmc1 | 6270 |
Azin2 | 6044 |
Odc1 | 5920 |
Psmc2 | 5913 |
Psmd14 | 5733 |
Srm | 5697 |
Psmc5 | 5693 |
Psmc3 | 5625 |
Psmd4 | 5559 |
Psma1 | 5378 |
Psme2 | 5280 |
Psma5 | 5259 |
Nqo1 | 5146 |
Psmd12 | 3996 |
Psmc6 | 3784 |
Sat1 | 3688 |
Psmd10 | 3670 |
Psmf1 | 3034 |
Paox | 2877 |
Psmd6 | 2341 |
Psmb8 | 1878 |
Azin1 | 1858 |
Agmat | 1740 |
Psmd1 | 1686 |
Oaz3 | 635 |
Sms | 237 |
Psmd2 | -281 |
Psmb9 | -1520 |
Amd1 | -3314 |
Psme3 | -4000 |
Psmd11 | -4032 |
Psmd5 | -4580 |
Psme4 | -4962 |
PKA ACTIVATION IN GLUCAGON SIGNALLING
710 | |
---|---|
set | PKA ACTIVATION IN GLUCAGON SIGNALLING |
setSize | 16 |
pANOVA | 0.000115 |
s.dist | -0.557 |
p.adjustANOVA | 0.000879 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Adcy4 | -9080 |
Adcy7 | -8971 |
Prkar2a | -8858 |
Adcy6 | -8795 |
Adcy3 | -7802 |
Adcy5 | -7709 |
Adcy8 | -7344 |
Prkacb | -7235 |
Adcy2 | -6526 |
Adcy9 | -4486 |
Prkar2b | -3762 |
Prkar1a | -3133 |
Prkar1b | -1887 |
Prkaca | -1090 |
Adcy1 | -640 |
Gnas | 3417 |
GeneID | Gene Rank |
---|---|
Adcy4 | -9080 |
Adcy7 | -8971 |
Prkar2a | -8858 |
Adcy6 | -8795 |
Adcy3 | -7802 |
Adcy5 | -7709 |
Adcy8 | -7344 |
Prkacb | -7235 |
Adcy2 | -6526 |
Adcy9 | -4486 |
Prkar2b | -3762 |
Prkar1a | -3133 |
Prkar1b | -1887 |
Prkaca | -1090 |
Adcy1 | -640 |
Gnas | 3417 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES
191 | |
---|---|
set | CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES |
setSize | 46 |
pANOVA | 8.69e-11 |
s.dist | 0.553 |
p.adjustANOVA | 2.63e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Psma6 | 7167 |
Psmd7 | 7050 |
Psma2 | 6851 |
Psme1 | 6829 |
Psmb10 | 6606 |
Psmd8 | 6594 |
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Psma6 | 7167 |
Psmd7 | 7050 |
Psma2 | 6851 |
Psme1 | 6829 |
Psmb10 | 6606 |
Psmd8 | 6594 |
Psmb1 | 6446 |
Psmc1 | 6270 |
Psmc2 | 5913 |
Psmd14 | 5733 |
Psmc5 | 5693 |
Psmc3 | 5625 |
Psmd4 | 5559 |
Psma1 | 5378 |
Psme2 | 5280 |
Psma5 | 5259 |
Mrc1 | 4179 |
Psmd12 | 3996 |
Psmc6 | 3784 |
Psmd10 | 3670 |
Psmf1 | 3034 |
Psmd6 | 2341 |
Psmb8 | 1878 |
Psmd1 | 1686 |
Psmd2 | -281 |
Psmb9 | -1520 |
Mrc2 | -1907 |
Psme3 | -4000 |
Psmd11 | -4032 |
Psmd5 | -4580 |
Psme4 | -4962 |
Fcgr1 | -7025 |
COHESIN LOADING ONTO CHROMATIN
165 | |
---|---|
set | COHESIN LOADING ONTO CHROMATIN |
setSize | 10 |
pANOVA | 0.00269 |
s.dist | -0.548 |
p.adjustANOVA | 0.0129 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Nipbl | -8451 |
Pds5b | -7910 |
Pds5a | -7606 |
Stag2 | -6441 |
Rad21 | -5793 |
Mau2 | -4510 |
Wapl | -4102 |
Smc1a | -3291 |
Stag1 | -3077 |
Smc3 | -523 |
GeneID | Gene Rank |
---|---|
Nipbl | -8451 |
Pds5b | -7910 |
Pds5a | -7606 |
Stag2 | -6441 |
Rad21 | -5793 |
Mau2 | -4510 |
Wapl | -4102 |
Smc1a | -3291 |
Stag1 | -3077 |
Smc3 | -523 |
SIGNALING BY HIPPO
965 | |
---|---|
set | SIGNALING BY HIPPO |
setSize | 20 |
pANOVA | 2.26e-05 |
s.dist | -0.547 |
p.adjustANOVA | 0.000224 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Amotl1 | -9038 |
Wwc1 | -8850 |
Wwtr1 | -8757 |
Tjp1 | -8192 |
Stk4 | -7897 |
Yap1 | -7464 |
Amotl2 | -7277 |
Nphp4 | -7161 |
Mob1a | -7095 |
Lats1 | -7088 |
Dvl2 | -6862 |
Tjp2 | -6608 |
Mob1b | -6521 |
Sav1 | -5864 |
Lats2 | -4165 |
Amot | -3465 |
Ywhae | 673 |
Casp3 | 1034 |
Stk3 | 3451 |
Ywhab | 3924 |
GeneID | Gene Rank |
---|---|
Amotl1 | -9038 |
Wwc1 | -8850 |
Wwtr1 | -8757 |
Tjp1 | -8192 |
Stk4 | -7897 |
Yap1 | -7464 |
Amotl2 | -7277 |
Nphp4 | -7161 |
Mob1a | -7095 |
Lats1 | -7088 |
Dvl2 | -6862 |
Tjp2 | -6608 |
Mob1b | -6521 |
Sav1 | -5864 |
Lats2 | -4165 |
Amot | -3465 |
Ywhae | 673 |
Casp3 | 1034 |
Stk3 | 3451 |
Ywhab | 3924 |
RRNA PROCESSING
897 | |
---|---|
set | RRNA PROCESSING |
setSize | 194 |
pANOVA | 1.95e-39 |
s.dist | 0.546 |
p.adjustANOVA | 2.87e-37 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Xrn2 | 7991 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Xrn2 | 7991 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Rps15 | 7805 |
Rps10 | 7793 |
Rpl13 | 7786 |
Rpl11 | 7781 |
Rpl31 | 7729 |
Rpl34 | 7726 |
Rrp36 | 7723 |
Rps12 | 7721 |
Rpl26 | 7699 |
Rps8 | 7676 |
Rplp1 | 7662 |
Rpl23 | 7655 |
Rpl27 | 7644 |
Rpl7a | 7609 |
Rpl24 | 7605 |
Rps23 | 7560 |
Rps27a | 7519 |
Rpl36a | 7511 |
Ddx49 | 7500 |
Rps18 | 7494 |
Rpl18 | 7478 |
Rps7 | 7471 |
Rps9 | 7456 |
Rps15a | 7440 |
Rpl18a | 7438 |
Tsr3 | 7436 |
Wdr18 | 7427 |
Nhp2 | 7421 |
Rpl9 | 7416 |
Rpp25 | 7294 |
Rpl21 | 7270 |
Rps19 | 7268 |
Hsd17b10 | 7267 |
Uba52 | 7262 |
Rpl29 | 7250 |
Nol12 | 7213 |
Imp3 | 7188 |
Gar1 | 7151 |
Rpl30 | 7145 |
Rpl8 | 7137 |
Nip7 | 7111 |
Rps13 | 7086 |
Ltv1 | 7076 |
Rplp0 | 7009 |
Rpl10a | 6965 |
Nop10 | 6928 |
Rpl22l1 | 6916 |
Rps16 | 6913 |
Rps2 | 6912 |
Rpl7 | 6885 |
Rps11 | 6883 |
Rps25 | 6881 |
Rpl14 | 6873 |
Exosc9 | 6857 |
Snu13 | 6788 |
Rpl13a | 6776 |
Rpl4 | 6774 |
Rps3 | 6754 |
Rps27l | 6682 |
Pes1 | 6661 |
Rps6 | 6648 |
Rpl3 | 6642 |
Rps24 | 6631 |
Rps5 | 6627 |
Rpl23a | 6619 |
Rpl17 | 6604 |
Rpp21 | 6513 |
Pno1 | 6501 |
Rpl27a | 6473 |
Rps26 | 6384 |
Rcl1 | 6364 |
Rps3a1 | 6345 |
Exosc5 | 6327 |
Rpl28 | 6319 |
Rpl15 | 6281 |
Rpl5 | 6276 |
Rps20 | 6232 |
Rpl12 | 6198 |
Exosc2 | 6188 |
Fbl | 6136 |
Rps4x | 5999 |
Exosc7 | 5805 |
Trmt112 | 5791 |
Rpsa | 5712 |
Krr1 | 5651 |
Exosc8 | 5591 |
Rpl6 | 5583 |
Fcf1 | 5548 |
Gnl3 | 5453 |
Nob1 | 5386 |
Ddx52 | 5358 |
Utp3 | 5284 |
Rrp1 | 5278 |
Bop1 | 5245 |
Nop56 | 5221 |
Mrm2 | 5061 |
Mrm3 | 5053 |
Mrm1 | 4982 |
Wdr46 | 4876 |
Tbl3 | 4813 |
Dcaf13 | 4793 |
Emg1 | 4785 |
Eri1 | 4705 |
Ddx47 | 4688 |
Rpp38 | 4674 |
Exosc4 | 4518 |
Thumpd1 | 4454 |
Exosc1 | 4434 |
Bud23 | 4422 |
Rpp40 | 4207 |
Rrp9 | 3958 |
Trmt10c | 3820 |
Rrp7a | 3744 |
Dkc1 | 3707 |
Ebna1bp2 | 3437 |
Utp11 | 3289 |
Rpp14 | 2980 |
Ncl | 2918 |
Rpp30 | 2888 |
Ftsj3 | 2863 |
C1d | 2657 |
Riok3 | 2620 |
Noc4l | 2492 |
Rpl10 | 2228 |
Wdr43 | 2017 |
Riok2 | 2000 |
Mtrex | 1949 |
Utp25 | 1908 |
Nol11 | 1648 |
Elac2 | 1632 |
Mphosph10 | 1478 |
Mphosph6 | 1439 |
Riok1 | 1412 |
Pdcd11 | 1269 |
Pelp1 | 1114 |
Prorp | 1109 |
Senp3 | 604 |
Imp4 | 580 |
Nsun4 | 294 |
Exosc3 | 46 |
Nop58 | 38 |
Tsr1 | -124 |
Isg20l2 | -210 |
Tfb1m | -267 |
Wdr36 | -693 |
Nop14 | -761 |
Wdr12 | -844 |
Utp18 | -1147 |
Csnk1d | -1262 |
Exosc10 | -1325 |
Bms1 | -1382 |
Utp14a | -1600 |
Mterf4 | -1656 |
Dhx37 | -2585 |
Ddx21 | -2647 |
Pwp2 | -2873 |
Las1l | -2878 |
Nol9 | -3131 |
Tex10 | -3206 |
Bysl | -3379 |
Utp6 | -3513 |
Dis3 | -3955 |
Wdr75 | -4319 |
Nat10 | -4487 |
Csnk1e | -4763 |
Nop2 | -5029 |
Nol6 | -5450 |
Rbm28 | -5700 |
Utp15 | -6335 |
Utp4 | -6611 |
Heatr1 | -7687 |
Utp20 | -7746 |
Dimt1 | -8598 |
Wdr3 | -8666 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS
1003 | |
---|---|
set | SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS |
setSize | 11 |
pANOVA | 0.00197 |
s.dist | 0.539 |
p.adjustANOVA | 0.00988 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Snrpg | 8071 |
Snrpe | 8046 |
Snrpf | 7594 |
Snrpd3 | 7420 |
Snrpb | 5978 |
Ncbp2 | 5725 |
Slbp | 4416 |
Lsm10 | 2950 |
Ncbp1 | 1338 |
Zfp473 | -194 |
Lsm11 | -4548 |
GeneID | Gene Rank |
---|---|
Snrpg | 8071 |
Snrpe | 8046 |
Snrpf | 7594 |
Snrpd3 | 7420 |
Snrpb | 5978 |
Ncbp2 | 5725 |
Slbp | 4416 |
Lsm10 | 2950 |
Ncbp1 | 1338 |
Zfp473 | -194 |
Lsm11 | -4548 |
PROCESSING OF SMDT1
744 | |
---|---|
set | PROCESSING OF SMDT1 |
setSize | 16 |
pANOVA | 0.000195 |
s.dist | 0.538 |
p.adjustANOVA | 0.00136 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Smdt1 | 7625 |
Parl | 7243 |
Phb2 | 7087 |
Phb | 6780 |
Stoml2 | 6592 |
Maip1 | 6266 |
Pmpca | 6174 |
Micu2 | 5807 |
Micu3 | 5678 |
Pmpcb | 5609 |
Micu1 | 4015 |
Mcub | 3200 |
Spg7 | 2297 |
Afg3l2 | -613 |
Yme1l1 | -1450 |
Mcu | -4412 |
GeneID | Gene Rank |
---|---|
Smdt1 | 7625 |
Parl | 7243 |
Phb2 | 7087 |
Phb | 6780 |
Stoml2 | 6592 |
Maip1 | 6266 |
Pmpca | 6174 |
Micu2 | 5807 |
Micu3 | 5678 |
Pmpcb | 5609 |
Micu1 | 4015 |
Mcub | 3200 |
Spg7 | 2297 |
Afg3l2 | -613 |
Yme1l1 | -1450 |
Mcu | -4412 |
STABILIZATION OF P53
1014 | |
---|---|
set | STABILIZATION OF P53 |
setSize | 54 |
pANOVA | 6.7e-11 |
s.dist | 0.513 |
p.adjustANOVA | 2.08e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Uba52 | 7262 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
Psmd7 | 7050 |
Psma2 | 6851 |
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Uba52 | 7262 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
Psmd7 | 7050 |
Psma2 | 6851 |
Psme1 | 6829 |
Psmb10 | 6606 |
Psmd8 | 6594 |
Psmb1 | 6446 |
Psmc1 | 6270 |
Psmc2 | 5913 |
Psmd14 | 5733 |
Psmc5 | 5693 |
Psmc3 | 5625 |
Psmd4 | 5559 |
Psma1 | 5378 |
Psme2 | 5280 |
Psma5 | 5259 |
Psmd12 | 3996 |
Psmc6 | 3784 |
Psmd10 | 3670 |
Mdm2 | 3579 |
Trp53 | 3197 |
Psmf1 | 3034 |
Chek2 | 2920 |
Psmd6 | 2341 |
Psmb8 | 1878 |
Psmd1 | 1686 |
Psmd2 | -281 |
Phf20 | -847 |
Cop1 | -1350 |
Psmb9 | -1520 |
Ubc | -2250 |
Psme3 | -4000 |
Psmd11 | -4032 |
Psmd5 | -4580 |
Psme4 | -4962 |
Atm | -7179 |
Mdm4 | -8409 |
PINK1 PRKN MEDIATED MITOPHAGY
708 | |
---|---|
set | PINK1 PRKN MEDIATED MITOPHAGY |
setSize | 22 |
pANOVA | 3.23e-05 |
s.dist | 0.512 |
p.adjustANOVA | 0.000303 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tomm7 | 8227 |
Map1lc3b | 7988 |
Tomm22 | 7943 |
Pink1 | 7825 |
Tomm6 | 7722 |
Rps27a | 7519 |
Tomm5 | 7349 |
Uba52 | 7262 |
Ubb | 7197 |
Map1lc3a | 6741 |
Tomm40 | 6684 |
Vdac1 | 5077 |
Sqstm1 | 3819 |
Mfn1 | 3000 |
Atg5 | 2596 |
Atg12 | 2426 |
Mterf3 | 540 |
Tomm20 | 206 |
Tomm70a | -2163 |
Ubc | -2250 |
GeneID | Gene Rank |
---|---|
Tomm7 | 8227 |
Map1lc3b | 7988 |
Tomm22 | 7943 |
Pink1 | 7825 |
Tomm6 | 7722 |
Rps27a | 7519 |
Tomm5 | 7349 |
Uba52 | 7262 |
Ubb | 7197 |
Map1lc3a | 6741 |
Tomm40 | 6684 |
Vdac1 | 5077 |
Sqstm1 | 3819 |
Mfn1 | 3000 |
Atg5 | 2596 |
Atg12 | 2426 |
Mterf3 | 540 |
Tomm20 | 206 |
Tomm70a | -2163 |
Ubc | -2250 |
Prkn | -2505 |
Mfn2 | -4838 |
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT
7 | |
---|---|
set | ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT |
setSize | 23 |
pANOVA | 2.21e-05 |
s.dist | 0.511 |
p.adjustANOVA | 0.000221 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Polr2l | 8217 |
Polr2i | 8118 |
Polr2j | 8067 |
Polr2f | 7953 |
Polr2h | 7653 |
Polr2g | 7391 |
Polr2k | 7373 |
Polr2e | 7011 |
Supt4a | 6970 |
Gtf2f2 | 6459 |
Nelfcd | 5988 |
Ncbp2 | 5725 |
Polr2c | 5408 |
Nelfe | 4751 |
Polr2d | 4021 |
Nelfb | 3767 |
Gtf2f1 | 3363 |
Ctdp1 | 2747 |
Ncbp1 | 1338 |
Polr2b | -2618 |
GeneID | Gene Rank |
---|---|
Polr2l | 8217 |
Polr2i | 8118 |
Polr2j | 8067 |
Polr2f | 7953 |
Polr2h | 7653 |
Polr2g | 7391 |
Polr2k | 7373 |
Polr2e | 7011 |
Supt4a | 6970 |
Gtf2f2 | 6459 |
Nelfcd | 5988 |
Ncbp2 | 5725 |
Polr2c | 5408 |
Nelfe | 4751 |
Polr2d | 4021 |
Nelfb | 3767 |
Gtf2f1 | 3363 |
Ctdp1 | 2747 |
Ncbp1 | 1338 |
Polr2b | -2618 |
Nelfa | -4430 |
Supt5 | -6418 |
Polr2a | -6656 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21
911 | |
---|---|
set | SCF SKP2 MEDIATED DEGRADATION OF P27 P21 |
setSize | 58 |
pANOVA | 1.96e-11 |
s.dist | 0.509 |
p.adjustANOVA | 7.22e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Cdkn1a | 8015 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Uba52 | 7262 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
Psmd7 | 7050 |
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Cdkn1a | 8015 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Uba52 | 7262 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
Psmd7 | 7050 |
Psma2 | 6851 |
Psme1 | 6829 |
Psmb10 | 6606 |
Psmd8 | 6594 |
Psmb1 | 6446 |
Psmc1 | 6270 |
Cdk4 | 6231 |
Cks1b | 6134 |
Psmc2 | 5913 |
Psmd14 | 5733 |
Psmc5 | 5693 |
Psmc3 | 5625 |
Psmd4 | 5559 |
Psma1 | 5378 |
Psme2 | 5280 |
Psma5 | 5259 |
Ccne1 | 4983 |
Skp1 | 4875 |
Psmd12 | 3996 |
Psmc6 | 3784 |
Psmd10 | 3670 |
Psmf1 | 3034 |
Psmd6 | 2341 |
Psmb8 | 1878 |
Psmd1 | 1686 |
Ccne2 | -51 |
Psmd2 | -281 |
Psmb9 | -1520 |
Ubc | -2250 |
Cdk2 | -2490 |
Cul1 | -2566 |
Cdkn1b | -2773 |
Psme3 | -4000 |
Psmd11 | -4032 |
Psmd5 | -4580 |
Ccnd1 | -5372 |
Ccna2 | -8038 |
Skp2 | -8063 |
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES
780 | |
---|---|
set | RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES |
setSize | 20 |
pANOVA | 8.67e-05 |
s.dist | -0.507 |
p.adjustANOVA | 0.000715 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Slitrk2 | -8943 |
Slitrk6 | -8593 |
Ppfia2 | -7676 |
Ptprd | -7495 |
Ppfia3 | -7156 |
Ptprf | -6704 |
Ntrk3 | -6453 |
Slitrk5 | -6164 |
Slitrk3 | -6078 |
Slitrk1 | -5723 |
Ptprs | -5441 |
Lrrc4b | -5373 |
Slitrk4 | -5168 |
Il1rapl1 | -3568 |
Ppfia1 | -2853 |
Ppfia4 | -2574 |
Ppfibp1 | -1332 |
Il1rap | -1162 |
Ppfibp2 | 741 |
Il1rapl2 | 1482 |
GeneID | Gene Rank |
---|---|
Slitrk2 | -8943 |
Slitrk6 | -8593 |
Ppfia2 | -7676 |
Ptprd | -7495 |
Ppfia3 | -7156 |
Ptprf | -6704 |
Ntrk3 | -6453 |
Slitrk5 | -6164 |
Slitrk3 | -6078 |
Slitrk1 | -5723 |
Ptprs | -5441 |
Lrrc4b | -5373 |
Slitrk4 | -5168 |
Il1rapl1 | -3568 |
Ppfia1 | -2853 |
Ppfia4 | -2574 |
Ppfibp1 | -1332 |
Il1rap | -1162 |
Ppfibp2 | 741 |
Il1rapl2 | 1482 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT
1075 | |
---|---|
set | THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT |
setSize | 66 |
pANOVA | 1.33e-12 |
s.dist | 0.505 |
p.adjustANOVA | 5.59e-11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Cdkn1a | 8015 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Psma4 | 7495 |
Tuba8 | 7467 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Uba52 | 7262 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Cdkn1a | 8015 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Psma4 | 7495 |
Tuba8 | 7467 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Uba52 | 7262 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
Psmd7 | 7050 |
Psma2 | 6851 |
Psme1 | 6829 |
Psmb10 | 6606 |
Psmd8 | 6594 |
Psmb1 | 6446 |
Psmc1 | 6270 |
Psmc2 | 5913 |
Psmd14 | 5733 |
Psmc5 | 5693 |
Psmc3 | 5625 |
Psmd4 | 5559 |
Psma1 | 5378 |
Psme2 | 5280 |
Psma5 | 5259 |
Fkbpl | 4698 |
Psmd12 | 3996 |
Tuba1a | 3987 |
Tubb3 | 3980 |
Psmc6 | 3784 |
Tubb4a | 3742 |
Psmd10 | 3670 |
Tubb4b | 3469 |
Trp53 | 3197 |
Psmf1 | 3034 |
Tuba4a | 3009 |
Plk1 | 2582 |
Psmd6 | 2341 |
Tuba1c | 2197 |
Tubb2a | 2036 |
Tuba1b | 1910 |
Psmb8 | 1878 |
Psmd1 | 1686 |
Gtse1 | -105 |
Psmd2 | -281 |
Tubb6 | -996 |
Psmb9 | -1520 |
Mapre1 | -1634 |
Ubc | -2250 |
Tubb2b | -3180 |
Psme3 | -4000 |
Psmd11 | -4032 |
Hsp90ab1 | -4099 |
Psmd5 | -4580 |
Psme4 | -4962 |
Hsp90aa1 | -5295 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY
820 | |
---|---|
set | REGULATION OF RUNX3 EXPRESSION AND ACTIVITY |
setSize | 53 |
pANOVA | 2.78e-10 |
s.dist | 0.501 |
p.adjustANOVA | 7.44e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Uba52 | 7262 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
Psmd7 | 7050 |
Psma2 | 6851 |
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Uba52 | 7262 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
Psmd7 | 7050 |
Psma2 | 6851 |
Psme1 | 6829 |
Psmb10 | 6606 |
Psmd8 | 6594 |
Psmb1 | 6446 |
Psmc1 | 6270 |
Psmc2 | 5913 |
Psmd14 | 5733 |
Psmc5 | 5693 |
Psmc3 | 5625 |
Psmd4 | 5559 |
Psma1 | 5378 |
Psme2 | 5280 |
Psma5 | 5259 |
Psmd12 | 3996 |
Psmc6 | 3784 |
Psmd10 | 3670 |
Mdm2 | 3579 |
Psmf1 | 3034 |
Psmd6 | 2341 |
Psmb8 | 1878 |
Psmd1 | 1686 |
Psmd2 | -281 |
Tgfb1 | -509 |
Psmb9 | -1520 |
Ubc | -2250 |
Src | -3681 |
Psme3 | -4000 |
Psmd11 | -4032 |
Smurf1 | -4520 |
Psmd5 | -4580 |
Cbfb | -4841 |
Ep300 | -4856 |
Smurf2 | -7891 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO
792 | |
---|---|
set | REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO |
setSize | 10 |
pANOVA | 0.00637 |
s.dist | -0.498 |
p.adjustANOVA | 0.0259 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Robo1 | -8470 |
Slit1 | -7905 |
Robo3 | -7106 |
Slit2 | -6451 |
Robo2 | -5272 |
Dcc | -4988 |
Nell2 | -4229 |
Src | -3681 |
Ntn1 | 342 |
Slit3 | 374 |
GeneID | Gene Rank |
---|---|
Robo1 | -8470 |
Slit1 | -7905 |
Robo3 | -7106 |
Slit2 | -6451 |
Robo2 | -5272 |
Dcc | -4988 |
Nell2 | -4229 |
Src | -3681 |
Ntn1 | 342 |
Slit3 | 374 |
DEGRADATION OF DVL
225 | |
---|---|
set | DEGRADATION OF DVL |
setSize | 55 |
pANOVA | 1.84e-10 |
s.dist | 0.497 |
p.adjustANOVA | 5.31e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Uba52 | 7262 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
Psmd7 | 7050 |
Rbx1 | 6958 |
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Uba52 | 7262 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
Psmd7 | 7050 |
Rbx1 | 6958 |
Psma2 | 6851 |
Psme1 | 6829 |
Psmb10 | 6606 |
Psmd8 | 6594 |
Psmb1 | 6446 |
Psmc1 | 6270 |
Psmc2 | 5913 |
Psmd14 | 5733 |
Psmc5 | 5693 |
Psmc3 | 5625 |
Psmd4 | 5559 |
Dact1 | 5533 |
Psma1 | 5378 |
Psme2 | 5280 |
Psma5 | 5259 |
Psmd12 | 3996 |
Psmc6 | 3784 |
Psmd10 | 3670 |
Psmf1 | 3034 |
Psmd6 | 2341 |
Klhl12 | 2007 |
Psmb8 | 1878 |
Psmd1 | 1686 |
Dvl1 | 1408 |
Psmd2 | -281 |
Psmb9 | -1520 |
Ubc | -2250 |
Psme3 | -4000 |
Psmd11 | -4032 |
Psmd5 | -4580 |
Psme4 | -4962 |
Cul3 | -5825 |
Dvl2 | -6862 |
Dvl3 | -7526 |
Hecw1 | -7675 |
PYROPTOSIS
764 | |
---|---|
set | PYROPTOSIS |
setSize | 20 |
pANOVA | 0.000128 |
s.dist | 0.495 |
p.adjustANOVA | 0.000966 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Chmp4b | 7618 |
Chmp2a | 7038 |
Bax | 6756 |
Gsdmd | 6391 |
Cycs | 6115 |
Chmp6 | 6076 |
Irf1 | 6055 |
Chmp2b | 5458 |
Il18 | 5274 |
Chmp3 | 4730 |
Casp1 | 4025 |
Gsdme | 3899 |
Chmp4c | 3321 |
Trp53 | 3197 |
Hmgb1 | 3012 |
Bak1 | 3003 |
Casp3 | 1034 |
Irf2 | -107 |
Chmp7 | -1429 |
Trp63 | -4081 |
GeneID | Gene Rank |
---|---|
Chmp4b | 7618 |
Chmp2a | 7038 |
Bax | 6756 |
Gsdmd | 6391 |
Cycs | 6115 |
Chmp6 | 6076 |
Irf1 | 6055 |
Chmp2b | 5458 |
Il18 | 5274 |
Chmp3 | 4730 |
Casp1 | 4025 |
Gsdme | 3899 |
Chmp4c | 3321 |
Trp53 | 3197 |
Hmgb1 | 3012 |
Bak1 | 3003 |
Casp3 | 1034 |
Irf2 | -107 |
Chmp7 | -1429 |
Trp63 | -4081 |
PURINE CATABOLISM
758 | |
---|---|
set | PURINE CATABOLISM |
setSize | 16 |
pANOVA | 0.000645 |
s.dist | 0.493 |
p.adjustANOVA | 0.00378 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Xdh | 8180 |
Nudt16 | 7945 |
Nt5c | 6653 |
Nudt9 | 6623 |
Itpa | 5971 |
Nudt1 | 5768 |
Nudt18 | 5653 |
Nt5e | 5333 |
Gda | 4547 |
Pnp2 | 3114 |
Nudt5 | 2613 |
Adprm | 2289 |
Nudt15 | 1583 |
Dnph1 | 1422 |
Nt5c2 | -2513 |
Nt5c1a | -3549 |
GeneID | Gene Rank |
---|---|
Xdh | 8180 |
Nudt16 | 7945 |
Nt5c | 6653 |
Nudt9 | 6623 |
Itpa | 5971 |
Nudt1 | 5768 |
Nudt18 | 5653 |
Nt5e | 5333 |
Gda | 4547 |
Pnp2 | 3114 |
Nudt5 | 2613 |
Adprm | 2289 |
Nudt15 | 1583 |
Dnph1 | 1422 |
Nt5c2 | -2513 |
Nt5c1a | -3549 |
METABOLISM OF AMINO ACIDS AND DERIVATIVES
544 | |
---|---|
set | METABOLISM OF AMINO ACIDS AND DERIVATIVES |
setSize | 317 |
pANOVA | 1.02e-50 |
s.dist | 0.489 |
p.adjustANOVA | 6.01e-48 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rida | 8127 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Psmb5 | 8036 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Psat1 | 7940 |
Pstk | 7909 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Auh | 7876 |
Rps17 | 7858 |
GeneID | Gene Rank |
---|---|
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rida | 8127 |
Rpl39 | 8121 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Rpl22 | 8043 |
Psmb5 | 8036 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Psat1 | 7940 |
Pstk | 7909 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Auh | 7876 |
Rps17 | 7858 |
Rpl37 | 7845 |
Psma3 | 7831 |
Psmb3 | 7826 |
Gcsh | 7822 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Psmb7 | 7813 |
Rps15 | 7805 |
Rps10 | 7793 |
Rpl13 | 7786 |
Rpl11 | 7781 |
Smox | 7730 |
Rpl31 | 7729 |
Rpl34 | 7726 |
Rps12 | 7721 |
Kyat1 | 7710 |
Rpl26 | 7699 |
Psmb2 | 7679 |
Rps8 | 7676 |
Rplp1 | 7662 |
Rpl23 | 7655 |
Rpl27 | 7644 |
Sem1 | 7641 |
Ndufab1 | 7639 |
Rpl7a | 7609 |
Rpl24 | 7605 |
Psmb6 | 7604 |
Rps23 | 7560 |
Psmd9 | 7553 |
Pdhb | 7550 |
Psma7 | 7531 |
Rps27a | 7519 |
Rpl36a | 7511 |
Psma4 | 7495 |
Rps18 | 7494 |
Rpl18 | 7478 |
Rps7 | 7471 |
Qdpr | 7465 |
Rps9 | 7456 |
Rps15a | 7440 |
Rpl18a | 7438 |
Rpl9 | 7416 |
Psmd13 | 7414 |
Slc25a21 | 7413 |
Psmb4 | 7374 |
Dao | 7368 |
Pxmp2 | 7340 |
Rpl21 | 7270 |
Rps19 | 7268 |
Hsd17b10 | 7267 |
Uba52 | 7262 |
Rpl29 | 7250 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Lias | 7223 |
Nmral1 | 7204 |
Psma6 | 7167 |
Rpl30 | 7145 |
Rpl8 | 7137 |
Th | 7131 |
Sds | 7129 |
Rps13 | 7086 |
Psmd7 | 7050 |
Rplp0 | 7009 |
Rpl10a | 6965 |
Ckb | 6960 |
Echs1 | 6936 |
Rpl22l1 | 6916 |
Rps16 | 6913 |
Rps2 | 6912 |
Rpl7 | 6885 |
Rps11 | 6883 |
Rps25 | 6881 |
Rpl14 | 6873 |
Psph | 6865 |
Psma2 | 6851 |
Aimp1 | 6838 |
Psme1 | 6829 |
Acat1 | 6813 |
Gpt2 | 6801 |
Rpl13a | 6776 |
Rpl4 | 6774 |
Rps3 | 6754 |
Gamt | 6749 |
Pycr2 | 6716 |
Rps27l | 6682 |
Rps6 | 6648 |
Rpl3 | 6642 |
Rps24 | 6631 |
Rps5 | 6627 |
Rpl23a | 6619 |
Gls2 | 6618 |
Psmb10 | 6606 |
Rpl17 | 6604 |
Slc25a13 | 6600 |
Psmd8 | 6594 |
Rpl27a | 6473 |
Psmb1 | 6446 |
Tstd1 | 6408 |
Oaz1 | 6405 |
Rps26 | 6384 |
Gstz1 | 6366 |
Oaz2 | 6349 |
Rps3a1 | 6345 |
Rpl28 | 6319 |
Rpl15 | 6281 |
Rpl5 | 6276 |
Psmc1 | 6270 |
Rps20 | 6232 |
Hnmt | 6205 |
Rpl12 | 6198 |
Acad8 | 6126 |
Azin2 | 6044 |
Rps4x | 5999 |
Aldh9a1 | 5991 |
Txn2 | 5985 |
Bckdha | 5924 |
Odc1 | 5920 |
Psmc2 | 5913 |
Cdo1 | 5907 |
Serinc3 | 5860 |
Apip | 5810 |
Glul | 5773 |
Hoga1 | 5743 |
Psmd14 | 5733 |
Rpsa | 5712 |
Srm | 5697 |
Psmc5 | 5693 |
Rars | 5661 |
Bckdhb | 5646 |
Psmc3 | 5625 |
Dio2 | 5621 |
Aimp2 | 5587 |
Rpl6 | 5583 |
Psmd4 | 5559 |
Bbox1 | 5536 |
Csad | 5495 |
Sars | 5488 |
Tdo2 | 5404 |
Psma1 | 5378 |
Mpst | 5306 |
Aspa | 5293 |
Psme2 | 5280 |
Psma5 | 5259 |
Gcat | 5212 |
Ass1 | 5162 |
Nqo1 | 5146 |
Sdsl | 5065 |
Ckmt1 | 5010 |
Slc25a10 | 5000 |
Kars | 4985 |
Gnmt | 4925 |
Lipt1 | 4840 |
Prodh | 4829 |
Suox | 4683 |
Grhpr | 4541 |
Pcbd1 | 4501 |
Phgdh | 4377 |
Hibadh | 4349 |
Ahcy | 4336 |
Pdhx | 4176 |
Lipt2 | 4090 |
Ddo | 4077 |
Naalad2 | 4022 |
Sephs2 | 4018 |
Psmd12 | 3996 |
Eef1e1 | 3982 |
Adi1 | 3960 |
Aass | 3939 |
Cbs | 3934 |
Hibch | 3864 |
Crym | 3831 |
Psmc6 | 3784 |
Mccc2 | 3756 |
Mtap | 3740 |
Sat1 | 3688 |
Psmd10 | 3670 |
Bckdk | 3406 |
Ido2 | 3282 |
Pycrl | 3237 |
Amt | 3232 |
Slc7a5 | 3227 |
Lars | 3073 |
Gadl1 | 3050 |
Psmf1 | 3034 |
Dbh | 3001 |
Slc6a8 | 2961 |
Paox | 2877 |
Pdha1 | 2836 |
Mri1 | 2776 |
Asrgl1 | 2715 |
Tst | 2649 |
Carns1 | 2610 |
Enoph1 | 2597 |
Bcat2 | 2581 |
Bcat1 | 2566 |
Dld | 2564 |
Oat | 2506 |
Asl | 2477 |
Serinc2 | 2432 |
Rimkla | 2379 |
Psmd6 | 2341 |
Aspg | 2229 |
Rpl10 | 2228 |
Got1 | 2224 |
Dct | 2182 |
Shmt1 | 2044 |
Dlst | 1937 |
Psmb8 | 1878 |
Azin1 | 1858 |
Slc3a2 | 1823 |
Gpt | 1772 |
Sepsecs | 1756 |
Agmat | 1740 |
Psmd1 | 1686 |
Aanat | 1666 |
Ethe1 | 1609 |
Fah | 1593 |
Sqor | 1224 |
Scly | 1184 |
Gatm | 1030 |
Dars | 1026 |
Arg2 | 871 |
Eprs | 817 |
Slc44a1 | 768 |
Gcdh | 645 |
Oaz3 | 635 |
Glud1 | 606 |
Dlat | 495 |
Got2 | 418 |
Sms | 237 |
Mars1 | 200 |
Phykpl | -15 |
Ado | -18 |
Tpo | -42 |
Psmd2 | -281 |
Hdc | -376 |
Srr | -823 |
Pycr1 | -938 |
Slc25a44 | -952 |
Aldh7a1 | -971 |
Tshb | -1085 |
Aldh4a1 | -1141 |
Gldc | -1160 |
Qars | -1167 |
Slc25a15 | -1221 |
Slc5a5 | -1440 |
Gsr | -1485 |
Psmb9 | -1520 |
Afmid | -1534 |
Kyat3 | -1583 |
Ddc | -1595 |
Nat8l | -1740 |
Asns | -1790 |
Acadsb | -1855 |
Secisbp2 | -1908 |
Ivd | -1958 |
Eefsec | -2058 |
Tph2 | -2061 |
Aldh6a1 | -2099 |
Dmgdh | -2594 |
Ido1 | -2709 |
Mtrr | -2961 |
Slc6a7 | -3040 |
Papss1 | -3074 |
Mtr | -3147 |
Amd1 | -3314 |
Dhtkd1 | -3492 |
Dbt | -3990 |
Psme3 | -4000 |
Psmd11 | -4032 |
Hal | -4242 |
Aldh18a1 | -4362 |
Pipox | -4506 |
Cth | -4528 |
Hykk | -4543 |
Psmd5 | -4580 |
Serinc5 | -4592 |
Txnrd1 | -4597 |
Psme4 | -4962 |
Chdh | -4998 |
Papss2 | -5124 |
Gls | -5266 |
Ogdh | -5395 |
Slc36a4 | -5729 |
Mccc1 | -5990 |
Slc25a12 | -6200 |
Serinc1 | -6333 |
Folh1 | -6648 |
Rimklb | -6746 |
Ppm1k | -6985 |
Iars | -7028 |
Carnmt1 | -7102 |
Sardh | -7561 |
Bhmt2 | -7706 |
Slc6a11 | -8225 |
ANTIMICROBIAL PEPTIDES
60 | |
---|---|
set | ANTIMICROBIAL PEPTIDES |
setSize | 16 |
pANOVA | 0.000715 |
s.dist | 0.489 |
p.adjustANOVA | 0.0041 |
Top enriched genes
GeneID | Gene Rank |
---|---|
S100a8 | 8212 |
Pglyrp1 | 8142 |
S100a9 | 7802 |
Atox1 | 7598 |
Lyz2 | 7585 |
Defb42 | 7364 |
Pdzd11 | 5456 |
Prtn3 | 5317 |
Slc11a1 | 4408 |
Rnase6 | 3952 |
Defb1 | 3737 |
Chga | 2822 |
Lcn2 | -167 |
Tlr2 | -920 |
Clu | -2549 |
Atp7a | -7694 |
GeneID | Gene Rank |
---|---|
S100a8 | 8212 |
Pglyrp1 | 8142 |
S100a9 | 7802 |
Atox1 | 7598 |
Lyz2 | 7585 |
Defb42 | 7364 |
Pdzd11 | 5456 |
Prtn3 | 5317 |
Slc11a1 | 4408 |
Rnase6 | 3952 |
Defb1 | 3737 |
Chga | 2822 |
Lcn2 | -167 |
Tlr2 | -920 |
Clu | -2549 |
Atp7a | -7694 |
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX
78 | |
---|---|
set | ASSEMBLY OF THE PRE REPLICATIVE COMPLEX |
setSize | 65 |
pANOVA | 1.36e-11 |
s.dist | 0.485 |
p.adjustANOVA | 5.36e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Gmnn | 7669 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Uba52 | 7262 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
Psmd7 | 7050 |
GeneID | Gene Rank |
---|---|
Psmb5 | 8036 |
Psma3 | 7831 |
Psmb3 | 7826 |
Psmb7 | 7813 |
Psmb2 | 7679 |
Gmnn | 7669 |
Sem1 | 7641 |
Psmb6 | 7604 |
Psmd9 | 7553 |
Psma7 | 7531 |
Rps27a | 7519 |
Psma4 | 7495 |
Psmd13 | 7414 |
Psmb4 | 7374 |
Uba52 | 7262 |
Psmd3 | 7229 |
Psmc4 | 7224 |
Ubb | 7197 |
Psma6 | 7167 |
Psmd7 | 7050 |
Psma2 | 6851 |
Psme1 | 6829 |
Psmb10 | 6606 |
Psmd8 | 6594 |
Psmb1 | 6446 |
Mcm3 | 6296 |
Psmc1 | 6270 |
Orc5 | 6206 |
Psmc2 | 5913 |
Orc6 | 5748 |
Psmd14 | 5733 |
Psmc5 | 5693 |
Psmc3 | 5625 |
Psmd4 | 5559 |
E2f2 | 5549 |
Psma1 | 5378 |
Psme2 | 5280 |
Psma5 | 5259 |
Mcm5 | 4598 |
Psmd12 | 3996 |
E2f1 | 3915 |
Psmc6 | 3784 |
Mcm7 | 3753 |
Psmd10 | 3670 |
Psmf1 | 3034 |
Orc2 | 2772 |
Psmd6 | 2341 |
Psmb8 | 1878 |
Psmd1 | 1686 |
Mcm4 | 835 |
Mcm6 | 558 |
Mcm2 | 220 |
Cdt1 | -136 |
Psmd2 | -281 |
E2f3 | -814 |
Psmb9 | -1520 |
Ubc | -2250 |
Psme3 | -4000 |
Psmd11 | -4032 |
Psmd5 | -4580 |
Orc4 | -4772 |
Psme4 | -4962 |
Orc1 | -7340 |
Mcm8 | -7436 |
Orc3 | -7666 |
SIGNALING BY FGFR2 IIIA TM
955 | |
---|---|
set | SIGNALING BY FGFR2 IIIA TM |
setSize | 19 |
pANOVA | 0.000266 |
s.dist | 0.483 |
p.adjustANOVA | 0.00176 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Polr2l | 8217 |
Polr2i | 8118 |
Polr2j | 8067 |
Polr2f | 7953 |
Polr2h | 7653 |
Polr2g | 7391 |
Polr2k | 7373 |
Polr2e | 7011 |
Gtf2f2 | 6459 |
Ncbp2 | 5725 |
Polr2c | 5408 |
Polr2d | 4021 |
Gtf2f1 | 3363 |
Fgf1 | 2680 |
Ncbp1 | 1338 |
Polr2b | -2618 |
Fgf2 | -4238 |
Fgfr2 | -5660 |
Polr2a | -6656 |
GeneID | Gene Rank |
---|---|
Polr2l | 8217 |
Polr2i | 8118 |
Polr2j | 8067 |
Polr2f | 7953 |
Polr2h | 7653 |
Polr2g | 7391 |
Polr2k | 7373 |
Polr2e | 7011 |
Gtf2f2 | 6459 |
Ncbp2 | 5725 |
Polr2c | 5408 |
Polr2d | 4021 |
Gtf2f1 | 3363 |
Fgf1 | 2680 |
Ncbp1 | 1338 |
Polr2b | -2618 |
Fgf2 | -4238 |
Fgfr2 | -5660 |
Polr2a | -6656 |
INFLUENZA INFECTION
446 | |
---|---|
set | INFLUENZA INFECTION |
setSize | 145 |
pANOVA | 1e-23 |
s.dist | 0.483 |
p.adjustANOVA | 6.95e-22 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Polr2l | 8217 |
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Polr2i | 8118 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Polr2j | 8067 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Polr2f | 7953 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Nup54 | 7871 |
Rps17 | 7858 |
GeneID | Gene Rank |
---|---|
Polr2l | 8217 |
Rps21 | 8174 |
Rps29 | 8168 |
Rpl35a | 8136 |
Rps27 | 8135 |
Rpl39 | 8121 |
Polr2i | 8118 |
Rpl38 | 8113 |
Rps28 | 8081 |
Rpl36 | 8077 |
Polr2j | 8067 |
Rpl22 | 8043 |
Rpl37a | 8035 |
Rpl32 | 8005 |
Polr2f | 7953 |
Fau | 7889 |
Rpl35 | 7880 |
Rplp2 | 7877 |
Nup54 | 7871 |
Rps17 | 7858 |
Rpl37 | 7845 |
Rps14 | 7821 |
Rpl36al | 7817 |
Rpl19 | 7814 |
Rps15 | 7805 |
Rps10 | 7793 |
Rpl13 | 7786 |
Rpl11 | 7781 |
Rpl31 | 7729 |
Rpl34 | 7726 |
Rps12 | 7721 |
Rpl26 | 7699 |
Rps8 | 7676 |
Rplp1 | 7662 |
Rpl23 | 7655 |
Polr2h | 7653 |
Rpl27 | 7644 |
Rpl7a | 7609 |
Rpl24 | 7605 |
Rps23 | 7560 |
Rps27a | 7519 |
Rpl36a | 7511 |
Rps18 | 7494 |
Rpl18 | 7478 |
Rps7 | 7471 |
Rps9 | 7456 |
Rps15a | 7440 |
Rpl18a | 7438 |
Rpl9 | 7416 |
Polr2g | 7391 |
Polr2k | 7373 |
Rpl21 | 7270 |
Rps19 | 7268 |
Uba52 | 7262 |
Rpl29 | 7250 |
Rpl30 | 7145 |
Rpl8 | 7137 |
Rps13 | 7086 |
Polr2e | 7011 |
Rplp0 | 7009 |
Rpl10a | 6965 |
Rpl22l1 | 6916 |
Rps16 | 6913 |
Rps2 | 6912 |
Rpl7 | 6885 |
Rps11 | 6883 |
Rps25 | 6881 |
Rpl14 | 6873 |
Rae1 | 6790 |
Rpl13a | 6776 |
Rpl4 | 6774 |
Rps3 | 6754 |
Rps27l | 6682 |
Rps6 | 6648 |
Rpl3 | 6642 |
Rps24 | 6631 |
Rps5 | 6627 |
Rpl23a | 6619 |
Rpl17 | 6604 |
Grsf1 | 6562 |
Rpl27a | 6473 |
Gtf2f2 | 6459 |
Rps26 | 6384 |
Rps3a1 | 6345 |
Rpl28 | 6319 |
Rpl15 | 6281 |
Rpl5 | 6276 |
Rps20 | 6232 |
Rpl12 | 6198 |
Clta | 6101 |
Sec13 | 6081 |
Rps4x | 5999 |
Rpsa | 5712 |
Aaas | 5610 |
Rpl6 | 5583 |
Ran | 5472 |
Polr2c | 5408 |
Nup85 | 4733 |
Nup107 | 4316 |
Polr2d | 4021 |
Kpna2 | 3804 |
Gtf2f1 | 3363 |
Nup35 | 2840 |
Rpl10 | 2228 |
Pabpn1 | 1944 |
Nup62 | 1465 |
Nup43 | 1374 |
Nup88 | 849 |
Cpsf4 | 539 |
Tgfb1 | -509 |
Parp1 | -702 |
Seh1l | -1259 |
Nupl2 | -1391 |
Ipo5 | -1682 |
Ndc1 | -2259 |
Polr2b | -2618 |
Nup153 | -2717 |
Nup188 | -2906 |
Nup93 | -3493 |
Nup160 | -3619 |
Nup37 | -3635 |
Kpna4 | -4272 |
Nup214 | -4457 |
Kpna1 | -5173 |
Hsp90aa1 | -5295 |
Eif2ak2 | -5648 |
Nup98 | -6071 |
Calr | -6155 |
Cltc | -6383 |
Nup133 | -6528 |
Polr2a | -6656 |
Tpr | -6677 |
Ranbp2 | -6762 |
Isg15 | -6852 |
Kpnb1 | -6899 |
Nup50 | -6975 |
Canx | -7313 |
Pom121 | -7600 |
Dnajc3 | -7613 |
Nup210 | -7859 |
Kpna3 | -7906 |
Xpo1 | -8362 |
Nup205 | -8390 |
Hspa1a | -8452 |
Nup155 | -8677 |
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS
27 | |
---|---|
set | ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS |
setSize | 10 |
pANOVA | 0.00845 |
s.dist | -0.481 |
p.adjustANOVA | 0.032 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fos | -8514 |
Jun | -7633 |
Atf2 | -7475 |
Mapk1 | -7185 |
Mapk10 | -7114 |
Mapk9 | -6076 |
Mapk8 | -3829 |
Mapk14 | -3757 |
Mapk11 | 1027 |
Mapk3 | 4669 |
GeneID | Gene Rank |
---|---|
Fos | -8514 |
Jun | -7633 |
Atf2 | -7475 |
Mapk1 | -7185 |
Mapk10 | -7114 |
Mapk9 | -6076 |
Mapk8 | -3829 |
Mapk14 | -3757 |
Mapk11 | 1027 |
Mapk3 | 4669 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.2.1 (2022-06-23)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.1 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] pkgload_1.3.0 GGally_2.1.2
## [3] gtools_3.9.3 echarts4r_0.4.4
## [5] beeswarm_0.4.0 vioplot_0.3.7
## [7] sm_2.2-5.7.1 kableExtra_1.3.4
## [9] topconfects_1.12.0 limma_3.52.4
## [11] eulerr_6.1.1 mitch_1.8.0
## [13] MASS_7.3-58.1 fgsea_1.22.0
## [15] gplots_3.1.3 DESeq2_1.36.0
## [17] SummarizedExperiment_1.26.1 Biobase_2.56.0
## [19] MatrixGenerics_1.8.1 matrixStats_0.62.0
## [21] GenomicRanges_1.48.0 GenomeInfoDb_1.32.4
## [23] IRanges_2.30.1 S4Vectors_0.34.0
## [25] BiocGenerics_0.42.0 reshape2_1.4.4
## [27] forcats_0.5.2 stringr_1.4.1
## [29] dplyr_1.0.10 purrr_0.3.5
## [31] readr_2.1.3 tidyr_1.2.1
## [33] tibble_3.1.8 ggplot2_3.3.6
## [35] tidyverse_1.3.2 zoo_1.8-11
##
## loaded via a namespace (and not attached):
## [1] googledrive_2.0.0 colorspace_2.0-3 ellipsis_0.3.2
## [4] XVector_0.36.0 fs_1.5.2 rstudioapi_0.14
## [7] bit64_4.0.5 AnnotationDbi_1.58.0 fansi_1.0.3
## [10] lubridate_1.8.0 xml2_1.3.3 codetools_0.2-18
## [13] splines_4.2.1 cachem_1.0.6 knitr_1.40
## [16] geneplotter_1.74.0 jsonlite_1.8.2 broom_1.0.1
## [19] annotate_1.74.0 dbplyr_2.2.1 png_0.1-7
## [22] shiny_1.7.2 compiler_4.2.1 httr_1.4.4
## [25] backports_1.4.1 assertthat_0.2.1 Matrix_1.5-1
## [28] fastmap_1.1.0 gargle_1.2.1 cli_3.4.1
## [31] later_1.3.0 htmltools_0.5.3 tools_4.2.1
## [34] gtable_0.3.1 glue_1.6.2 GenomeInfoDbData_1.2.8
## [37] fastmatch_1.1-3 Rcpp_1.0.9 jquerylib_0.1.4
## [40] cellranger_1.1.0 vctrs_0.4.2 Biostrings_2.64.1
## [43] svglite_2.1.0 xfun_0.33 rvest_1.0.3
## [46] mime_0.12 lifecycle_1.0.3 XML_3.99-0.11
## [49] googlesheets4_1.0.1 zlibbioc_1.42.0 scales_1.2.1
## [52] hms_1.1.2 promises_1.2.0.1 parallel_4.2.1
## [55] RColorBrewer_1.1-3 yaml_2.3.5 memoise_2.0.1
## [58] gridExtra_2.3 sass_0.4.2 reshape_0.8.9
## [61] stringi_1.7.8 RSQLite_2.2.18 highr_0.9
## [64] genefilter_1.78.0 caTools_1.18.2 BiocParallel_1.30.3
## [67] systemfonts_1.0.4 rlang_1.0.6 pkgconfig_2.0.3
## [70] bitops_1.0-7 evaluate_0.17 lattice_0.20-45
## [73] htmlwidgets_1.5.4 bit_4.0.4 tidyselect_1.2.0
## [76] plyr_1.8.7 magrittr_2.0.3 R6_2.5.1
## [79] generics_0.1.3 DelayedArray_0.22.0 DBI_1.1.3
## [82] pillar_1.8.1 haven_2.5.1 withr_2.5.0
## [85] survival_3.4-0 KEGGREST_1.36.3 RCurl_1.98-1.9
## [88] modelr_0.1.9 crayon_1.5.2 KernSmooth_2.23-20
## [91] utf8_1.2.2 rmarkdown_2.17 tzdb_0.3.0
## [94] locfit_1.5-9.6 grid_4.2.1 readxl_1.4.1
## [97] data.table_1.14.2 blob_1.2.3 webshot_0.5.4
## [100] reprex_2.0.2 digest_0.6.29 xtable_1.8-4
## [103] httpuv_1.6.6 munsell_0.5.0 viridisLite_0.4.1
## [106] bslib_0.4.0
END of report